Agrégation des protéines thérapeutiques à l'interface triple solide/liquide/air : application aux procédés industriels de  production, stockage et d'administration by Frachon, Thibaut
HAL Id: tel-01763419
https://tel.archives-ouvertes.fr/tel-01763419
Submitted on 11 Apr 2018
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Therapeutic protein aggregation at the triple interface
air-liquid-solid : relevance to medical devices for drug
delivery
Thibaut Frachon
To cite this version:
Thibaut Frachon. Therapeutic protein aggregation at the triple interface air-liquid-solid : relevance
to medical devices for drug delivery. Biological Physics [physics.bio-ph]. Université Grenoble Alpes,
2017. English. ￿NNT : 2017GREAY070￿. ￿tel-01763419￿
 
 
THÈSE 
Pour obtenir le grade de 
DOCTEUR DE LA COMMUNAUTE UNIVERSITE 
GRENOBLE ALPES 
Spécialité : Physique pour les sciences du vivant  
Arrêté ministériel : 25 mai 2016 
 
Présentée par 
Thibaut FRACHON 
 
Thèse dirigée par Franz BRUCKERT   
codirigée par Marianne WEIDENHAUPT et Remy VOMSCHEID 
 
préparée au sein du Laboratoire des Matériaux et du Génie 
Physique (LMGP)  
dans l'École Doctorale de Physique de Grenoble 
 
 
Agrégation des protéines thérapeutiques à 
l'interface triple solide/liquide/air: 
application aux procédés industriels de 
production, stockage et d’administration. 
 
 
 
Thèse soutenue publiquement le 18 octobre 2017 , 
devant le jury composé de :  
 
Mr. Alain ASTIER 
Hôpitaux Universitaires Henry Mondor, Rapporteur 
Mr. Didier BAZILE 
Sanofi France, Rapporteur 
Mme. Elisabeth CHARLAIX 
Laboratoire Interdisciplinaire de Physique (LIPHY), Examinatrice 
Mme Karine ANSELME 
Institut de Science des Matériaux de Mulhouse (IS2M), Examinatrice, 
Présidente du jury 
Mr. Sylvain HUILLE 
Sanofi France, Examinateur 
Mr. Jean BRETON 
Institut Nanoscience et Cryogénie (INAC), Examinateur 
 
  
 
 
 
 
 
Therapeutic protein aggregation at the triple 
interface air/liquid/solid: relevance to drug 
production, storage and delivery processes 
 
  
 
 
  
i 
Remerciements 
Je souhaiterais tout d’abord remercier Pr. Alain Astier et Dr. Didier Bazile de m’avoir fait l’honneur de rapporter 
mon manuscrit de thèse et Dr. Karine Anselme, Pr. Elisabeth Charlaix, Dr. Jean Breton et Dr. Sylvain Huille d’avoir 
eu la gentillesse d’accepter de faire partie de monjury de thèse. 
Je remercie l’Agence Nationale de la Recherche et d la Technologie (ANRT) de m’avoir accordé une bourse CIFRE 
(2013/0600). 
J’aimerais remercier Olivier Theodoly et Marie-Paule Valignat qui m’ont gracieusement et chaleureusement accueilli 
au sein de leur laboratoire (Laboratoire Adhésion et Inflammation) à Marseille ainsi que Vincent Forge qui m’a 
gentiment fourni des peptides Aβ. 
J’aimerais ensuite remercier Remy, Emmanuel, Hakim et Quentin, mes directeurs de thèse chez Eveon, qui ont, 
chacun, apporté une contribution significative à ce travail, ainsi que Vincent Tempelaere, président d’Eveon, et tous 
les collaborateurs, passés et présents, pour leur acc eil chaleureux, leur disponibilité et leur volonté de partager avec 
moi leurs travaux et leur vision de l’entreprise.  
Je remercie aussi l’ensemble du personnel du LMGP, permanent, non-permanent, administratif et support technique 
qui m’ont épaulé, encouragé et aidé tout au long de ma thèse. Travailler au LMGP a été un réel plaisir et j’en 
garderai un excellent souvenir. Merci à Michèle, Virginie et Josiane pour m’avoir facilité la vie côté administratif. 
Merci à Micha et Laurent pour leur aide en électronique et dans la mise en place des setups. Merci à Daniel, Mélanie 
et Thomas pour m’avoir fourni les transparent heaters. Merci à la Team Insuline : Karim, Charlotte, Myriam, 
Morgane, Guillaume et à tous ceux que j’ai oublié. 
Je souhaiterais particulièrement remercier Marianne et Franz, mes directeurs de thèse côté LMGP, pour leur 
investissement total et leur soutien durant toute ma thèse, aussi bien sur le plan scientifique que humain. Je vous 
remercie tout d’abord de m’avoir fait confiance et confié ce sujet de thèse. J’ai pris beaucoup de plaisir à travailler 
dessus et je suis maintenant convaincu d’avoir trouvé un domaine où je pourrais m’épanouir professionnellement. 
J’aimerais aussi vous remercier énormément de ne jamais avoir mis de frein à ma pratique sportive intensive, malgré 
vos inquiétudes quand je revenais un peu abimé. Le hockey sur glace fait partie de mon équilibre et arrête  aurait été 
un déchirement donc, pour cela, je vous suis extrêmement reconnaissant. J’aimerais aussi insister sur le fait que votre 
porte m’a toujours été ouverte pour discuter de scince aussi bien que d’autres sujets plus personnels, et ce, malgré 
vos emplois du temps ultra chargés et vos multiples casquettes de chercheur, enseignant, responsable de filière, 
directeur… Enfin, je ne pourrais pas énumérer tout ce que vous avez pu m’apprendre durant ces trois années (et un 
peu plus) de thèse : scientifiquement dans de nombreux domaines et expérimentalement puisque vous m’avez laissé 
carte blanche pour bidouiller les microscopes du LMGP et essayer toutes sortes de setups farfelus. Vous m’avez 
également fait beaucoup progresser en termes de prés ntation, de rigueur, de rédaction... 
ii 
Et bien sûr, à tous mes amis et mes proches qui ont toujours été là, dans les bons comme dans les mauvais moments, 
MERCI : 
A tous les doctorants, ex-doctorants et stagiaires du LMPG, nous sommes une grande famille et vous allez beaucoup 
me manquer. Force et Honneur ! Mention spéciale à Karim, mon co-thésard, sans qui je n’y serais pas arriver. A nos 
débriefs de réunion, nos théories sur les néons et les caméras cachées. A Vincent, mon compère de soirée, aussi bien 
au labo pendant les nuits de rédaction que en dehors et à sa petite Annette (annette, hanneton, caneton, canard…vous 
voyez ou je veux en venir). 
A mon équipe de hockey. 
Aux campinois, rien à changer depuis que je suis parti il y a 10 ans, et c’est parfait comme cela ! C’est toujours une 
immense bouffée d’oxygène quand je reviens vous voir.
Aux grenoblois, Antho, Helene pour les apéros et les diners du dimanche soir et Caro, pour le GRAND Caro (et pas 
de mélo) 
A mes tantes et oncles, merci de toujours répondre présent lorsque j’ai besoin de vous. 
A mamie et grand-mère, deux personnes extraordinaires, courageuses, fortes, avec une grande ouverture d’esprit, qui 
ont tant donné à tous leurs petits-enfants. A papi et grand-père. 
A mon petit frère, qui va commencer une nouvelle étape de sa vie en septembre, tu as toutes les qualités requises 
pour réaliser tes rêves, peu importe le chemin que tu prends, si tu y mets le temps et l’énergie, les portes s’ouvriront. 
J’ai confiance en toi et je serai toujours derrière toi pour te soutenir quelle que soit la route que tu choisis (même si, 
sur lol, c’est plutôt toi le support !). Merci d’être là. 
A mes parents, qui, d’après eux, « n’ont pas besoin de remerciements », vous m’avez toujours donné les meilleures 
conditions possibles afin que je puisse réussir tout ce que j’ai voulu entreprendre. Mais le plus important, vous 
m’avez donné énormément d’amour, un soutien indéfectibl  et un petit frère. Je n’aurais pas pu rêver mieux. 
  
iii 
Abstract 
 
Due to the high specificity of their interactions, proteins are increasingly used in therapy. 
Nevertheless, these molecules are fragile and therapeutic protein stability is a major concern in 
pharmaceutical industry. Protein degradation and aggregation can occur at every step during 
production, storage, transport and delivery. In addition to chemical modification, exposure to 
shear stress and interactions with material surfaces or/and air interfaces are known to affect 
protein stability. The growing use of automated medical devices for the handling and injection of 
therapeutics increases the exposure to shear stressand material interactions. 
In this thesis, we interrogate the possible role of intermittent wetting in protein aggregation which 
frequently occurs in protocols involving pumping (cavitation), agitation, liquid handling. During 
intermittent wetting, the air/liquid and liquid/solid interfaces meet at a triple contact line or triple 
interface, which is a local trigger for protein aggre ation because it concentrates the mechanical 
action of the recessing fluid on the adsorbed proteins. 
To demonstrate and monitor the effect of the triple nt rface on protein aggregation, we designed 
two sets of experiments that allow us to decorrelate the effects of shear stress from those induced 
by a moving triple interface. In our setups, we observe the formation of protein aggregates in real 
time and in situ. Insulin was used as a model therapeutic protein, well-known to form amyloid 
aggregates at hydrophobic surfaces. Thioflavin T, afluorescent beta sheet conformation marker, 
was used to visualize the formation of amyloid fibers during insulin aggregation. 
We first investigated the effect of a moving air/liqu d interface on a hydrophobic bead surface 
with respect to insulin aggregation kinetics at low flow rates. Under these conditions, the 
recorded fluorescence signal follows a complex kinetics with three distinct phases: a lag phase 
where the fluorescence remains very low, a growth phase where the fluorescence increases 
strongly with time and where many amyloid fibers are forming on the bead surface and a plateau 
phase where the fluorescence stabilizes, indicating that no more fibers are created. At a place 
away from the air/liquid interface, where adsorbed proteins are submitted to shear stress alone, no 
aggregation is observed, meaning that shear stress i s lf has a negligible effect on the stability of 
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adsorbed proteins. Using a hydrophilic surface, no aggregation was induced by a moving 
air/liquid interface. These results demonstrate that it is the movement of the triple interface on 
adsorbed proteins that triggers their amyloid aggreation. 
Then we used THT fluorescence microscopy to study the formation of insulin amyloid fibers in a 
microfluidic channel, where a protein solution moves repetitively back and forth over a 
hydrophobic surface. In parallel, reflection interference contrast microscopy was used to record 
the morphology of the liquid film remaining on the surface after dewetting. During dewetting, we 
observe that liquid droplets remain on the surface. After about 30 minutes of intermittent wetting, 
these droplets become anchored to the microchannel surface, presumably by an adsorbed protein 
layer and they reform at the same place at each cycle. This phenomenon reproduces during the 
entire lag phase, while the droplet growth kinetics indicates that protein material accumulates at 
the microchannel surface. During the growth phase, myloid aggregates start to appear and grow 
concentrically outwards and around the droplets, forming an expanding THT fluorescent ring. No 
fiber grows within the droplets or on the surface devoid of droplets. The fluorescent rings expand 
until the entire channel surface swept by the triple nterface is totally covered by amyloid fibers. 
These results demonstrate that the triple interface lin , where a droplet edge meets the 
hydrophobic microchannel surface, allows progressive protein accumulation, and finally triggers 
local insulin aggregation. Additives such as polysorbates were also tested, showing that the 
modification of the surface tension of a protein soluti n impacts its ability to form aggregates. 
Based on this work, we propose recommendations for the design of drug delivery and preparation 
devices in order to limit the risk of protein aggreation at the triple interface. 
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CHAPTER 1: INTRODUCTION 
2 
1.1 Therapeutic proteins in the pharmaceutical industry 
1.1.1 Emergence and growing use of therapeutic proteins 
The use of recombinant proteins as therapeutic drugs began in the early 1980’s (first F.D.A 
accepted recombinant protein: insulin in 1982 and first monoclonal antibody: anti-CD3 in 1986). 
The so called “recombinant proteins” are proteins that are produced by the expression of 
recombinant DNA in microorganisms such as yeast, bacteri  or in mammalian or insect cells 
(Leader et al. 2008). They have been favored over small chemical molecules because of their 
high specificity and target affinity and because thy are less likely to provoke an unwanted 
immune response. There is also a high financial interest: because proteins are quite unique, so are 
their functions, it is possible to make “blockbuster” drugs which are protected by patents and thus 
uncontested in the pharmaceutical market because they cannot be copied. At first, recombinant 
proteins were used to replace their natural homologue in case of functional deficit. Soon after, 
thanks to advances in protein engineering, proteins were modified and designed in order to 
improve their clinical efficiency. A summary of the different engineered protein types is given in 
Figure 1. For example, the use of rapid or long-acting insulin analogs, which have been created 
by amino acid replacement, allows a better control of the blood glucose level just after (rapid-
acting, insulin lispro, aspart or glulisine) and betw en meals (long-acting, insulin glargine or 
detemir) (Vigneri et al. 2010). An other example is the protein conjugation with chemical 
compounds such as polyethylene glycol (PEG). PEGylated proteins have an increased 
hydrodynamic radius which lowers the renal clearance and provides a longer life-time in the 
blood (Carter 2011). One last type worth mentioning are antibody-related drugs: full length 
monoclonal antibodies, monoclonal antibody fragments, Fc-fusion proteins (which are fusions 
between an antibody (usually IgG) crystallisable fragment (Fc) and a protein domain), and 
antibody-drug conjugates. 
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Figure 1: The different therapeutic proteins available on the pharmaceutical market in 2011, namely the recombinant 
proteins with their analogs and the antibody-related proteins, along with their possible conjugation or modification.  
Figure taken from (Carter 2011). 
Since the 80’s, the therapeutic protein market has skyrocketed to reach a total sales of US$ 163 
billion in 2012 which represents 71% of the ten top-selling drugs (Mitragotri et al. 2014). In 
2013, it has been recorded that 210 therapeutic proteins are available in the pharmaceutical 
market along with over 900 products that are in development and that nearly 19 tons of proteins 
have been produced (see Figure 2) (Ecker et al. 2015). The antibody-related drugs are the market 
dominant class in terms of sales as well as of production. In 2014, 47 antibody-related drugs were 
commercialized and market sales predictions reach around US$ 125 billion for 2020 (Ecker et al. 
2015). Note also that the recombinant insulin protein accounts for 50 % in sales and more than 90 
% in production of the microbial fermentation produced proteins. Additionally, with the end of 
the already existing patents, a new therapeutic protein class, namely biosimilars that are copies of 
the existing blockbuster proteins, emerges and will participate to the market sales growth (the 
first biosimilar monoclonal antibody was accepted by the FDA in 2013). 
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Figure 2: Therapeutic protein market sales evolution between 2008 and 2013 in US$ billion.  
Differences have been made between the protein types, recombinant proteins or monoclonal antibodies related drugs, and 
between the production methods, mammalian, plant or microbial cell culture.  
Figure taken from (Ecker et al. 2015). 
 
1.1.2 Fabrication processes of a therapeutic protein 
The ever increasing therapeutic protein demand has to be answered with an industrial production 
that is able to deliver thousands of kilograms of protein per year while ensuring the quality 
required for pharmaceutical products. The majority of the recombinant proteins (about 70 %, a 
major contribution comes from the monoclonal antibod es, insulin is the principal exception) are 
expressed in mammalian cells (usually in immortalized Chinese hamster ovary) cultivated in 
bioreactors (Kim et al. 2012). The production in mammalian cells allows a better control of 
protein folding and modification than in other cells. A general mammalian cell protein production 
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pattern is described in Figure 3. The first step is the insertion of two genes in the cells, one coding 
for the protein of choice and an other that is a “selector” (for example, a gene coding for a 
specific enzyme that is essential for cell survival in particular or “selective” conditions). The 
protein gene is usually composed of a promoter that will enhance the gene expression and the 
complementary DNA (cDNA) sequence coding for the protein. The most used transfection 
techniques are calcium phosphate transfection, lipofecti n, electroporation and polymer-mediated 
gene transfer (Norton and Pachuk 2003). After applying the selective condition, the only 
surviving cells are the ones that have expressed both genes. Each single cell is then cultivated 
alone and the resulting clones are selected again and again in order to finally obtain an optimized 
cell line for the protein production. The cell line s lection takes between 6 and 12 months. The 
recorded cell protein production reached 4.7 g/L in 2004 (Wurm 2004) and over 10 g/L in 2012 
(Kim et al. 2012). 
 
Figure 3: Summary of the principal steps to develop a mammalian cell culture for industrial therapeutic protein 
production.  
Figure taken from (Lai et al. 2013). 
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1.1.3 The challenging aspect of therapeutic protein formulation and delivery 
The emergence of therapeutic proteins on the pharmaceutical market has considerably increased 
the difficulty in the formulation, storage and deliv ry of these drugs. Indeed, these proteins, due 
to their marginally stable structure, are often subject to degradations triggered by a large number 
of phenomena such as environmental factors (pH, temperature, ionic strength…), chemical 
modification (deamidation, hydrolysis, oxidation…), shear stress, high concentration, viscosity, 
protein-material interactions and air/liquid interfaces that are present in industrial processes 
(Rathore and Rajan 2008). Figure 4 shows some common industrial processes and the associated 
phenomena that could potentially threaten protein stability. These degradations may affect the 
protein’s biological activity and in the most extrem  cases, the formation of protein aggregates 
could be injected into the patient and lead to side eff cts that are unacceptable for therapeutic 
applications. 
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Figure 4: List of the common industrial processes used in therapeutic protein formulation, storage and delivery and 
potentially associated protein degrading phenomena.  
Figure taken from (Rathore and Rajan 2008). 
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The addition of specific compounds called excipients i  formulations has been found to increase 
protein stability. For example, sugars (trehalose, sucrose, mannitol…) favor the protein hydration 
(by a preferential exclusion mechanism) so that proeins are protected by a water molecule shell. 
They also avoid protein drying in freeze-dried formulations by replacing the water molecules that 
interact with the proteins. Polysorbates are usually used at a concentration from 0.0003 % (w/v) 
to 0.3 % (w/v) (Kerwin 2008) to prevent the protein adsorption at hydrophobic interfaces 
(solid/liquid or air/liquid). Basic amino acids (histidine, glycine and arginine) or salts can be 
added to increase the formulation ionic strength and reduce the electrostatic interactions. 
Preservatives such as m-cresol lower the risks of bacterial contamination. Polymers, like dextran 
and PEG (also acts as a surfactant), are known to icrease the native conformation stability of 
globular proteins. Although they are quite efficient formulation stabilizers, the excipients can also 
increase the formulation toxicity and the risk of side effects (Challener 2015). A better 
understanding of the protein molecular structure, its interactions and the aggregation processes is 
thus needed to optimize the therapeutic protein formulation. 
The delivery of therapeutic proteins is an other challenge. Injection is the principal administration 
mode because proteins, due their high molecular weight, have a poor diffusivity through natural 
barriers such as skin, mucous or cell membranes. However, this delivery method has several 
drawbacks. First, injections can be painful for the patient, especially for frequent injection 
treatments which are often the case with therapeutic proteins. In the worst scenario, it can 
provoke a needle phobia. Additionally, some protein degradations have been observed at the site 
of frequent injections. Indeed, insulin fibril plaques have been found at the site of repeated 
injections (Dische et al. 1988). Second, the handling of highly concentrated therapeutic 
formulations (mainly antibodies that can be injected at hundreds of mg/mL), which are very 
viscous, is an issue because the needles used are bigger, the injection time is longer and the 
required force to inject the solution is bigger. All these parameters strongly affect both the 
patients (increased pain) and the medical staff (stres ful work conditions). 
The number of injections can be limited by a better control of the drug release in the body. With 
the encapsulation of proteins by polymers (poly(lactic- o-glycolic acid), poly(lactic acid), 
polyglycolic acid…), the drug release is dictated by the protein diffusion rate through the 
polymer and the polymer degradation rate and lasts weeks instead of days. This microparticle 
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depot delivery method has led to several commercialized drugs such as Enantone LP® (against 
prostate cancer) or Bydureon® (against type-2 diabetes). Nanoparticle-based drug delivery is also 
a very promising and much investigated technique, mainly for cancer therapy, but has not yet 
seen approved therapeutic protein clinical applications. As well as microparticle based delivery, it 
protects the protein from degradation and slows down protein release but has the advantage to 
have a targeted drug release. A more detailed summary of the different needle-based therapeutic 
protein delivery techniques is proposed in Figure 5. 
 
Figure 5: Pros and cons of the available needle-based delivery technique for therapeutic protein delivery in 2014.  
Figure adapted from (Mitragotri et al. 2014). 
Numerous delivery devices, external or implantable, have been developed in order to increase the 
commodity of the injection delivery methods. The usof automated devices for the preparation of 
the injection dose enhances the dosage precision and repeatability, lowers the time of preparation 
and frees time for the medical staff. Furthermore, in the case of homecare devices and frequent 
injection treatments, it greatly increases the patient autonomy, avoiding daily or weekly travels to 
the hospital. It also offers a better protection against needle accidents, a constant injection rate 
which is more convenient for patients and a better control of the injected dose. Autoinjectors are 
vastly used for injection of therapeutic proteins. Implantable pumps are also a viable alternative 
although it is invasive and requires a frequent refill (implantable insulin pumps are 
commercialized). Microfluidic-designed pumps are investigated that are lighter, provide a more 
precise drug release and save consumables. One should n te that a major drawback of these 
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delivery devices is the potential degradation of the proteins. The presence of different material 
surfaces, hydrophobic interfaces such as air/water or oil/water, shear stress and local temperature 
differences could have a critical impact on protein stability (Lougheed et al. 1980; Jiskoot et al. 
2012). 
Alternative routes have also been investigated with the ultimate goal of avoiding the use of 
needles and having the best patient compliance and comfort possible. Transdermal drug delivery 
has been improved by the use of peptide-based techniques (TD-1 or SPACE) that increase the 
diffusion of bio-macromolecules through intact skin, microneedle-based techniques (for vaccines 
and microneedle patches for insulin delivery are currently investigated (Ling and Chen 2013)), 
chemical, ultrasound, iontophoresis or electroporati n techniques. However, the transdermal drug 
delivery is, for the moment, restricted to small molecules (Mitragotri et al. 2014). Oral 
therapeutic protein delivery remains a difficult route because of the natural barriers and foremost 
because of the protein degradation by stomach enzymes and low pH. Indeed, no product is yet 
commercially available but oral delivery techniques have emerged and are currently developed. A 
good example is Oramed Pharmaceuticals Inc oral insu in capsule which is in advanced clinical 
trials. In contrast, pulmonary delivery through inhalation has known more success. A rapid-acting 
inhaled insulin is currently commercialized (Afrezza®). This method is favored over the oral 
route because it has a better absorption rate and cnot be digested by the stomach enzymes 
(Anselmo and Mitragotri 2014). A summary of alternative administration methods (from 2014) is 
proposed in Figure 6 
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Figure 6: Overview of some promising alternative therapeutic protein administration techniques in 2014.  
Figure taken from (Mitragotri et al. 2014). 
 
1.1.4 Innovative drug delivery systems at EVEON 
Eveon is a company based in Montbonnot Saint Martin (Isère, France) which designs, develops 
and manufactures smart and innovative medical devices for the preparation and administration of 
complex therapeutic drugs. For example, Eveon was engaged in 2009 on a 3 years development 
project of a microfluidic MEMS micropump in silicon able to deliver drugs with a very high 
volume accuracy and a low dead volume. EVEON thrives to offer flexible and innovative 
solutions of automated preparation and administration of complex drugs that secure and simplify 
treatments for the patients and the nurses at home and for the medical professionals at the 
hospital. Its recent development, the Intuity® technological platform, offers custom-based 
medical device solutions, depending on their use. Th  platform is composed of two parts: 
Intuity® Mix (Figure 7.A) is a combination of automated preparation devices dedicated to 
lyophilized and powder drug reconstitution, liquid/liquid mixing, nano to micro particle 
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suspension, and emulsions. It is compatible with the p armaceutical industry’s own primary 
containers, vials, cartridges, and syringes from microliters to hundreds of milliliters and proposes 
unique benefits: minimum component handling and mini um training, no needle handling during 
preparation, time saving for the medical professional and/or the patient (from 10 steps for 
preparation to only 2 steps), perfect homogeneity and dosage repeatability, product loss reduced 
by 50%, patient comfort increased by allowing homecar  treatment instead of hospital care. This 
medical device received a Pharmapack Europe Award 2016, with the special distinction "Ease of 
use & Patient Compliance ". 
Intuity® Ject (Figure 7.B) is an “all-in-one platform” containing a set of fully automated 
preparation (Intuity® Mix) and administration devices. Additionally to the improvement of the 
drug preparation step performed by Intuity® Mix, this platform increases the security and the 
comfort of non “ease of use” drug formulation delivry. It has the following advantages: a thin 
needle to minimize pain, a controlled injection of viscous drug, up to 100 cps, an accurate 
dosage, a controlled flow rate for injection types from infusion to bolus injection and a zero force 
activation. This medical device also received a Pharmapack Europe Award 2017, with the special 
distinction "Ease of use & Patient Compliance". 
 
Figure 7: Eveon’s Intuity® devices 
A, Eveon’s Mix platform. 
B, Eveon’s Intuity® Ject platform.  
Picture taken from http://www.eveon.eu/en/. 
The devices that Eveon produces are therefore optimized to automatically solubilize, mix and 
distribute, at high precision, speed and repeatability, solutions of therapeutic proteins which can 
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also be in freeze-dried form at first. The general p ocesses involved in Eveon’s devices and their 
associated physical phenomena are described below (Figure 8). Two main steps are usually 
necessary: 
In a first step, the solvent is extracted from a container to dissolve a lyophilized protein (powder). 
This generates agitation, a solid (vial surface)/liquid interface and foam, thus a large air / liquid 
interface. 
In a second step, the drug in solution is administered by a pump. In order to achieve rapid 
administration, the pump generates large variations of the pressure in the fluid in order to move 
it, which generates cavitation phenomena (creation of bubbles), often regarded as a possible 
cause of protein degradation in pumps (Thomas and Geer 2010). 
 
Figure 8: General processes involved in Eveon’s devices.  
These processes faces industrial problems similar to those encountered by drug formulation 
companies (Rathore and Rajan 2008) but with devices involving microfluidic systems thus much 
lower volumes. The effects generated by interactions with surfaces and interfaces (liquid / solid 
or liquid / air) are critical for protein stability and need to be studied carefully.  
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1.2 Generalities on proteins 
1.2.1 Protein structure and conformational changes 
Proteins are biopolymers that are found in every living organism and are responsible of most of 
the essential functions of life. They were first discovered in 1838 by Gerardus Johannes Mulder 
and Jöns Jacob Berzelius and are composed of a sequence of elementary bricks called amino 
acids (aa) linked by peptide bonds (protein structure model proposed by Emil Fisher and Franz 
Hofmeister in 1902). The first amino acid (asparagine) was discovered in 1806 by Louis-Nicolas 
Vauquelin and Pierre Jean Robiquet. Amino acids are all composed of an amino group, a 
carboxyl group and a side chain which is specific for each amino acid and defines their 
physicochemical properties (Figure 9). 
 
Figure 9: Schematic view of the amino acid formula.  
The figure is adapted from http://www.nutrientsreview.com. 
The side chain can be positively or negatively charged or neutral, polar or nonpolar, hydrophobic 
or hydrophilic. We record about 500 amino acids but only 20 of them are used to synthesize 
human proteins. The protein diversity is nearly infinite, as are their functions which range from a 
structural role to transport, signaling, catalysis, regulation and many more. Their size varies from 
a few amino acids (Neuropeptide GWa (cuttlefish), 2 aa) to tens of thousands (titin (mouse), 35 
213 aa). The study and understanding of proteins is an ever-evolving field. Up to now (21 mars 
2017), 553 941 reviewed protein sequences, including 157 433 human proteins, are identified and 
indexed in informatics data bases (numbers taken from the Swiss-prot data bank 
http://www.uniprot.org/uniprot/) and these numbers increase every day. The protein sequence 
knowledge evolution over time is shown in Figure 10. The protein amino acid order is 
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determined by the DNA sequence coding for the protein and its amino acid chain is assembled, 
amino acid by amino acid, in the ribosome during a process called translation. 
 
Figure 10: The reviewed protein sequence number in the Swiss-prot data base over the time.  
Note that in 2010, the data base was reorganized, which explains the lower entries number increase since 2010. 
Figure taken from http://www.uniprot.org/statistics/Swiss-Prot. 
The protein structure is described in four levels (introduced by Kaj Ulrik Linderstrøm-Lang in 
1951, Figure 11). The protein amino acid sequence represents the primary structure of the protein 
(Figure 11.A). The secondary structure is defined by characteristic local 3D patterns of the amino 
acid chain (Figure 11.B, (L Pauling & Corey, 1951)). The most common patterns are alpha 
helices, parallel and antiparallel beta sheets and turns. They are stabilized by hydrogen bonds 
between the atoms (mainly N and O) of the main chain. The tertiary structure is the global 3D 
arrangement of the protein amino acid chain (native or folded conformation, Figure 11.C). It 
depends on distant non bounding amino acid interactions, such as electrostatic forces, van der 
Waals forces, hydrogen bonds or disulfide bonds betwe n cysteine amino acids that stabilize the 
structure in oxidizing conditions and interactions with water (hydrophobic interactions) or other 
proteins (molecular crowding). The achievement of its tertiary structure (also called protein 
folding), for a neo synthetized protein, is often spontaneous or guided by other proteins, named 
chaperones. The tertiary structure is of critical importance because it ensures the biological 
activity of the protein. A loss of tertiary structure almost always leads to a loss of the protein 
function. The final structural level is the quaternary structure that describes the subunit 
organization of big protein complexes (Figure 11.D). 
CHAPTER 1: INTRODUCTION 
16 
 
Figure 11: The four different structure levels of the Proliferating Cell Nuclear Antigen (PCNA) protein.  
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The primary structure (amino acid sequence) of a PCNA monomer is represented in A.  
Secondary structures found in PCNA are detailed in B. A monomer is composed of alpha helices and beta sheets.  
The tertiary structure is represented in C, with, in blue, the beta sheets and, in red, the alpha helices.  
The quaternary structure is represented in D. The PCNA protein is composed of three monomers.  
Figure credit to Thomas Shafee, adapted from https://commons.wikimedia.org/w/index.php?curid=52821068. 
 
1.2.2 Protein folding thermodynamics and energy landscape 
Once they are synthetized, proteins pass quasi immediately from a random coil to their native 
conformation (tertiary structure). This phenomenon is called protein folding. It occurs within 
milliseconds and even starts during the protein synthesis on the ribosome. In the case of globular 
proteins, the linear amino acid chain collapses to a c mpact sphere with a core composed of the 
hydrophobic amino acids, surrounded by the more hydrophilic ones. 
Protein folding is a complex mechanism to describe theoretically. The intrinsic heterogeneity of 
the proteins, concerning their amino acid sequence, leads to many possible interactions between 
amino acids within a protein, between proteins, andbetween amino acids and water solvent 
molecules. One very useful tool to statistically describe such a system without the need of an 
individual molecular resolution is thermodynamics. A system, at constant temperature and 
pressure, can be energetically described by the Gibbs free energy G:  
  =  −  Equation 1 
With H being the enthalpy function, S, the entropy function and T the temperature of the system. 
G is a state function, meaning that G is fixed for a state of the system, regardless of the pathway 
leading to that state. For our biological concerns, the enthalpy is simplified, here, as the internal 
energy of the system, which includes the translation l, rotational and vibrational energies of the 
molecules, and chemical bonding and non-bonding interac ions between molecules (Silverstein 
1999). The entropy is a measure of disorder which can be interpreted as the probability associated 
to the state of the system. The probability of a stte will increase with the number of 
configurations available to reach this state. Thus, it can be seen as the degree of freedom of the 
molecules. At constant temperature and pressure, the equilibrium state of a system corresponds to 
a minimum in its Gibbs free energy function. It follows that a system, to reach an equilibrium 
state, will have to minimize its internal energy (H) and maximize its randomness (S). The 
CHAPTER 1: INTRODUCTION 
18 
modification of the system state by a process (chemical reaction, mixing…) towards an other 
state can be predicted by the difference ∆G, of the Gibbs free energies of the concerned states. If 
∆G is negative, the process allows the system to be in a state with a lower free energy, i.e. closer 
to an equilibrium state, so that it will be achieved spontaneously. Vice versa, if ∆G is positive, the 
process will not be favored. ∆G is expressed as: 
 ∆ = ∆ − ∆ Equation 2 
Where ∆H is the enthalpy change, ∆S the entropy change and T the temperature of the system. 
The Gibbs free energy is, thus, of importance in determining the equilibrium state and 
furthermore, it is of particular interest in predicting the evolution of a biological process such as 
protein folding. 
At room temperature, the ∆G between a protein in its native or unfolded state is very low (about 
5-20 kcal/mol (Privalov 1979)) so that a lot of different types of interactions can play a role in the 
folding process. The principal forces that contribute to the free energy of the solvent-protein 
system are electrostatics, hydrogen bonding (Bernal a d Fowler 1933), van der Waals and 
hydrophobic interactions (Dill 1990). The evidence that hydrophobic interaction is the driving 
force of protein folding was, accordingly to many researchers (Tanford 1997), firstly brought 
about  by Kauzmann in 1954-59 (Kauzmann 1959). He argued that the expulsion of a water 
molecule of the protein core (i.e. the breaking of a protein-water hydrogen bond, replaced by a 
protein-protein interaction) is actually a huge gain in entropy because the expelled water 
molecule is free to form a hydrogen bond with any other water molecule. His hypothesis was 
confirmed later with the resolution of protein crystal structures showing that globular proteins 
have their hydrophobic amino acids buried inside the protein, avoiding as much as possible the 
contact with water (Perutz 1965; Perutz et al. 1965). However, hydrophobic interactions alone 
don’t suffice to explain protein folding entirely. The ∆G between a protein’s native and unfolded 
states is overestimated at 100-200 kcal/mol (Tanford 1962) when only hydrophobic interactions 
are taken into account. The main force that opposes to protein folding is the conformational 
entropy (similar to the polymer configurational entropy (Levy et al. 1984)). Indeed, the protein 
unfolded state has much more degrees of freedom (thus a higher entropy) than the compact native 
one. In the case of globular proteins, the amino acid chain is restricted to a small volume and the 
first layer of surrounding water molecules is ordered to minimize the hydrogen bonds with the 
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protein (often illustrated as an iceberg (Frank and Evans 1945)) which gives the globular 
conformation a very low entropy. 
Anfinsen’s experiments (Anfinsen et al. 1961) on the reverse folding of ribonuclease A showed 
that the protein’s native (or folded) conformation corresponds to a minimum of free energy 
meaning that it is the most thermodynamically stable conformation for a protein. Therefore, 
protein folding is the result of the search of a free energy minimum. Later, it has been shown that 
proteins with a native globular tertiary structure in physiological conditions are in their most 
stable conformation (Dobson et al. 1998). Note that not every protein has a stable compact 
tertiary structure. Note also that proteins can have more than one stable 3D conformation (e.g. 
prion proteins) and that there are intrinsically disordered proteins (IDP) which can fold upon 
interaction with ligands (other proteins, nucleic aids, chemicals…), and thus adopt multiple 
conformations depending on the binding partner. Today, we know that at least 30 % of the human 
proteome is either totally or partially unfolded (IDP, (Levine and Shea 2017)). In 1968, following 
Anfinsen’s breakthrough, Cyrus Levinthal raised thefollowing paradox (Levinthal 1968): if 
protein native conformation is the result of a random search of its free energy minimum, protein 
folding should take more than 1010 years to achieve due to the immense number of possible 
configuration. However, secondary structures such as alpha helices or turns can form in less than 
1 millisecond (Eaton et al. 1998) and small alpha helix structure-based proteins generally fold in 
the millisecond timescale (Mayor et al. 2003). Levinthal suggested that protein folding is 
kinetically driven, following a specific pathway (contrary to a thermodynamic point of view that 
implies that the final state of a system is independent of the pathway) through one or more 
mandatory transitional states (partially folded conformations (Dobson 2003)). After Levinthal’s 
assumption, studies were focused on the finding of intermediate states until the early 90’s when 
Joseph Bryngelson and Peter Wolynes, thanks to biophysical characterization methods and 
computer simulation improvements, proposed a new theory (which is still up to date), the so 
called “new view” (Baldwin 1995), based on protein folding funneled energy landscapes. An 
energy landscape is a representation of the free enrgy of all the different protein conformations. 
This energy mapping is funneled towards the native conformation of the protein which has the 
lowest free energy (Figure 12). 
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Figure 12: Example of a funneled protein folding energy landscape with associated protein structures, from unfolded (top) 
to folded (bottom) states.  
The figure is taken from (Dill and MacCallum 2012). 
In other terms, when an energetically favorable interaction occurs between amino acids, the 
protein free energy is lowered so that every protein conformation with a higher energy cannot be 
reached anymore, and so forth until the native conformation is adopted. In this case, the number 
of conformations to test is highly reduced and the folding time becomes biologically relevant. 
The folding pathway is thus not unique since there is many potential starting points and routes to 
reach the native conformation such as “small water s reams running down a mountainside to 
reach the same lake at the bottom” (Dill and Chan 1997). This energy landscape specific 
topology guarantees the proteins to fold rapidly and efficiently. It is defined by the amino acid 
sequence that is the result of a natural selection throughout evolution of the ones that achieve the 
folding process with sufficient robustness (Onuchic and Wolynes 2004). 
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Protein folding is a complex and sensitive mechanism but of crucial importance for the proper 
running of biological processes. Protein unfolding or misfolding can lead to a protein loss of 
activity and also a possible formation of aggregates that cause severe diseases. For example, the 
cystic fibrosis is a misfolding associated disease. A mutation in the DNA sequence coding for the 
CFTR (cystic fibrosis transmembrane conductance regulator) protein modifies its amino acid 
sequence which ultimately prevents the protein to fold correctly. The misfolded CFTR protein 
cannot regulate the chlorine ion exchange properly th ough the cell membrane resulting in thicker 
secretions. Alzheimer is an example of cytotoxic aggre ate-associated disease. The amyloid beta 
protein aggregation into amyloid plaques, in brain, is believed to provoke the neuron death. 
 
1.3 Insulin as a study model for therapeutic protein agregation 
1.3.1 History 
Diabetes has been known long before the discovery of proteins. Traces of its observation and 
description were found in Egyptian texts in 552 BC and of its name from Greece in 129-199 AD 
(Quianzon and Cheikh 2012) but it is not until 1889 that a link between the pancreas and diabetes 
was discovered and that pancreatic secretions were suspected to play a role in the metabolic 
control (Oskar Minkowski and Joseph von Mering, 1889). This discovery was followed by more 
and more hypotheses suggesting that secretions from pancreas islet cells regulate blood glucose 
levels (Zuelzer and Paulesco, 1916). In 1922, the collaboration between Frederik Banting, a 
medical doctor, JJR Macleod, a professor in physiology, Charles Best, his assistant researcher, 
and James Collip, a biochemist results in the firstsuccessful treatment via beef pancreatic extract 
injection against diabetes and the discovery of the first human hormone: insulin (Joshi et al. 
2007). 
Due to its early discovery, its medical importance and its accessibility, the insulin protein has 
often been at the center of scientific progress. It amino acid sequence (primary structure) was the 
first to be determined in 1955 by Frederick Sanger and its tertiary structure was resolved in 1969 
by Dorothy Hodgkin. Human insulin was also the first recombinant human protein to be used 
therapeutically since 1982 (produced by Genentech and Eli Lilly). In 2014, about 2150 millions 
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of vials have been distributed which make insulin the world most produced protein (Wirtz et al. 
2016). 
 
1.3.2 Role of insulin and associated disease: diabetes mellitus 
Insulin is a hormone found in most of the vertebrates. Its main role is to regulate the carbohydrate 
metabolism, principally glucose blood concentration. Indeed, a high level of glucose in blood 
triggers the blood release of insulin proteins which will start, by binding to its receptor, the 
glucose absorption into fat, liver and mostly skeletal muscle cells and its transformation into 
glycogen and storage in the cells. Insulin is produce  and stored in the pancreas beta cells located 
in the islets of Langerhans. 
A dysfunction in the blood glucose regulation is asociated to a type of disease called Diabetes 
Mellitus. The symptoms are an increased thirst and hunger and frequent urination. The most 
spread diabetes are the type 1 and type 2. In type 1 diabetes, also called insulin-dependent, an 
autoimmune reaction destroys the islet of Langerhans beta cells, thus stopping the production and 
blood release of insulin. Glucose cannot be absorbed and transformed into energy anymore. 
Diabetes type 1 patients are treated all their life with daily insulin injections to regulate their 
glucose metabolism. The diabetes type 2, or non-insulin-dependent, is caused by an insulin 
resistance. Since insulin is less recognized by the cells anymore, the glucose is not absorbed and 
not stored by the cells resulting in an over secretion of the hormone until the beta cells “run out of 
gas”. The diabetes type 2 is by far the most common diabetes (90 % of diabetes patients are type 
2 (Mealey 2000)) and generally affects adults and the elderly. It is often associated with obesity. 
Type 2 diabetes treatment is focused on improving the patient’s lifestyle with an equilibrated 
nutrition and physical exercises. Oral anti-diabetic medication can be added to fight the cell 
insulin resistance and if it is not sufficient to regulate blood glucose, insulin injections are 
required. 
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1.3.3 Insulin structure and conformations 
Human insulin is a small globular protein of 51 amino acids (about 5.8 kDa) organized in two 
chains (namely A-chain, 21 aa, and B-chain, 30 aa, Figure 13) linked to each other by two 
disulfide bridge between the cysteines A20 to B19 and A7 to B7 (Figure 13.A). The A-chain is 
composed of alpha helices (A1-A8 and A12-A20) and a internal disulfide bridge (between the 
A6 to A11 cysteines). The B-chain contains one hydrophobic alpha helix (B8-B19) in the center 
of the chain surrounded by the two interchain disulfide bridges, and a turn (B20-B23). The rest of 
the B-chain is a random coil (B1-B9 and B24-B30) (Bocian et al. 2008). As many globular 
proteins, the insulin tertiary structure is composed of a hydrophobic core (Adams et al. 1969; 
Blundell, Cutfield, Cutfield, et al. 1971), isolating several of its hydrophobic amino acids (A2, 
A3, A13, A16, B11, B12, B15, B18 and B24) from the solvent (Figure 13.B). 
 
Figure 13: Human insulin primary, secondary and tertiary structure. 
A, primary and secondary structure of an insulin monomer. Disulfide bridges are represented with a dotted line and alpha 
helices by sinusoids.  
B, insulin monomer tertiary structure.  
The color scale represents the hydrophobicity of the amino acids from blue for most hydrophilic to red for most 
hydrophobic. NA and CA indicate the A-chain N and C-terminus and NB and CB, the ones of the B-chain. 
Figure taken from (Ballet 2010). 
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One should note that there are a few differences in the insulin amino acid sequence between 
species. The bovine and porcine insulin proteins, which were used as therapeutic drug as well as 
for in vitro studies, have respectively one and three different amino acids. A sequence 
comparison is shown in  
Figure 14. 
Insulin A-chain B-chain 
Human GIVEQCCTSICSLYQLENYCN FVNQHLCGSHLVEALYLVCGERGFFYTPKT 
Bovine GIVEQCCASVCSLYQLENYCN FVNQHLCGSHLVEALYLVCGERGFFYTPKA 
Porcine GIVEQCCTSICSLYQLENYCN FVNQHLCGSHLVEALYLVCGERGFFYTPKA 
 
Figure 14: Human, porcine and bovine insulin amino acid sequences.  
The red colored amino acids are different from the human sequence.  
Insulin has three main quaternary structures: monomer (Figure 13.B), dimer (Figure 15.A) and 
hexamer (in presence of zinc ions, Figure 15.B) that coexist in an equilibrium in vivo as well as 
in vitro. The monomer is the biologically active form and the hexamer is the most stable one and 
used for insulin storage and conservation. In vivo, nsulin is stored in the pancreas beta cells in 
the hexameric form (Blundell, Cutfield, Dodson, et al. 1971) and in vitro, therapeutic insulin 
preparations are highly concentrated to favor the formation of hexamers. Insulin dimerization is 
directed by the formation of an antiparallel beta sheet between two monomer B-chain C-terminals 
and the packing of the monomer B-chain alpha helices which increases the number of 
hydrophobic interactions and stabilizes the dimer structure (Murray‐Rust et al. 1992). An insulin 
hexamer is composed of three dimers held together by two zinc ions that are conjugated by the 
histidine (B10) of each monomer (Huus et al. 2005). Most of the hydrophobic parts are located 
inside the hexameric structure, isolated from the solvent, resulting in an increased stability. 
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Figure 15: Structure visualization of an insulin dimer (A) and of an insulin hexamer (B).  
The two zinc ions are represented by grey spheres, chelated to the monomer histidine residues.  
Figure A adapted from (Ganim et al. 2010). 
In physiological conditions and in presence of zinc ons (without zinc, insulin only forms 
hexamers at millimolar concentrations) , insulin is mainly in its hexameric form, except for low 
concentration conditions (Hvidt 1991). The hydrodynamic diameter of the insulin monomer, 
dimer and hexamer have been estimated to be 3.0, 3.9, and 5.9 nm respectively (Jensen et al. 
2014). Bovine insulin self-association studies, in solution and at neutral pH, by Milthorpe et al 
with sedimentation equilibrium experiments (Milthorpe et al. 1977), extended later by Attri et al 
with a static and dynamic light scattering concentration-dependence study (Attri et al. 2010b) 
shed light on a isodesmic hexamer self-association leading to the formation of oligomers of 
hexamers when the concentration exceeds 0.07 g/L. Below this concentration, an equilibrium 
between monomers and hexamers is found. We extrapolate the data of Milthorpe and colleagues 
to obtain the monomer/dimer/hexamer proportions for a 0.5 g/L bovine insulin solution at pH 7, 
25 °C (in a 0.1 M TRIS-HCl and 0.1 M NaCl buffer), which are 5 %, 10 % and 85 %, 
respectively. For Zn-free bovine insulin at neutral pH, insulin adopts an isodesmic self-
association scheme but, in this case, with the monoer as basic unit (Attri et al. 2010a). 
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1.3.4 Amyloid fibrils: the “dark side” of insulin 
Insulin instability, in vitro as well as in vivo, has been a thorn in the side of patients, doctors, 
biologists and pharmaceutical companies. Insulin amyloid plaques have been reported at the site 
of repeated subcutaneous injections of diabetic patients (Dische et al. 1988; Shikama et al. 2010). 
Degradation of insulin pharmaceutical preparations during storage has also been noticed (Brange 
et al. 1992) as well as the tendency of insulin to aggregate in delivery systems (Lougheed et al. 
1980). Note that a difference should be made between insulin self-association (see 1.3.3) where 
the protein tertiary structure and activity remain u touched and insulin aggregation where the 
protein is denatured. Insulin has the distinguishing feature, along with other proteins such as 
prions, beta amyloids, alpha synuclein or huntingtin ( his list is non exhaustive), to form, under 
specific conditions, highly ordered fibrillary aggre ates named amyloid fibrils (Burke and 
Rougvie 1972). These aggregates are involved in severe diseases (Alzheimer, Parkinson, 
Huntington, type 2 diabetes…) as well as important biological functions (Chiti and Dobson 
2006): in humans, the intraluminal domain of the Pmel17 protein produces a fibrous media that 
helps the melanin granule formation (Fowler et al. 2006), in E. coli, the protein curlin forms 
fibrous matrices on surfaces that allow the spreading of the bacteria (Chapman et al. 2002). The 
amyloid fibrils are composed of several protofilaments entwined together. The protofilaments 
have in common a rich beta-sheet structure with beta strands perpendicular to the fibril axis 
resulting in the stacking of monomeric proteins. Their shape is thin (5-15 nm) and long (reaching 
several micrometers) (Toyama and Weissman 2011). They are characterized by an X-ray cross 
beta diffraction pattern and by their intrinsic proerties to bind congo red and thioflavin T (THT) 
fluorescent dyes. Amyloid fibril protein aggregation generally follows a nucleation-dependent 
mechanism with characteristic kinetics (Figure 16) that is composed of three phases: a lag phase 
where nuclei are formed, a growth phase where the nuclei recruit bulk proteins to rapidly grow 
into fibrils and a plateau phase where all the bulk proteins have been incorporated into the fibrils 
that cannot grow anymore. In vitro studies (Nielsen et al. 2001) showed that insulin forms 
amyloid fibrils in solution at low pH and high temperature (60 °C and above) and high 
concentration (usually starting from 1 or 2 mg/mL) with a nucleation-dependent aggregation 
kinetics. 
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Figure 16: Standard nucleation-dependant aggregation kinetics 
A, typical amyloid fibril nucleation-dependent aggregation kinetics. The kinetic curve is represented in blue and the three 
different phases are annotated in red. The aggregate percentage is usually monitored by THT or congo red fluorescence or 
circular dichroism.  
B, Gibbs free energy level of the monomers, nuclei and fibrils during the aggregation process.  
Figure adapted from (Arosio et al. 2015). 
Resolving the insulin amyloid fibril structure is a difficult challenge because (i) of the high 
variability in fibril morphology (referred to as amyloid fibril polymorphism (Pellarin et al. 
2010)), which is extremely dependent of the experimntal conditions and (ii) fibrils don’t have a 
crystalline structure. New sample preparations and characterization techniques such as solid state 
nuclear magnetic resonance (SSNMR), single crystal X-ray diffraction of small peptides or tip 
enhanced Raman spectroscopy (TERS) lead to a better und rstanding of the molecular amyloid 
fibrillary organization. Still, the molecular mechanisms that rule amyloidogenesis are not fully 
understood. However, general features of the insuli amyloid fibril structure can be extracted. 
During the aggregation growth phase, insulin undergo s a secondary structure transition from 
mainly alpha helices to beta-sheets. The fibrils are mostly left handed twisted and the insulin 
native disulfide bridges are conserved (Kurouski et al. 2012). Both parallel (Nettleton et al. 2000) 
and antiparallel (Sawaya et al. 2007) beta sheets have been found but it is still not clear which 
type is predominant. It is also supposed that the B-chain C-terminus doesn’t take part in the 
fibrillation process (Nielsen et al. 2001) 
Jimenez et al  proposed a fibril molecular organization model from cryo electron microscopy 
observations and 3D reconstructions for bovine insul  (Jiménez et al. 2002). A native monomer 
totally looses its secondary structure, then bends under the disulfide bridge constraints and forms 
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beta sheets. An insulin protein thus occupies two “floors” in the protofibril (schematics in Figure 
17). One protofibril side interacts with other protofibrils to form the beta-sheet-structured fibril 
core and the other side of the protofibril interacts with water molecules. A tip enhanced Raman 
spectroscopy (TERS) fibril surface study (Kurouski et al. 2012), that finds that only 34 % of the 
surface is composed of pure beta sheet structures, matches well with the idea that only specific 
protofibril parts ( the beta sheet composed part) interact with other protofibrils and the that the 
rest is exposed to water (the surface should be mainly composed of alpha helices and random 
coils that interact more favorably with water). 
 
Figure 17: Bovine insulin fibril model schematics.  
A native insulin monomer (A) completely unfolds (B) in denaturing conditions, curves (C) and self-reorganizes its 
secondary structure into beta sheets (D). The beta sheet monomers stack to form protofibrils that wrap together (E) into 
fibrils (F, fibril composed of 4 protofibrils).  
In figure A to D, green, blue and yellow represent he A- chain, B-chain and the disulfide bridges, respectively. NA and CA 
indicate the A-chain N and C-terminus and NB and CB, the ones of the B-chain. 
In figure F, the colors represent different protofibrils.  
Figure taken from (Jiménez et al. 2002). 
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Several years later, Ivanova and co-workers produced an insightful work (Ivanova et al. 2009) on 
the effect of insulin fragment peptides on human insuli  aggregation kinetics. They show that the 
LVEALYLV peptide (B11-B18) promotes insulin aggregation at sub stoichiometric 
concentrations (1:1/40) and inhibits it at equimolar concentration whereas the SLYQLENY 
peptide (A12-A19) has no significant effect at any of the concentrations tested. Insulin fibril X-
ray diffraction pattern reveals a distance between beta strands of 4.7 Å and between beta sheets of 
9 and 11 Å. From scanning transmission electron microscopy (STEM) observation of the thinnest 
fibrils, assumed to be protofibrils, mass per unit length of insulin (MPL) has been estimated to 
2.85 ± 0.35 kDa/Å so that a fibril layer has a molecular weight of 13.395 kDa, close to the dimer 
weight (11.161 kDa). Their experimental results lead them to a new fibril structure proposal. The 
B-chain LVEALYL segment undergoes an alpha helix to beta sheet transition, similarly to the 
peptide crystal structure, at the contact of an other insulin protein to form the fibril core. The 
disulfide bridge conservation between the B-chain LVEALYL and A-chain SLYQLENY 
segments forces the A-chain segment to also adopt a beta sheet conformation which will be 
located at the periphery of the fibril. The rest of the protein structure is supposed to remain in a 
native-like structure although no structural information is available. The stretched dimer is 
assumed to be the insulin fibril basic unit (Figure 18).  
 
Figure 18: A stretched insulin dimer as basic unit in Ivanova’s fibril model. 
A, native human insulin dimer (PDB code 1GUJ).  
B, modelized stretched insulin dimer, basic unit of the fibril model which is composed of an unfolded dimer staking, with 
the LVEALYL beta-sheet forming the hydrophobic fibr il core.  
The insulin A and B-chain are represented in pale red and blue respectively, the SLYQLENY and LVEALYL segments in 
dark red and blue respectively and the disulfide bridges in yellow.  
Figure taken from (Ivanova et al. 2009). 
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Ivanova’s model is supported by consequent experimental evidences and should be close to 
reality even though it has not been shown that the alpha helix to beta sheet transition occurs for 
insulin native dimers or other self-assembly states (principally monomers). Note that the 
observed insulin fibrils have been obtained by soluti n agitation at pH 2.5 and 37 °C. The fibril 
formation mechanism could differ with other experimental conditions but the final fibril structure 
should retain the same amyloid properties, with respect to its secondary structure. 
 
1.3.5 In vitro agitation induced insulin aggregation in physiological conditions 
Insulin is particularly sensitive to environmental f ctors such as pH, ionic strength, temperature, 
agitation, zinc presence, interfaces and so on. The number of studies that focus on insulin 
stability since its discovery is tremendous and covers a wide range of conditions. One should be 
careful comparing and correlating the results of studies with different conditions because critical 
factors such as the insulin self-assembly state or the interaction free energy (hydrogen bonds or 
hydrophobic interactions) will differ, thus leading to distinct aggregation mechanisms. Note that 
the physiological conditions (pH = 7 and 37 °C) areth  ones usually used for therapeutical 
formulations. 
An extensive study from Sluzky and co-workers (Sluzky et al. 1992) has set the basis for insulin 
aggregation assays in physiological conditions.  A study of the effects of concentration, agitation 
rate, air/water and Teflon/water interface on bovine insulin aggregation has been carried out with 
the setup described below. Glass vials with Zn-insul  at variable concentrations (0.1, 0.2, 0.3, 
0.4 or 0.6 mg/mL) in PBS (0.14 M NaCl, pH 7.4) were taped horizontally on a shaker, sealed 
with Parafilm and agitated (at 80, 160 or 250 rpm) at 37 °C. For the Teflon/water interface study, 
Teflon spheres of 0.64 cm diameter were added in the vial and the headspace was removed. After 
filtration, the remaining native insulin concentration was determined by UV absorbance and its 
size distribution by quasielastic light scattering (QELS), also called dynamic light scattering 
(DLS). The results are shown in Figure 19. 
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Figure 19: Zn-insulin aggregation kinetics under various concentrations, interfaces and agitation rates at 37 °C. 
The native insulin concentration is shown as a function of time in different conditions of concentration, agitation or 
interfaces.  
A, air/water interface study: insulin solutions in glass vials with headspace and without Teflon beads shaken at 250 rpm at 
initial concentrations of 0.1 (black circles), 0.3 (black squares) and 0.6 (black triangles) mg/mL.  
B, Teflon surface study: insulin solutions in glass vials without headspace and with 5 Teflon beads shaken at 80 rpm at 
initial concentrations of 0.2 (white circles), 0.4 (white squares) and 0.6 (white triangles) mg/mL.  
C, Teflon surface area study: insulin solutions in glass vials without headspace and with 5 (white squares) and 10 (white 
circles) Teflon beads shaken at 80 rpm at initial concentrations of 0.6 mg/mL.  
D, Agitation rate study: insulin solutions in glass vials without headspace and with 10 Teflon beads shaken at 80 (white 
squares) and 160 (white circles) rpm at initial concentrations of 0.6 mg/mL.  
Results taken from (Sluzky et al. 1991). 
Aggregation kinetics in presence of an air/water or a Teflon/water interface has a similar 
nucleation-dependent behavior. The concentration dependence study shows that insulin stability 
is increased with concentration and inversely, for agitation, shorter aggregation lag times are 
observed when the shaking rate or the hydrophobic surface is increased. Without agitation nor 
hydrophobic interfaces (no headspace or with borosilicate spheres), insulin solutions remain 
stable after 2 weeks at 37 °C. Put together, these ob rvations indicate that agitation and the 
presence of hydrophobic interfaces induce aggregation. Following this study, Sluzky and co-
workers proposed, in a second article (Sluzky et al. 1992), a hydrophobic interface-induced 
insulin aggregation mechanism (Figure 20) based on the kinetic parameters previously obtained 
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in order to explain the aggregation concentration-dependence. The model suggests that an insulin 
monomer (U in Figure 20) partially unfolds when it is adsorbed on the Teflon surface. The 
protein unfolding is assumed to be caused by hydrophobic interactions, supported by adsorption 
(Sefton and Antonacci 1984) and aggregation kinetics studies with different hydrophobic surfaces 
(Teflon, polypropylene, silicone). The dimeric (N2 in Figure 20) and hexameric (N6 in Figure 20) 
insulin forms are supposed to only reversibly adsorb on the Teflon surface due to their higher 
conformational stability. However no experimental proof has been obtained to support this 
statement. The unfolded monomer, when released in solution, can either retrieve its native form 
or interact with other unfolded monomers to create in rmediate aggregates (Un in Figure 20). 
Then, unfolded monomer assemblies can either fall apart or continue to accumulate unfolded 
species until reaching a critical size of 170 nm. The intermediate aggregate critical size has been 
determined by a DLS analysis. Indeed, after one hour of shaking, and also for a fully aggregated 
solution, a single peak appears (besides the one corr sp nding to the insulin native forms) 
revealing the presence of a new species in solution of 170 nm in diameter. This step corresponds 
to the nucleation phase. Once the critical size is r ached, intermediates become stable and start to 
recruit also native monomeric or dimeric species which corresponds to the beginning of 
aggregation (growth phase). To summarize, Sluzky and co-workers propose an in-solution insulin 
aggregation mechanism driven by the unfolding of monomers when adsorbed at a Teflon surface 
and the formation of 170 nm stable intermediate aggre ates. The increasing of solution stability 
with its concentration is explained by a competitive adsorption between monomer and other 
insulin species. When the insulin concentration is increased, so does the proportion of hexamer, 
implying that less Teflon surface remains available to monomer adsorption and so longer times 
are needed to form intermediate aggregates which is tran lated kinetically by a longer lag-time. 
This is backed up by Zn-free insulin aggregation studies that show that a solution concentration 
increase accelerates the aggregation kinetics becaus  of the quasi absence of hexamers and a 
higher proportion of monomers in Zn-free insulin. 
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Figure 20: Sluzky’s model for the mechanism of insulin aggregation mediated by a Teflon/water interface.  
N6, N2 and N represent the hexameric, dimeric and monomeric insulin native forms and Un represents an unfolded 
intermediate state with n, the number of unfolded monomers that composes the intermediate.  
Figure taken from (Sluzky et al. 1992). 
Sluzky’s work has been seminal for insulin stability s udies in physiological conditions however 
several assumptions are questionable. First, the structure and oligomeric state of adsorbed insulin 
proteins have not been probed. This will be studied in etails in the next section. Still, one could 
wonder if the unfolded monomer release from the surface is thermodynamically acceptable. If a 
new protein free energy minimum is reached during adsorption with the unfolding of the 
monomer, it should either stay unfolded on the surface or retrieve its native form if released 
because it is its most energetically favorable state in solution. Also, the presence of a single peak 
at 170 nm, associated to a stable intermediate aggregate, in the DLS solution analysis, is 
somewhat intriguing because there is no trace of other Un species. It should be noted that, for 
DLS analysis, insulin solutions are filtered so that igher aggregates are removed. Furthermore, 
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since the scattered light intensity scales with the 6th power of the object size, the contribution of 
the largest aggregates is dominant and could overshadow the contribution of smaller ones. Last 
but not least, the role of agitation has not been tackled. 
Later, Ballet and co-workers extended the work of Sluzky with seeding experiments on human 
insulin (Nault and Ballet thesis manuscripts (Nault 2012; Ballet 2010)). It was shown that pre-
incubated hydrophobic beads decrease the aggregation l g-time of a fresh insulin solution. If the 
pre-incubation time is long enough, the lag-time is suppressed. By contrast, when an insulin 
solution containing amyloid fibrils is incubated with hydrophilic beads, no aggregation is 
observed. The amount of adsorbed insulin has been chara terized at time-points over the course 
of the aggregation kinetics using a bicinchoninic acid assay (BCA) after protein desorption with 
SDS 5% from the beads. It showed a slow increase of the adsorbed protein mass during the lag-
time, further enhanced in the case of pre-incubated beads. The results of this study are shown in 
Figure 21. In light of these findings, it can be confidently claimed that the amyloid fibril growth 
is located on the hydrophobic surface and not in solution. 
 
Figure 21: Ballet’s HI aggregation kinetics experiments: standard (A) and after seeding (B).  
A, an insulin solution with hydrophobic (closed symbols) or hydrophilic (open symbols) beads and no headspace is 
agitated at 37 °C.  
B, HI was pre-incubated with hydrophobic beads for 2 hours (37 °C, 1200 rpm). Then, the hydrophobic beads were 
retrieved, washed and incubated with a fresh HI solution (closed symbols). The pre-incubated solution, in turn, was 
further incubated with new hydrophilic beads (open symbols) at 37 °C and 1200 rpm.  
Triangles, circles and square symbols represent the amount of amyloid fibers, native and adsorbed insulin, respectively.  
Figure taken from (Ballet et al. 2012). 
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They also proposed a rapid high throughput screening aggregation assay with the use of 96-well 
microplates agitated at 1200 rpm (pH = 7 and 37 °C). The amyloid fibril formation is monitored 
by THT fluorescence. HI aggregation kinetics displays  similar behavior (nucleation-dependent) 
as in the Sluzky study. Identically, it has been found that insulin aggregates in presence of a 
hydrophobic surface (polystyrene) but surprisingly, not in the presence of a hydrophilic surface 
combined with an air/water interface (compared to Sluzky’s glass vial experiment without Teflon 
beads but with headspace). This could be explained by the fact that Sluzky used Parafilm which 
is very hydrophobic to seal the vials and since the vials were taped horizontally, the insulin 
solution was in contact with Parafilm that could serve as a hydrophobic surface and promote 
aggregation. 
Also in this study, the aggregate size distribution during the lag and growth phase has been 
characterized by dynamic light scattering (DLS) and micro flow imaging (MFI). The former 
technique is used for small size particles (up to 100 nm) and the second for micrometer size 
particles. No aggretates smaller than 100 nm are detected during both the lag and growth phase 
and bigger aggregates from 1 to 10 µm appear during the growth phase. This confirms that 
nothing is released in solution during nucleation and that the nuclei are created at the surface of 
the beads. However, the range of the used techniques do sn’t allow formally rejecting or 
confirming the existence of the 170 nm stable intermediates found by Sluzky. 
Consequently to these new insights, Ballet proposed a surface-aggregation mechanism (Figure 
22) instead of the “in-solution” one of Sluzky. In accordance with Sluzky’s model, insulin 
monomers are assumed to be the driving force of the aggregation process. The adsorption on a 
hydrophobic surface leads to the monomer unfolding but, instead of Sluzky’s model, the 
monomer remains strongly attached to the surface and interacts with other adsorbed monomers to 
form nuclei or “aggregation centers”. Once created, hey start to recruit native insulin and evolve 
to mature amyloid fibrils by accumulating more and more proteins. The mature fibrils can be 
released into solution by mechanical breaking due to agitation. 
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Figure 22: Surface insulin amyloid formation model proposed by Ballet and co-workers.  
N (triangles) and U (rectangles) represent a native and an unfolded insulin monomer, respectively. The red and blue colors 
represent the hydrophobic and hydrophilic part of the insulin protein, respectively.  
Figure taken from (Ballet 2010). 
The idea that the aggregation nuclei are formed at the hydrophobic surface instead of in solution 
is strongly supported by the previously described experimental data. It is also indicating that not 
only a hydrophobic interface but a solid hydrophobic surface is needed because no aggregation is 
observed when an insulin solution is agitated in a hydrophilic 96-well microplate at 37 °C. In this 
case, the presence of an air/water interface, alone, is not sufficient to trigger insulin aggregation 
(contrary to Sluzky’s claim). 
The role of the agitation has not yet been fully understood. In Ballet’s model, it provides mixing 
that prevents the aggregation mechanism to be diffusion-limited and mechanical forces that break 
and release the surface-matured fibrils into solutin but has no significant effect on the nucleation 
process and more precisely on the adsorbed monomer unfolding.  
A controversy is seen in the literature on the question of whether hydrodynamic shear stress (due 
to solution stirring or flow) can cause protein unfolding. Jaspe and Hagen (Jaspe and Hagen 
2006) answered a firm “No” in their study of cytochrome c unfolding under high shear stress. 
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The flowing of a cytochrome c solution through a silica capillary (inner diameter of 150-180 µm) 
at a flow rate of 10 m/s resulting in a shear stres of 2  105 s-1 shows no detectable change in 
the protein conformation. They conclude on the facttha  unfolding a bulk protein would need an 
extremely high hydrodynamic shear stress (estimated to 107 s-1) which is not relevant in the field 
of pharmaceutical drug delivery. This point of view is shared by an interesting review of Thomas 
and Geer (Thomas and Geer 2010) that puts more emphasis on the interfacial phenomenon as a 
preponderant cause of protein unfolding. However, other studies attribute protein conformational 
changes to high shear stress values. Bekar et al. investigated the effect of shear stress on insulin at 
low pH with a “Couette cell” and shear rates ranging from 200 to 600 s-1 (Bekard and Dunstan 
2009). An increasing loss of insulin alpha helix content with increasing shear rates was observed 
by circular dichroism. The presence of aggregates (although the aggregate amyloid phenotype has 
not been verified) was confirmed by AFM after 2 hours of incubation. Note that, in this study, the 
different material surfaces of the Couette cell or the presence of an air/water interface have not 
been investigated. Using the same setup, Teoh et al. showed an irreversible loss of the secondary 
structure for the Apolipoprotein C-II at a shear rate of 500 s-1 and that shear stress accelerates the 
formation of amyloid fibrils (Teoh et al. 2011). Obviously, these studies indicated a 
hydrodynamic shear stress effect on the amyloid fibril formation kinetics but intriguingly, in the 
cited studies, aggregation is also observed in the absence of shear stress, meaning that proteins 
unfold without the help of shear so that shear should not thermodynamically contribute to protein 
unfolding. 
Nault studied during his PhD the effect of agitation on insulin aggregation kinetics with Ballet’s 
96-well microplate assay (Nault 2012). Below 600 rpm, no THT fluorescence increase is 
observed in correlation with the fact that no fluid movement is visible in the well and that a 
solution of sucrose and colored water doesn’t mix below 600 rpm. The absence of aggregation is 
related to the absence of solution stirring which is assumed to provide a constant insulin 
concentration near the well surface. The aggregation lag-time is highly decreased for an agitation 
rate between 600 and 700 rpm and, above 900 rpm, it is proportional to the hydrodynamic shear 
stress increase. Indeed, the shear stress in an orbital shaker is proportional to ω3/2 where ω 
represents the rotation speed (Reddy et al. 2002) and the obtained data are fitted with the equation 
k(ω) = Aω3/2. The results are shown in Figure 23. 
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Figure 23: Effect of agitation on insulin aggregation kinetics, studied by Nault.  
The aggregation lag-time is plotted as function of the rotation speed used. The lag-time increase is fitted with the equation 
k(ω) = Aω3/2 (continuous line).  
Figure adapted from (Nault 2012). 
Nault concludes that the agitation effect is a competition between mixing which favors the 
nucleation on one hand, and hydrodynamic shear stress hat depletes the surface layer of adsorbed 
insulin proteins and delays nuclei formation on theother hand. This interpretation is further 
adopted by Mcbride and co-workers in a publication (McBride et al. 2015) where  bovine and 
human insulin aggregation kinetics, at pH 1.6 and 65 °C, were compared under different shear 
stresses, from 0 to 150 s-1, with a Couette cell (cf Figure 24). 
 
Figure 24: McBride and co-workers’ Couette flow apparatus.  
The inner and outer cylinders are made of glass. The outer cylinder rotates to induce a simple and controlled shear stress.  
Figure taken from (McBride et al. 2015) 
The in-solution insulin concentration over time is fitted with the Finke-Watzky crystallization 
model (Equation 3, (Morris et al. 2009)) that is usually used to describe amyloid fibril formation 
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kinetics (Crespo et al. 2012) in order to obtain a nucleation (k1 in Equation 3) and a growth (k2 in 
Equation 3) rate constant. 
 	 =


  	1 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 
 Equation 3 
Where C represents the in-solution insulin concentration, C0, the initial insulin concentration, k1 
and k2 the nucleation and growth rate constants respectively. 
The nucleation rate constant displays a peak at an intermediate (but different) shear rate for both 
human and bovine insulin and the growth rate constant is increasing with the shear rate. The 
results are shown in Figure 25. Therefore, the minium aggregation lag-time is observed for an 
intermediate shear rate value which should bring toether optimized conditions to promote 
nucleation. Intriguingly, the optimal conditions for nucleation are not the same as those for the 
fibril growth. The difference of the “nucleation optimal shear value” between human and bovine 
insulin could be explained by their amino acid sequence: the B30 residue is different between 
both sequences and is located in the beta-sheet formed during insulin dimer self-association. At 
this low pH, bovine insulin is mainly dimeric (Attri et al. 2010a). A B30 residue modification 
could change the free energy of the dimer state or the monomer-dimer equilibrium which could 
explain the different behaviors. Additionally, bovine insulin is known to aggregate faster than 
human insulin without agitation (pH = 1.6 and 60 °C) (Nielsen et al. 2001). 
 
Figure 25: Effect of different shear rates on the insulin aggregation kinetics.  
A, nucleation constant (k1) as a function of the shear rate.  
B, growth constant (k2) as a function of the shear rate.  
Figure adapted from (McBride et al. 2015). 
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They conclude that agitation and shear stress has no influence on the insulin monomer 
conformational changes. During the nucleation phase, gitation has a dual effect: mixing provides 
a constant monomer supply to the aggregation nuclei which favors their formation and shear 
stress mechanically depletes the nuclei by ripping off insulin monomers which slows down their 
formation. A nucleation theory for sheared systems that supports this view is proposed by Mura 
et al (Mura and Zaccone 2016). During the growth phase of a surface-induced aggregation, 
agitation provokes surface-formed fibril release by mechanical breaking. As the shear rate 
increases, smaller amyloid fibrils are released into solution. In the case of bulk fibril formation 
(low pH and high temperature), McBride and co-workers xplain the growth constant and shear 
rate related increases by a better monomer supply from mixing. One could mention the existence 
of a hydrophobic interface (mineral oil) where amyloid fibrils could grow and that an increased 
shear stress could accelerate their release into solution. The agitation induced mixing is however 
of critical importance during both lag and growth pase and even a necessary condition for 
aggregation at physiological pH and temperature.  
 
1.3.6 Insulin adsorption on hydrophobic solid surfaces 
In physiological conditions, insulin aggregation is induced by nucleation and amyloid fibril 
formation on hydrophobic surfaces and its driving force is the monomer unfolding upon surface 
adsorption. Insulin adsorption and desorption kinetics has been characterized on a C16 alkyl-thiol 
coated gold prism (Nault et al. 2013), on Teflon (Mollmann et al. 2006) and on PTFE-like 
(Mollmann et al. 2005) hydrophobic surfaces using surface plasmon resonance (SPR), total 
internal reflection fluorescence and ellipsometry, respectively. The results show a common 
adsorption behavior with two different adsorbed protein species: one that is loosely adsorbed and 
easily removed by buffer rinsing and an other that is irreversibly attached to the surface. 
Adsorption isotherms have been estimated to 1.52 mg/m2 for PTFE-like surfaces (Mollmann et 
al. 2005) and 1.7 mg/m2 for Teflon particles (Mollmann et al. 2006) which is higher than the 
theoretical value of a monomer monolayer coverage (1.1 mg/m2) and lower than the one of a 
dimer monolayer coverage (2.2 mg/m2) (Arnebrant and Nylander 1988). Thus, it can be assumed 
that an insulin monolayer that is composed of a mixture of different protein self-association states 
remains irreversibly adsorbed at a hydrophobic surface. However, theoretical values do not take 
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into account the potential protein unfolding at thesurface. Insulin conformational changes during 
adsorption have also been investigated. Circular dichro sm (CD) spectra comparisons between 
bulk and Teflon adsorbed insulin highlights a decrease of alpha helix content in favor of 
unordered structures (random coil) or beta sheet. Intriguingly, in the case of an excess of Teflon 
surface, adsorbed insulin CD spectra are similar to those of amyloid fibrils (Jorgensen et al. 
2011). This could indicate that surface crowding slow  down the adsorbed protein unfolding and 
could explain the increased stability of high concentration solution. In accordance with the 
previous study, significant ATR-FTIR spectra differences have been found between adsorbed 
insulin and either bulk or aggregated insulin. Additionally, adsorbed insulin spectra were 
adsorption-time dependent (Nault et al. 2013). Therefore, it is clear that adsorption leads to 
conformational changes although it has not been asserted that it is toward a rich beta sheet 
structure. 
The generally accepted adsorption mechanism is the urface dehydration and the interaction with 
the insulin hydrophobic amino acids but there is no clear view of the molecular mechanism 
involved. However, the B-chain N-terminus does not seem to play a role because FITC-insulin 
(FITC label is located at the N-terminus of the B-chain) has the same adsorption behavior as non-
modified insulin. Also, a tryptophan fluorescence emission shift is observed during the 
hydrophobic surface adsorption of a TprB30 insulin mutant, which suggests that the B-chain C-
terminus is displaced and is involved in the adsorpti n process (Mollmann et al. 2006). The work 
of Nault (Nault et al. 2013) and Chouchane (Chouchane et al. 2015) on surface-induced insulin 
amyloid fibril formation catalyzed by small peptide sequences that form beta-sheets on 
hydrophobic surfaces is another clue that insulin undergoes an alpha helix to beta-sheet transition 
on hydrophobic surfaces. 
 
1.4 Thesis goals and motivations: to locate early state aggregates and 
study their growth mechanism in intermittent wetting processes 
1.4.1 Protein aggregation triggered by the movement of an air/water interface 
The role of the air/water interface in agitation-induced protein aggregation has often been 
eclipsed by the other agitation effects that are shar stress and mixing. However, this interface 
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displays a hydrophobic character promoting protein adsorption that is known to induce protein 
aggregation with the specific feature of being flexible and breakable. Several interesting studies 
investigated the effect of a repeated disturbance of an air/water interface on protein aggregation. 
Bee and co-workers (Bee et al. 2012) examined the effect of an air/water interface repeated 
compression/dilatation on the monoclonal IgG antibody aggregation. To this end, a half filled 
polypropylene vial with a monoclonal IgG solution was very slowly rotated resulting in a cyclic 
compression/dilatation of the air/water interface, without breaking it or creating air bubbles or 
foam. After incubation at room temperature, the particle number was determined by Micro-Flow 
Imaging. It has been found that IgG antibody aggregation is induced by a repeated 
compression/dilatation of an air/liquid interface. It has also been shown that IgG aggregates 
released in solution didn’t act as seeds and didn’t form spontaneously new aggregates in the bulk. 
Indeed, when the compression/dilatation cycles were stopped, the number of particles present in 
solution remained the same (Figure 26.A). Additionally, the aggregation rate and particle 
generation maximum depended on the compression/dilatation ratio (CR, maximum air/water 
interface surface over the minimum one) and was reach d for a value of 7 (higher values have 
been tested but didn’t have the same aggregation efficiency, Figure 26.B) and the solution 
concentration didn’t have a significant effect on the protein aggregation kinetics. From these 
results, they concluded that the compression of the air/water interface provokes the aggregation 
of the adsorbed IgG proteins and that the air/water in face dilatation releases the aggregates into 
the solution (Figure 26.C). 
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Figure 26: Bee’s study on the effect of air/water interface compression/dilatation on the aggregation of an IgG antibody 
solution.  
A, the number of particles in solution as a function of the incubation time. Blue symbols (dotted line) represent the case 
where the vial rotation was stopped after 1 hour.  
B, the effect of the compression/dilatation ratio (CR) on the number of aggregates created and released in solution.  
C, Bee’s aggregation mechanism. Figure taken from (Bee et al. 2012). 
In the same spirit, Rudiuk and co-workers imagined an ingenious setup to study the impact of a 
repeated air/water interface breaking on the aggregation of IgG polyclonal antibodies (Rudiuk et 
al. 2012). The protein solution was introduced in aglass tube and sealed with a cap pierced with a 
needle. The needle position was off-centered and it dipped about 2 or 3 mm into the solution. 
Then the tube was set in rotation, vertically or tilted at two different angles, so that either the 
needle never left the solution or it broke the air/water interface at each rotation (Figure 27.A). 
After incubation, they performed dynamic light scattering (DLS) measurements to determine the 
particle size distribution (i.e. the presence of aggre ates) in the solution. They observed the 
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formation of aggregates in the case of a repetitive a r/water interface breaking but not in the case 
when the needle always stayed in the solution (Figure 27.B). Subsequently, they proposed an 
aggregation mechanism based on the adsorption and aggregation of the IgG antibodies at the 
air/water interface and their release in solution due to the needle interface breaking (Figure 27.C). 
 
Figure 27: Rudiuk’s study on the effect of a mechanical breaking of an air/water interface on IgG polyclonal antibody 
aggregation.  
A, experimental setup.  
B, DLS results, the scattered light intensity of the interface breaking and non-breaking conditions and without needle after 
incubation. Note that the scattered light intensity increases with the number of particle in solution.  
C, Rudiuk and coworkers’ IgG aggregation mechanism. 
Figure taken from (Rudiuk et al. 2012). 
A more practically oriented case-study has been realized by Viellard and co-workers on the 
stability of the commercialized antibody Cetuximab®. In hospitals, therapeutic protein handling 
is often needed to distribute a purchased drug stock t  individual perfusion bags that will be 
injected to the patient (reconstitution, dilution, container change, transport…). Viellard and 
colleagues investigated the effect of transport via pneumatic conveying systems on the stability of 
a Cetuximax® solution in polyolefin perfusion bags (Vieillard et al. 2013). 2 mg/mL 
concentrated Cetuximax® solution filled perfusion bags with and without air-headspace were 
transported up to 6 times through a pneumatic system. After only one return travel, DLS 
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measurements show the presence of aggregates and FTIR analysis reveals changes in the 
antibody secondary structure in the bags with headspace only. Without headspace, neither 
aggregates nor structural changes were observed even after 6 travels. 
Altogether, these studies, among many others (Campioni et al. 2014; Jean et al. 2012), highlight 
that the presence of an air/water interface is a potential source of protein loss or degradation. 
 
1.4.2 Thesis overview: The meeting of a solid/liquid and an air/water interface as the 
preferential location for protein aggregation 
Focusing back on insulin, we have seen that, in physiological conditions, aggregation is triggered 
by agitation and the presence of a hydrophobic surface where the aggregates are created before 
being released in solution by mechanical breaking. However, it has not been determined yet 
whether the aggregates are created randomly at the surface or at specific and preferential 
locations. Interfacial adsorption at hydrophobic interfaces is known to destabilize the structure of 
the proteins. One could imagine that proteins located t the intersection of two interfaces could be 
even more destabilized and prone to form aggregates. An other possibility could be that if two 
hydrophobic interfaces, where proteins are adsorbed and potentially partially unfolded, enter in 
contact, the adsorbed and destabilized proteins will interact with each other to form aggregates. 
These aggregation favoring phenomena are encountered as soon as an air/water interface meets a 
hydrophobic solid surface (schematic view in Figure 28) and will be called a “triple interface” 
throughout this manuscript. Frequent examples of triple interfaces are the meniscus of protein 
solutions in hydrophobic containers or an air bubble in contact with a hydrophobic microchannel 
wall. Moreover, if one considers an air/water interface motion, one could imagine that the 
air/water interface, when passing over the surface, would deposit its adsorbed proteins then move 
away and replenish its interface with new adsorbed proteins and come back to the surface to 
deposit an other protein layer. Also, the adsorbed proteins at the solid surface will become 
partially dehydrated, when the air/water interface moves away. This dehydration could also add 
to conformational instability that favors the formation of aggregates.  
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Figure 28: Schematic view of a triple interface.  
Native proteins (black circle) are adsorbed at both the air/liquid and solid/liquid interface (black rectangles). When the 
interfaces come into close proximity (region marked by a red circle), the adsorbed proteins could interact with each other 
to form aggregates.  
The protein solution, the hydrophobic surface and air are represented in blue, grey and white, respectively.  
We therefore decided to investigate the effect of dynamic triple interfaces on protein aggregation 
with HI as a model protein. Thanks to adapted setups, we studied the effect of the presence of 
dynamic triple interfaces on the aggregation kinetics in chapter 3 (macroscopic aspect) and the 
aggregate formation and growth mechanism at the triple interface in chapter 4 (microscopic 
aspect). 
In the third chapter, we will study the effect of the creation of dynamic triple interface on beads 
on the HI aggregation kinetics. It will be shown that in the case of hydrophobic beads, HI 
aggregation is triggered by the presence of dynamic triple interfaces and amyloid aggregates are 
observed in solution as well as strongly attached on the beads. The shear stress endured by the 
bead adsorbed proteins will be theoretically estimated to be too low to destabilize the proteins 
compared to the shear values found in the literature and experimental evidences will be provided. 
It will also be shown that the creation of triple interfaces on hydrophilic beads induce HI 
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aggregation with slower kinetics. The triple interface creation speed also seems to have an impact 
on the HI aggregation kinetics. 
In the fourth chapter, we will build an experimental setup that will allow a direct in-situ and real-
time visualization of the insulin aggregate growth a  the triple interface: a microchannel surface 
will be repeatedly swept by an HI solution and the microchannel surface amyloid aggregates will 
be imaged by THT fluorescence. First, the previous re ults (overall nucleation-dependent 
aggregation kinetics, effect of shear stress and surface hydrophobicity) will be confirmed with 
this setup. Then, we will observe that liquid droplets, left after the dewetting of the microchannel 
surface, are anchored by adsorbed proteins and reform d at the same place after each dewetting. 
The first THT-positive HI aggregates appear at the edge of these droplets and grow exponentially 
and towards the outside of the liquid droplets, the droplet centers remaining free of aggregates, 
until the surface is totally covered by an amyloid layer and a continuous liquid film. Finally, we 
will propose a model describing our mechanistic understanding of the HI triple interface induced 
aggregation. 
The final chapter will display a summary of the previously presented results and a discussion 
about the role of the triple interface on HI or other therapeutic protein aggregation, with a 
literature review of other proposed protein aggregation mechanisms and a focus on the physical 
phenomena occurring inside a protein solution droplet. Finally the manuscript will conclude with 
the perspectives opened by this work. 
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2.1 Proteins and chemicals 
Proteins 
Recombinant human insulin (HI, dry powder, MW: 5807.57 g/mol, ref: I2643) produced in yeast 
and bovine serum albumin (BSA, 1mL vials at a concentration of 1 mg/mL in 150 mM NaCl, 
MW: 66 500 g/mol, ref: P0914) were purchased from Sigma Aldrich. Human beta amyloid 
peptide (Aβ 1-42, dry powder, MW: 4514.14 g/mol, amino acid sequence: Asp-Ala-Glu-Phe-
Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-
Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala, ref: 52487) was 
purchased from Genecust. 
Chemicals 
Beta sheet conformational fluorescent marker thioflavine T (THT, dry powder, ref: T3516, MW: 
318.86), polysorbates Tween® 20 (T20, MW: 1228 g/mol, ref: P1379) and Tween® 80 (T80, 
MW: 1310 g/mol, ref: P1754) and dichlorodimethylsilane (MW: 129.06 g/mol, ref: 440272) were 
purchased from Sigma Aldrich. Sodium dodecyl sulfate t 20% v/v (SDS, MW: 288.38 g/mol, 
ref: EU0460) was purchased from Euromedex. 
 
2.2 Stock solutions 
HI was dissolved in TN buffer (pH 7.4, Tris-HCl 25 mM, NaCl 125 mM). 1 M HCl was added to 
decrease the pH below 3 and to ensure that the powder as completely dissolved. Then, 1 M 
NaOH was added to restore the pH to 7.4. HI fresh stock solutions were filtered with a 0.22 µm 
low binding Millex syringe driven filter unit (ref: SLGV033RB) purchased from Merck 
Millipore. Stock solution concentrations were monitred by UV absorbance at 280 nm using an 
extinction coefficient of 5.53 mM-1cm-1 and adjusted to 0.5 g/L (86 µM). 
Aβ peptide were dissolved in 10 mM NaOH, sonicated (2*1 min) and centrifuged at 13 200 rcf at 
4°C. The supernatant was collected and used as a stock solution. The final concentration was 168 
µM, determined by UV absorbance at 280 nm using an exti ction coefficient of 1.49 mM-1cm-1. 
All protein stock solutions were stored at 4°C and used within 2 weeks. 
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Thioflavin T (THT) was dissolved in TN buffer (Tris-HCl 25 mM, NaCl 125 mM, pH 7.4), at a 
concentration of 1 mM, adjusted by absorbance measur ment (1% THT solution in ethanol, 
ɛ416(THT) = 26.6 mM
−1cm−1), then filtered at 0.22 µm with a Millex syringe driven filter unit 
(ref: SLGS033SB) and stored at 4°C, protected from light. 
Tween® stock solutions were composed of 10% of Tween® (v/v) diluted in deionized water. 
Solutions were briefly heated and agitated to obtain a homogeneous mixture and stored at 4°C. 
 
2.3 Materials, consumables and equipment 
Plastic straight microfluidic channel chips (four channels) with mini luer interface (ref: 01-0175-
0138-02), glass straight microfluidic channel chips (four channels) with olive interface 
(customized fabrication), male mini luer fluidic connectors (ref: 09-0545-0333-09) and male mini 
luer plugs (ref: 09-0550-0334-09) were purchased from Microfluidic Chipshop. 
Both glass and plastic microchannel dimensions were 200 µm deep, 58.5 mm long and 1 mm 
large (scheme in Appendix A). Plastic and glass microchannels have respectively a 140 µm and 
150 µm thick cover lid. Both cover lid thicknesses are compatible with the use of microscope 60x 
oil objectives. 
The plastic microchannels were made in cyclo-olefin copolymer (COC, grade: mcs-Topas-03 
mcs foil 011, developed formula in Appendix B), a nonpolar, amorphous and hydrophobic 
thermoplastic polymer from Topas. The water contact angle of COC and glass microchannels 
before any washing is 93.6°±1° and 60°±1°, respectiv ly. 
A programmable syringe pump Aladdin-6000 was purchased from World Precision Instruments 
and controlled with a Visual Basic program. 
125 µL Distritips® syringe bodies (ref: SOC-F164100) were purchased from Socimed. 
Tubing (ref: Tygon Lab E-3603 L/S 14) was purchased from Masterflex. 
Borosilicate solid-glass beads (diameter: 1 mm ± 10 %, ref: Z273619) were purchased from 
Sigma Aldrich 
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Empty micro chromatography columns equipped with a porous 30 µm polyethylene bed support 
(Empty Micro Bio-Spin Columns, ref: 732-6204, scheme in Appendix C) were purchased from 
Bio-Rad. 
Polystyrene nontreated flat-bottom 96 microwell plates were purchased from Thermo Fisher 
Scientific (ref: 237105). 
A plate reader Tecan infinite M1000® is used with the 96 microwell plates to quantify the THT 
fluorescence, or absorbance measurements. 
Sylgard 184 silicone elastomer kits composed of polydimethylsiloxane (PDMS) and a curing 
agent were purchased from Dow Corning. 
 
2.4 Microscopy setup 
An Olympus IX71 inverted microscope was equipped with an Olympus DP30BW camera, a 60x 
magnification oil objective with numerical aperture of 1.25 (ref: UPLanFLN) and a 100W Hg 
lamp (U-LH100HG and HBO103W/2, microscope schematics in Appendix D) and used for 
fluorescence and reflection interference contrast microscopy (RICM). The microscope lateral 
resolution is about 300 nm. The camera field of view was 200 by 150 µm. the acquired images 
are 1360 by 1024 pixels and have 256 grey levels (8 bits). Acquisition was done with the 
Olympus software (DPController) or with Image Pro Plus 5 thanks to a plug-in software 
compatible with the camera. 
The microscope was equipped with a motorized stage (with a smallest step size of 0.05 µm and 
an accuracy of ± 3 µm), purchased from Marzhauser Wtzlar, and used to move the camera field 
of view all along the channel. The motorized stage was controlled by the constructor software 
(Win-commander 4) or by programs written in Visual Basic via a library given by the 
constructor. 
A shutter and a controller were purchased from Vincent Associates (ref: Uniblitz 
VS35S2ZM1R3-NL-24 and VCM-D1). The shutter was placed just after the mercury lamp. The 
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shutter was manually piloted or controlled by sending ascii characters, corresponding to the 
opening or the closing of the shutter, via a RS232 port. 
Image Pro Plus 5, purchased from Media Cybernetics, is an image acquisition software that 
allows the user to write and run homemade programs written in Visual Basic. It was used to 
synchronize and automatize the shutter, the motorized stage, the syringe pump and the image 
acquisition with Visual Basic programs adapted to the different imaging methods. 
 
2.5 Biophysical characterization methods 
2.5.1 THT fluorescence 
The THT dye was used to monitor the amount of amyloid fibers formed at the channel surface. 
When incorporated into amyloid fibers, THT undergoes a fluorescence shift from (λex = 342nm; 
λem = 430nm) to (λex = 450nm; λem = 482nm), (LeVine III 1999). The THT fluorescence shift 
is represented in Figure 29. This property allows the direct quantification of amyloid fibers by 
fluorescence recordings at 482 nm. Fluorescence images were acquired with the microscope 
described above using a DEAC fluorescence cube (λex = 436 ± 10 nm, λem = 480 ± 15 nm, 
dichroic mirror λcutoff = 455 nm). Two neutral density filters (Olympus, ref: 32ND6 and 32ND12) 
were used to reduce the light intensity of the Hg lamp by 92.8 %. 
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Figure 29: Fluorescence spectra of free THT (A) and THT bound to amyloid fiber (B).  
Figure taken from (LeVine III 1999). 
 
2.5.2 Reflection Interference Contrast Microscopy (RICM) 
Reflection interference contrast microscopy allows a direct quantification of the distance (h in 
Figure 30.A) between a transparent object or an interface and a surface. It is based on the phase 
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shift between the reflections at the surface and at the object/interface (Figure 30.A). Considering 
a monochromatic incident beam with an intensity I0 encountering an interface (usually between 
the microscopic slide and water, or, in Figure 30, between the microchannel surface and water), 
one part of the beam is reflected with an intensity I1 and the other part is transmitted. When 
encountering another interface (the surface of the object under study or, in Figure 30, the 
interface between the water film and air), one part of the transmitted beam is reflected with an 
intensity I2. One should note that an interface is defined hereas a modification of the refractive 
index (i.e. changing of propagation media). The tworeflected beams interfere with each other and 
the camera acquires a resulting intensity I which can be expressed as (Curtis 1964): 
  =     2 cos(2
ℎ  ) Equation 4 
With k=2πn1/λ where n1 corresponds to the refractive index of the media through which the 
transmitted beam propagates (water in the example in Figure 30.A) and λ to wavelength of the 
monochromatic beam. Φ is the phase shift between the two reflected beams, which, in our case 
equals 0 (both I1 and I2 have a phase equal to π because they propagate through a media of higher 
refractive index before being reflected, plastic/water and water/air for I1 and I2 respectively, see 
Figure 30.A). h is the distance between the two reflections (i.e. th  distance separating the two 
interfaces causing reflections, respectively, solid/liquid and air/liquid in Figure 30). The 
intensities I1 and I2 are equal to: 
 
 = ! 	#$%	 = (1 − ! )!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Equation 5 
r i,j is called the Fresnel reflection coefficient and (0, 1, 2) are the different propagation medias, 
respectively solid, liquid and air in Figure 30. 
From Equation 4, the acquired intensity I varies with the cosinus term, and so, with h. RICM 
images are therefore composed of interference fringes representing the variation of the distance 
between two reflections, i.e. between two interfaces (Figure 30A). The distance between two 
fringes corresponds to a height variation of λ/2n1. One can calculate h with the following 
equation: 
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 2 − (.  /). − / = cos(41$ ℎ2) Equation 6 
Where IM and Im are the maximal and minimal resulting intensity (cosinus term equal 1 and -1) 
and are measurable experimentally. It should be noticed that h does not represent the exact 
distance, a kλ/2n1 term has to be added, with k a positive natural number, because of the 
periodicity of the cosinus. As a consequence, it is difficult to calculate the height of a sharp form 
(such as a step) since it is not possible to determin  k. On the opposite, a smooth form (such as a 
slope) is much easier to characterize since k is determined by the number of fringes visible 
between the bottom and the top of the object (Figure 30.B). 
 
Figure 30: RICM principle.  
A, side view of a microchannel after liquid withdrawal. A thin liquid film and punctual droplets (blue) remain at the 
microchannel surface (grey). The black, red, green and yellow sinusoids represent respectively the incident beam from the 
microscope, the reflected beam at the interface solid/liquid, the reflected beam at the air/liquid interface and the 
transmitted beam.  
B, RICM image of a liquid droplet at the microchannel surface after liquid withdrawal. 
In this work, we will use the RICM technique qualitt vely to observe the morphology of the 
remaining liquid at a microchannel surface after dewetting. 
For the RICM setup, a green filter selected the 546nm Hg emission peak of the lamp and a 
reflector cube, containing a polarizer, a semi-reflecting plate, set at 45° of the optical axis, and a 
analyzer (or crossed polarizer), was used to illuminate the sample as described in (Limozin and 
CHAPTER 2: Materials and methods  
56 
Sengupta 2009), except for the quarter-wave plate obj ctive (also called antiflex objective) which 
is not present in our setup. A neutral density filter (Olympus, 32ND12) was used to reduce the 
light intensity of the Hg lamp by 88%. 
 
2.6 Methodology: creating triple interfaces on glass beads 
2.6.1 Bead surface functionalization 
Beads Silanization (hydrophobic surface) 
Glass beads were first cleaned and hydroxylated by immersion in a 1 M HCl solution during 30 
minutes under agitation. After rising with ethanol and drying during 1 hour, beads are immersed 
in dichlorodimethylsilane 5% (v/v) in toluene during 2 hours. The Si-Cl bonds of the 
dichlorodimethylsilane (developed formula in Appendix E) are hydrolyzed by the residual water 
at the bead surface to form silanol molecules. These molecules interact with the bead surface by 
hydrogen bonding. During curing, Si-O-Si covalent bonds between silanols and the bead surface 
are formed with concomitant water evaporation. As a result, a monolayer of dimethylsilane is 
created at the surface of the beads, which become hydrophobic (the water contact angle of glass 
cover slides, silanized as described, is 100°±5°, indicating a significant hydrophobicity, similarly 
to (Chouchane et al. 2015)). A schematic view of the silanization reaction is presented in Figure 
31. 
 
Figure 31: Schematic view of a silane self-assembled monolayer formation on a glass substrate.  
X corresponds to a hydrolysable group.  
The scheme is adapted from (Fryxell et al. 2007). 
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Bead NaOH washing (hydrophilic surface) 
Glass beads were washed and hydroxylated with 14 M NaOH during 5 min and rinsed with 10 
mL deionized water. This washing step ensures the elimination of any contaminant particle 
(dust…) that can be a potential seed for HI aggregation. After NaOH treatment, the water contact 
angle of glass cover slips is 30°±1°. 
 
2.6.2 Experimental protocol: bead test 
The objective of this experiment is to study the influence on HI aggregation of the rupture of an 
air/liquid interface and the periodic creation of triple solid/liquid/air interfaces. The principle of
the experiment consists in repeatedly immersing and drying beads with an HI solution inside a 
column (Figure 32). When the liquid is withdrawn, triple interfaces are created between the bead 
surfaces and the meniscus of the solution. The experiment protocol is described just below. 
A solution of 86 µM HI and 20 µM THT (1 mL HI + 20 µL THT) was degased during 10 
minutes. In the meantime, a chromatography column was filled with 300 mg of previously 
functionalized beads (about 150 beads). Then, a 5 mL syringe was filled with 1 mL of the 
degased solution and connected to the chromatography column with tubing. The volume inside 
the column, when the syringe piston is pushed at its maximum, is 0.5 mL. A scheme of the setup 
is presented in Figure 32. The syringe was placed on a syringe pump which was manually 
programmed to repeatedly withdraw (pulling the piston back) the protein solution from the 
column then immerse (pushing the piston forward) the beads with the solution. The flow rate was 
set to 4 mL/min and the displaced volume was 0.5 mL. The column was closed with a cap 
pierced with two needles to avoid overpressure and evaporation. Without cap or with four 
needles, the evaporation was too pronounced, with only one needle, the overpressure stalled the 
pump so the best compromise was found to be with two needles. The whole system is put in an 
incubator at 37°C alongside with a beaker full of water to saturate the atmosphere with water 
vapor. 
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Figure 32: Setup schematics of the triple interface xperiment on beads.  
A syringe (bottom) fills a column (top) which contains 300 mg of glass beads with an HI solution. The solution is 
represented in blue, the piston and the column bed support (beneath the beads) in black, and the beads by black disks. 
The syringe is fixed on a syringe pump (not shown). The flow rate is set to 4 mL/min and the displaced volume to 0.5 mL. 
The setup is put at 37 °C in an incubator.  
A, beads are immersed in an HI solution.  
B, the HI solution is withdrawn from the column so that the air/liquid interface moves within the bead layer, thus creating 
triple interfaces at the bead surfaces. 
Two experiments with different conditions were conducted in parallel for a direct comparison of 
the aggregation kinetics. After 4 hours of incubation, 200 µL of solution was taken from the 
column at every hour, put in a 96 microwell plate and THT fluorescence was measured. After 
fluorescence measurement, the solution is put back into the column. The measurement error was 
determined by calculating the maximal standard deviation of THT values, measured at the same 
time, from five independent experiments with identical conditions (for four different time point). 
The obtained maximal standard deviation of the measur d THT was 23.5 %. The Tecan baseline 
was set to the mean measured THT fluorescence of a fresh and filtered HI + 20 µM THT 
solution. Controls with TN, TN + 20 µM THT and HI solution were made and are shown in 
Appendix F. When the experiment was finished, 20 beads are put in a 96 microwell plate with 
200 µL of TN and 4 µL (20 µM) of THT. Fluorescence was measured with the “multiple reads 
per well” function of the Tecan. This function records the fluorescence in nine different spots of 
the well. The resulting fluorescence value is the av r ge of the nine measures and their standard 
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deviation. It takes into account the bead non uniform reparation of the beads inside the well. The 
THT fluorescence of 20 fresh beads in 200 µL of TN + 20 µM of THT is 5 ± 1 A.U. 
 
2.7 Methodology: creating a triple interface in a microchannel 
2.7.1 Microchannel surface washing 
Plastic microchannels 
The plastic microchannels were washed before the exp riments with 10 mL of 5% SDS, then 10 
mL of deionized water, then 10mL of 96% ethanol andfi ally 10 mL deionized water. Initially, 
the washing step was done for cleaning the surface of the microchannel of potential contaminant 
particles, but washing with SDS also reduces the noise in the fluorescence images (see Appendix 
G for the effect of washing on the background noise on the fluorescence images). As a 
consequence of an SDS washing, an ethanol washing rinsing is needed to remove the adsorbed 
SDS molecules at the microchannel surface followed ith water rinsing to remove the adsorbed 
ethanol molecules. 
Glass microchannels 
Similarly to glass beads washing, the glass microchannels were washed with 14 M NaOH during 
5 min and rinsed with 10 mL deionized water. The water contact angle of NaOH treated glass 
microchannels is 30°±1°, similar to NaOH treated standard glass microscopic slides. 
 
2.7.2 Microfluidic setup 
This experiment was set up to be able to study microscopically, in situ and in real time, the 
formation of HI amyloid fibrils at a dynamic triple solid-liquid-air interface. The setup was 
designed in order to monitor, over time, HI aggregation at a microchannel surface, as an insulin 
solution is repetitively moved back and forth between two positions (lower and upper level) such 
that the channel comprises three different regions: a region which is always wet (blue in Figure 
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48, page 95), a region which is intermittently wet (dotted in Figure 48) and a region which is 
always dry (white in Figure 48). The experiment was conducted as described below. 
First, a 125 µL syringe, compatible with a syringe pump was made by gluing the end part of a 
standard 10 mL syringe plunger to a Distritips® yringe body (picture in Appendix H). The 
syringe was entirely filled with a solution of 86 µM HI and 20 µM THT (0.5 mL HI + 10 µL 
THT), previously degased during 10 minutes. The syringe tip was inserted in tubing and 
connected to a washed micro channel using a male mini luer fluid connector. All connections 
were sealed with parafilm. The microchannel chip (with the connected syringe) was, then, firmly 
clamped on the motorized microscope stage and completely filled up with protein solution until 
the outlet. A plug was introduced in the outlet that made the liquid move back to the upper level 
and the syringe was fixed on the syringe pump. The plug sealed the device, insured the 
repeatability of the liquid levels during the cycles and avoided evaporation. A transparent heater 
was placed over the chip to cover and uniformly heat at 37°C the triple interface zone and the 
adjacent zone remaining always wet (the transparent h a er will be described in section 2.7.3). 
The syringe pump flow rate was set to 16 µL/min andprogrammed to repeatedly withdraw and 
push 2 µL of HI/THT solution, thus moving the liquid-air interface between the upper and the 
lower level (Figure 48.B). A complete cycle of wetting-dewetting thus lasted 15 s. A new channel 
was used for each experiment. Schematics of the setup are shown in Figure 48 and a picture in 
Appendix I. 
Thioflavin T (THT) fluorescence was used to monitor he formation of amyloid deposits and 
reflection interference contrast microscopy (RICM) to monitor the morphology of the liquid film 
after liquid receding. 
 
2.7.3 Thermalisation 
The thermalisation at 37°C was performed thanks to a homemade conductive transparent heater 
applied directly on top of the microchannel chip. The transparent heater was made of a silver 
nanowire (AgNW) network deposited on a glass slide and covered by a thin PDMS coating. 
Thanks to the Joule effect, when an electrical current was applied through the network, heat was 
released and transferred to the substrate (Sorel et al. 2014).  
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The AgNW were purchased at Seashell Company and have, in average, a diameter of 117 nm and 
a length of 42.5 µm. A solution of 1mg/mL was deposited by spin coating. Two strips of 
electrodes composed of silver paste were deposited on both sides and a sintering for one hour at 
200°C followed. The created network was characterised by an electrical resistance close to 10 Ω 
while the optical transmittance was close to 82% (including substrate absorption). A droplet of 
PDMS (preparation of the PDMS mixture is detailed in Appendix J) was deposited on top of 
AgNW network and spin-coated for 1 minute at 250 turns/min, with an acceleration of 100 
turns/min/s. Then, it was cured overnight at 60°C to prevent any contact with AgNW and to 
ensure a better stability of the networks. A picture of the transparent heater is shown in Appendix 
K. The transparent heater was connected to a power generator through crocodile clips.  
The tension to be applied to reach a 37°C temperatur  inside the microchannel was determined 
using a thin Pt 500 platinum resistor placed underneath the microchannel (schematics in Figure 
33). 
 
Figure 33: Setup schematics for the determination of the voltage to apply to the transparent heater to reach 37 °C.  
The transparent heater is represented in dark grey, the Pt 500 resistor in yellow, the silver paste contacts in black and the 
microchannel chip in light grey.  
Figure credits to Mélanie Lagrange PhD thesis. 
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A calibration curve was obtained by applying 10 minute voltage steps to the transparent heater 
and measuring the resulting temperature (an example is shown in Figure 33.A). The temperature 
reached after 10 minutes was then reported, for each voltage step, as a function of the applied 
power (Figure 33.B) and a linear relationship betwen temperature and voltage was deduced 
(equation in Figure 33, Figure 34.B). A first estimation of the tension to apply to reach 37°C at 
the surface of the microchannel was determined by the following equation: 
 3 = 437 − # 7 Equation 7 
Where V is the estimated tension to apply to reach 37°C, T0, is the room temperature, R, the 
nanowire network resistance and a, the linear coefficient found in Figure 33.B. 
The calculated tension is usually not correct because (i) a 10 minute voltage step is not long 
enough to have a stabilized temperature and (ii) the resistance of the nanowire network is 
assumed to be constant but it actually varies slightly with the applied voltage. As a consequence, 
additional one hour control tests with constant applied tension were needed to find the right 
tension to apply to reach a temperature of 37°C with a precision of ± 1°C (Figure 33.C). 
During the experiment, the temperature was considered to be stable after 30 minutes (the 
temperature variation between 1800 and 3600 seconds was only of 0.08°C in Figure 33.C). One 
should also note that the temperature in the microchannel depends on the room temperature 
(Equation 7) so the room temperature was measured before and controlled during the entire 
experiment and the applied tension adjusted if needed. 
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Figure 34: Calibration curves of the transparent heater.  
A, temperature as a function of time, 10 minute voltage steps of 1V, 1.5V, 2V and 2.5V were applied tohe transparent 
heater.  
B, temperature as a function of the power. The temperature points correspond to the last temperature value for each step 
in A. The power is calculated as the current times the tension measured at those points. A linear fit gives the relationship 
between the temperature and the power. T0 represents the room temperature.  
C, temperature as a function of time when a tension of 2.3 V was applied to the transparent heater during one hour. 
2.7.4 Image acquisition 
Three different acquisition methods were used in this experiment: 
Time-lapse acquisition 
This method aims to follow microscopically and in real time, during the whole experiment, the 
HI amyloid fibril formation kinetics or the liquid roplets shape and position at the microchannel 
surface. The time-lapse images were used to determin  the overall HI aggregation kinetics 
(Figure 49.A), the droplet superimposition index (Figure 51.A) and the HI aggregation kinetics at 
a moving solid/liquid/air interface (Figure 53). It was proceeded as follow: 
After the whole setup (see 2.7.2) was fixed on the microscope stage, the microscope objective 
was focused on the cover lid, at 2.4 mm from the upper level and 200 µm from the channel wall 
(Figure 48). The pump was programed to stop for 1s, every 10 cycles (150 s). The shutter and the 
camera were synchronized to acquire one image each time the pump stopped. The Visual Basic 
program used to automatize the acquisition is shown in Appendix L. It is composed of two loops: 
the pumping cycle loop which is embedded in the image acquisition loop (Figure 47, page 89). 
First, the pumping cycle loop is initialized and set to perform 10 cycles of pulling-pushing the 
syringe piston. Then, the image acquisition loop is repeated 99 times: at each iteration, the shutter 
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is opened, an image is acquired, then the shutter is closed and the pumping cycle loop is run. The 
next acquisition loop iteration starts after the pum  has finished its 10 cycles of pulling-pushing 
(150 s). This procedure results in a time-lapse image sequence acquisition of 1 image every 150 s 
during the entire experiment. Fluorescence or RICM microscope images were acquired as the 
liquid meniscus was at the upper level or the lower level, respectively. 
With our microscope setup, it is not possible to simultaneously acquire both fluorescence and 
RICM time lapse image series. Consequently, the results based on different imaging mode time 
lapse series come from different experiments. Nevertheless, the Visual Basic program can be 
interrupted at the end of an acquisition loop so that t e imaging mode and the liquid level 
position (lower or upper) can be switched, allowing both a fluorescence and a RICM image to be 
acquired at the same cycle. The gain and acquisition time of the camera were chosen to prevent 
saturation during the recordings. 
End-point acquisition 
This acquisition was used to obtain the distribution, ver the microchannel length, of the HI 
amyloid aggregates attached at the surface after 6 hours of experiment (Figure 49.B, C and D). 
At the end of the experiment, the protein solution was withdrawn and the channel was filled with 
1 mL of TN buffer supplemented with 20µM THT. The microscope objective was placed at 200 
µm from the channel wall. Fluorescence images were then acquired along the x-axis, every 200 
µm, using the motorized stage and manually refocusing in z, allowing a total surface coverage 
along the x-axis. The three regions, always dry, triple interface and always wet, were covered by 
the image sequence.  
RICM Movie 
RICM movies were acquired at different times during the experiment in order to determine 
droplet growth kinetics (Figure 51.B). The shutter was kept open and there is no THT 
photobleaching in RICM recordings. A movie was acquired over several consecutive wetting-
dewetting cycles with the DPController software (Olympus) at 15 frames per seconds.  
Fluorescence Movie 
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Fluorescence movies were acquired in order to determin  the THT fluorescence increase during a 
wetting phase (Figure 73 and Figure 75, page 146 and 149, respectively). A movie was acquired 
over several consecutive wetting-dewetting cycles with the DPController software (Olympus) at 
15 frames per seconds. The shutter was kept open duri g the all acquisition time. Significant 
THT photobleaching is observed (Figure 73, page 146) and has to be taken into account in the 
image analysis. 
 
2.7.5 Image analysis 
All image treatment and analysis were performed with ImageJ. 
Fluorescence quantification of insulin aggregation kinetics and endpoint distribution of 
amyloid aggregates in microfluidic channels (Figure 49) 
At any given time point of the time-lapse acquisition, THT fluorescence was quantified by 
calculating the mean grey level intensity of the corresponding fluorescence image. Error bars 
represent the standard deviation of the measured int nsities. The same procedure was applied to 
quantify the THT fluorescence distribution along the microchannel at the end of an aggregation 
experiment (end-point acquisition). An ImageJ plug-in called “Measure Stack” was used to 
automatically calculate the mean grey level of all the fluorescence images of a time-lapse or an 
end-point acquisition. 
Detailed growth kinetics of amyloid aggregates around liquid droplets remaining in the 
microchannel after dewetting (Figure 53) 
The following image treatment protocol was used to etermine the radial distribution of the THT 
fluorescence increase around droplets, remaining on the microchannel surface, using time-lapse 
fluorescence images recorded every 10 cycles. At each time point, the radial fluorescence 
intensity profile (I (r)) was determined as a function of the distance to the center of the 
fluorescent ring (Figure 35.A-C), then the differential fluorescence increase distribution (∆I (r)) 
over 10 cycles was calculated and analyzed to obtain the net fluorescence increase (Σexp) and the 
radial position of the maximum fluorescent increase (8/9:;:< ) (Figure 35.D). 
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Figure 35: Image processing of the evolution of a THT-positive ring observed by fluorescence microscopy.  
A, example of a concentric circle drawn around the center of the droplet (white dot). r represents the radial distance to the 
center. Units : gl = grey level.  
B, integrated fluorescence intensity profile (F, gl x pixel2) as a function of radius r.  
C, radial fluorescence intensity profile (I,  gl x pixel) as a function of radius r.  
D, differential fluorescence increase distribution (∆I, gl x pixel) over a 10-cycle interval as a function of the radius r. 
Continuous line: fit of ∆I (r) by two Gaussian functions (see Equation 11). =>?@A@B  represents the radial position of the 
maximal fluorescence increase. 
For each fluorescent image, a circle around the outlines of the fluorescent ring was first drawn 
(Figure 35.A) and the center of this circle was used as the center of the droplet (white dot). 
Concentric circles of pixel-wise increasing radii were then defined, until they reached another 
fluorescent ring or the border of the image. The int grated fluorescence intensity profile was 
calculated by integrating the total fluorescence inside each circle defined by its radius r (Figure 
35.B). At every time point t expressed in cycles (1 cycle = 15 s), the integrated fluorescence 
intensity profile can be analytically expressed as: 
 C(!, () = 	D (E, F, ()E%E%FG,H, = I21(E, ()E%E
G

 Equation 8 
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Where I (u, t) corresponds to the average fluorescence intensity along the perimeter of the 
segmentation circle or radius u at a time point t. 
The radial fluorescence intensity profile I (r, t) at any time point was obtained by deriving F (r, 
t) from equation 1 (Figure 35.C): 
 (!, () = 121! %C(!, ()%!  Equation 9 
The F (r, t) derivative was calculated with the Savitzky and Goley algorithm, using 7 points 
(coefficients used: -3, -2, -1, 0, 1, 2, 3 normalized by dividing by 28) (Savitzky and Golay 1964). 
Then, consecutive radial fluorescence intensity profiles were subtracted, to define the differential 
fluorescence intensity distribution over a 10 cycle interval, ∆I (Figure 35.D).  
 ∆(!, () = (!, () − (!, ( − 1) Equation 10 
The net fluorescence increase over a 10 cycle interval, Σexp, is obtained by integration of the ∆I
differential profile along r.  
Finally, each differential profile was fitted with two Gaussian functions and six parameters 
(Figure 35.D): 
 ∆ = JKLGKMNOP
QPR ST  JK(GKG)
T  Equation 11 
Where A1, A2, represent the amplitudes, 8/9:;:< , r2, the peak positions and σ1, σ2, the widths of 
the two Gaussian functions. The first Gaussian functio  was used to fit the main peak of the 
profile and the second Gaussian function to fit the baseline (Figure 35.D). The radial position of 
the maximal fluorescence increase i  thus determined by the center of the first Gaussi n peak, 
8/9:;:<  (Figure 35.D). 
 
Droplet superimposition index at the surface of the microchannel (Figure 51.A) 
At each time point of a RICM time-lapse acquisition, the superimposition index was determined 
from two RICM images of droplets, obtained after dewetting (Figure 36.A) and separated by 10 
cycles (150 s). For each RICM image, a binary image was created by manually defining a 
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threshold so as to select the dark disc inside the droplets, and colored in red for the first image 
and in green for the second one, obtained 10 cycles lat r (Figure 36.B). Afterwards, the 10 cycle 
separated colored images were superimposed, resulting in an RGB image (Figure 36.C). The 
superimposition index is calculated from the 3 RGB images by the ratio of the yellow pixels (red 
AND green) to the sum of the red and green pixels minus the yellow pixels (red OR green). 
 UEV!'WVXU'('X$	'$%Y = XZ![#VV'$\	%!XV[(	#!#(X(#[	%!XV[(	#!#
= ]7   − ] 
Equation 12 
The error bars were calculated as the maximal error that could originate from alternative 
threshold choices. 
In order to estimate the probability that droplets overlap randomly, an other RGB image was 
created (Figure 36.D), where one image was superimposed with itself, flipped by 180°. The 
superimposition index is 0.09 in this case. We therefore consider that superimposition indices > 
0.15 indicate non-randomness. 
 
Figure 36: RICM image processing and superimposition index calculation.  
An RICM time-lapse image (A) is used to create a binary image (B) of the dark discs inside the droplets. Binary images 
separated by 10 cycles are then superimposed to form an RGB image (C) from which the superimposition index is 
calculated (see text). 
In (C) the superimposition index equals 0.58 (calculated at 49 min of experiment).  
A control is shown in (D), representing the superposition of (B) with itself rotated by 180 degrees. The superimposition 
index of (D) equals 0.09. 
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Droplet reformation kinetics at the surface of the microchannel (Figure 51.B) 
At different time points, the droplet reformation kinetics was determined by analyzing an RICM 
movie. First, the first and last frames obtained in the dewetted time interval at ROI were selected. 
Then, five droplets were selected and their initial and final size was determined using binary 
images of these two images, as shown in Figure 36.B. The reformation kinetics of each droplet 
was finally calculated as the droplet size difference between the two images divided by the dry 
time interval. A mean value was obtained by averaging the reformation kinetics of the five 
droplets and has been calculated at 10, 50, 75, 90 and 120 min of the experiment. Error bars 
represent the standard deviation of the growth kinetics values. 
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3.1 The accelerating effect of a dynamic triple solid/liquid/air interface 
on HI aggregation 
3.1.1 Experimental approach: creation of a dynamic triple interface on a bead surface. 
This chapter aims to demonstrate the accelerating effect of a moving solid/liquid/air triple 
interface on HI aggregation. Hydrophobic interfaces are known to adsorb and partially unfold 
proteins, leading further to their aggregation. A dynamic triple interface brings in contact two 
hydrophobic interfaces (solid/liquid and liquid/air) which locally increase the concentration of 
partially unfolded proteins. A very frequent case of a dynamic triple interface in protein solution 
handling is a solution meniscus moving up and down n a vial wall when the solution is moved 
due to handling or, in a more pronounced way, due to shaking. In this example, a triple contact 
line (the meniscus) regularly sweeps the vial walls provoking an intermittent wetting or 
immersion of a solid surface by a protein solution. Could such a phenomenon promote protein 
aggregation? To answer this question, we investigate the effect of solid surface intermittent 
wetting on the stability of proteins. A simple way to mimic, in a controlled manner, vial wall 
intermittent wetting is to repeatedly fill then empty a column with a HI solution. Two methods 
can be used to monitor HI aggregation: remaining native HI or HI aggregate (amyloid fibrils) 
quantification. 
Initially, UV absorbance at 280 nm was tried to measure the soluble HI concentration during the 
experiment by connecting a spectrophotometer, controlled with Labview, to the column. When 
the column was emptied, the HI solution that was inside went through the spectrophotometer 
chamber and absorbance at 280 nm was measured. Unfortunately, this setup has strong 
drawbacks. First, HI aggregates in the spectrometer chamber scattered light and created a bias on 
the absorbance measurement. A filter unit was added at the bottom of the column to retain HI 
aggregates but it induced a drift on the spectrometer electric signal. The filter unit was suspected 
to release particles (most likely glycerol or little pieces of the filter tissue membrane) with time 
that disturbed the absorbance measurement. Second, this setup involved too many environmental 
factors that could have an effect on HI aggregation (different tubing and fluidic connectors, 
spectrometer chamber in metal, plastic column, syringe body and piston). Third, it was 
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impossible to easily heat the setup to 37 °C in order to accelerate the aggregation process. 
Considering these difficulties, this HI aggregation monitoring method was abandoned. 
Then, THT fluorescence was chosen to monitor the amount of amyloid fibrils in the HI solution. 
Amyloid fibrils, which are HI aggregates, have a rich beta-sheet structure. THT is a 
conformational marker that, when inserted into beta-sheets, is subjected to a fluorescent shift. We 
used the setup described in 2.6.2 which can be put in an incubator at 37 °C but at the cost of 
manual measurements. Every hour, starting from 4 hours into the experiment, 200 µL of HI 
solution was withdrawn from the filled column (the syringe pump was previously stopped) and 
THT fluorescence was measured. Another advantage is the possibility to run two experiments in 
parallel at the same time with identical setups which allows direct comparison between different 
conditions and limits the impact of external factors n HI aggregation kinetics (such as the age of 
the HI solution, the difference between measurement times when the pump is stopped, 
temperature variation when the incubator is opened…). Limiting the external factors’ impact is 
important because HI aggregation kinetics has already a high intrinsic variability. Therefore, all 
the comparative studies shown in this chapter result from experiments run simultaneously. 
Also, hydrophobic glass beads are added in the column to increase the surface of the dynamic 
triple interface. Each bead causes the meeting of an air/liquid interface with a hydrophobic solid 
surface, increasing the available dynamic triple int rface total surface by a factor 2.53 (calculated 
as one plus the ratio of the number of beads, i.e. 150, times the bead surface over the column wall 
surface sweeped by the solution meniscus: 1 + (150 × Sbead)/Scol). This surface increase aims to 
accelerate the HI aggregation process. One should nte that the experimental time is an important 
constraint because of the manual measurements and liqui  evaporation that is not negligible after 
24 hours. As a control, a comparison between HI aggregation kinetics in the presence and 
absence of hydrophobic glass beads has been done (sch matics in Figure 37). Hourly THT 
fluorescence measurements are shown in Figure 38. 
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Figure 37: Experimental setup of the control experiment.  
The HI solution is represented in blue, the column bed support (beneath the beads) in black, and the beads by black disks. 
∆V represents the displaced liquid volume.  
A, standard bead condition, the column is completely emptied at each cycle resulting in the creation of dynamic triple 
interfaces on beads.  
B, control condition, the column does not contain beads. It is completely emptied at each cycle resulting in the creation of 
dynamic triple interfaces only on the column walls. 
 
Figure 38: HI aggregation kinetics in the presence (circles) and in the absence (diamonds) of hydrophobic beads.  
THT fluorescence is measured at 4, 5, 6, 7 and 9 hours, simultaneously for both conditions.  
The background fluorescence of a fresh and filtered HI solution (without amyloid fibril) with 20 µM of  THT (10.35 ± 1.81 
A.U) is subtracted. 
Error bars are estimated to be ± 23.5 % of the measured value and are representative of three different experiments.  
In the presence of hydrophobic beads, THT fluorescence at 4 hours is significantly above the 
baseline (> 15.78 which is the baseline fluorescence value plus three times its standard 
deviation), confirming the presence of HI amyloid fbrils, and 3.52 times higher than in the 
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absence of beads. The fluorescence signal increases quasi linearly with time with a rate of 19 A.U 
per hour to reach 150.65 A.U at 9 hours. In the absence of beads, the THT fluorescence is low 
(16.65 A.U) at 4 hours, increases slowly between 5 and 7 hours at a rate of 5 A.U per hour and 
more rapidly between 7 and 9 hours to reach 54.65 A.U which is 2.76 times lower than in the 
presence of beads. As a conclusion, the amount of HI amyloid fibrils created and released in 
solution is 4.29 times higher when the hydrophobic and dynamic triple interface surface is 
increased by a factor 2.53. This experiment shows that the concomitance of liquid movement, 
dynamic triple interface and hydrophobic surface induces amyloid fibril formation. It also 
validates the setup for the HI aggregation kinetics study. Nevertheless, a faster HI aggregation in 
presence of beads cannot be related directly to an accelerating effect of dynamic triple interfaces. 
In the presence of beads, the liquid has to flow through the bead network. Proteins adsorbed at 
the bead surface are thus exposed to a higher sheartr ss than the ones adsorbed at the column 
wall in the absence of beads. An approximation of the shear stress at a cylinder wall can be 
calculated as follows. The velocity profile v of a laminar flow through a cylinder of radius R 
(schematics in Figure 39), only varies as a functio of r and is described by a simplified Navier-
Stockes equation: 
 ^ _Z_! = %V%` Equation 13 
r and z are the cylindrical coordinates, p is the pressure and η the viscosity of the fluid (N.s/m2). 
 
Figure 39: Schematics of a Poiseuille flow in a cylinder,  
V(r) is the radial velocity profile, R is the radius of the cylinder, Vmax is the maximal velocity, reached for r = 0, r and z are 
the cylindrical coordinates.  
Figure taken from http://epiphys.emn.fr. 
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After applying the boundary conditions Z(7) = 0	and	 dedG (0) = 0, the solution of the equation is 
expressed as: 
 Z(!) = 14^ %V%` (7 − !) Equation 14 
 
Then, the Poiseuille equation is used to determine 
d<df: 
 g = DZ(!)! %! %F = 214^ %V%` I !(7 − !)
h
 =
17i8^ %V%` Equation 15 
 
 %V%` = 8^g17i Equation 16 
With D representing the volumetric flow rate (m3/s). 
And finally, 
 Z(!) = 2g17i (7 − !) Equation 17 
 
Now that the velocity profile is fully known, it is possible to calculate the shear stress at the 
cylinder wall with: 
 k = ^ l_Z_!mGnh = −4g^17o Equation 18 
With σ corresponding to the shear stress (N/m2) 
In the empty column condition experiment, the shear stress at the column wall σwall is directly 
calculated with Equation 18, considering η = 0.000692 N.s/m2 (water viscosity at 37 °C), D = 4 
mL/min = 6.7  10-8 m3/s (the pump flow rate), and replacing R by the radius of the column (Rcol 
= 3.25 mm), and equals 1.72  10-3 N/m2. When beads are added, the liquid goes through 
numerous microchannels, created by the gaps between th  beads (Figure 40.C). The volumetric 
flow and the radius of the cylinder are thus modified. A simple model is used below to estimate 
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the shear stress at the surface of the beads. One could assume that the beads, inside the column, 
are organized in 2D ordered layers with a 2D compacity c. The microchannels are supposed 
identical and cylindrical with a radius Rmc (Figure 40.C). The cross section of a microchannel is 
called s and equal to π times Rmc
2. The total surface Scovered by the 2D beads layer is equal to π
times the square of the column radius Rcol (corresponding to the cross section of the column). The 
volumetric flow d inside a microchannel is equal to the total volumetric flow D divided by n, the 
number of microchannels in a 2D layer. n can be written as a function of s, c and S: 
 $ = 	 (1 − p)U = (1 − p)7qrs

7/q  Equation 19 
 
That gives the volumetric flow in a microchannel: 
 % = g$ = g7/q

(1 − p)7qrs Equation 20 
 
Inserting d in Equation 18, we obtain the shear stress at a bead surface σbead: 
 kt;9d = − 4^g(1 − p)7/q17qrs Equation 21 
 
And finally, the shear stress ratio: 
 kt;9dku9ss = 7qrs(1 − p)7/q Equation 22 
 
One example of an organized 2D bead network is the hexagonal lattice (Figure 40.B) with a 
compacity c of 0.91, which is the densest 2D disk arrangement possible. In this configuration, a 
microchannel is formed by three beads in contact with each other. The three bead centers define 
an equilateral triangle of side equal to two times the bead radius Rb (which is 0.5 mm). The free 
surface inside this triangle is assumed to correspond to the cross section of a cylindrical 
microchannel which allows the determination of Rmc: 
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 7/q = 7t421 − 12 = 0.185	WW Equation 23 
 
For a hexagonal packing, the shear stress at the bead surface is 0.336 N/m2, 195 higher than at the 
wall surface. 
One other way to arrange beads in a plane is a cubic packing (compacity c of 0.79, Figure 40.A), 
which is the least dense 2D disk arrangement possible. This time, a microchannel is formed by 
four beads in contact with each other. The bead centers define a square of side equal to two times 
the bead radius Rb, so Rmc is expressed as: 
 7/q = 7t441 − 1 = 0.261	WW Equation 24 
 
The resulting shear stress at the bead surface is 0.102 and the ratio 
TyQOzT{O||  equals 59. 
 
Figure 40: Schematics of the used bead network model.  
The microchannels are represented by blue cylinders, the red colored areas correspond to s the cross section of a 
microchannel, Rmc is the microchannel radius, Rb is the bead radius, r and z the cylindrical coordinates 
 A, horizontal cross section of a cubic network. 
 B, horizontal cross section of a hexagonal packing. C, vertical cross section of the network. 
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Obviously, in reality, beads are randomly packed but the compacity of the network should be 
between the previously calculated values. Also, side effects due to the column geometry are 
neglected, liquid pathways inside the bead network are not straight and cylindrical, the flow is not 
laminar but the model gives a good overall estimation of the shear stress difference between the 
two experimental conditions. 
The shear stress at the bead surface is estimated to be between 0.1 and 0.34 N/m2, up to 195 
higher than the shear stress at the column wall in the absence of beads. It is thus impossible to 
unambiguously attribute the aggregation kinetics acceleration to protein interfacial adsorption 
and shear stress or to the presence of dynamic triple interfaces or both. Therefore, the setup has to 
be improved in order to work at equivalent shear stres . In this way, shear stress on adsorbed 
proteins and the effect of a triple interface can be decorrelated, allowing the study of the impact 
of the increase of the dynamic triple interface on HI aggregation kinetics. 
 
3.1.2 Comparing the effects of the hydrodynamic shear stre s and the creation of 
dynamic triple interfaces upon HI aggregation 
The presence of a dynamic triple interface is generally tightly linked with solution shaking. 
Agitation has been shown to be a mandatory condition to induce protein aggregation. It ensures a 
constant protein supply all along the aggregation process (aggregates grow by recruiting new 
proteins provided by the solution). It has also two effects on proteins: (i) solid surface adsorbed 
proteins are subjected to hydrodynamic shear stress i. . hear forces due to liquid movement on 
the solid surface. These forces may provide the energy needed to unfold proteins and then induce 
aggregation. (ii) It creates dynamic triple solid/liquid/air interfaces, regions where the local 
concentration of interfacially adsorbed and partially unfolded proteins is high. As a consequence, 
a critical point is to decorrelate and compare separately these two agitation effects on HI 
aggregation kinetics. 
We propose a new experiment based on the same setup (3.1). On one hand, a column containing 
150 hydrophobic beads is filled with 0.5 mL of a HIsolution, identical to the standard bead 
condition experiment used before (Figure 41.A). On the other hand, a column containing the 
same amount of beads is filled with 0.65 mL of the same HI solution (the total solution volume 
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used is 1.5 mL HI + 23 µL THT, Figure 41.B). The flow rate is set to 4 mL/min and the displaced 
volume equals 0.5 mL for both conditions. 
 
Figure 41: Schematic view of the two different experimental conditions.  
The HI solution is represented in blue, the column bed support (beneath the beads) in black, and the beads by black disks. 
∆V represents the displaced liquid volume.  
A, standard bead condition. The column is completely emptied at each cycle resulting in the creation of dynamic triple 
interfaces.  
B, the solution meniscus always remains above the beads so that no dynamic triple interfaces are created on the beads. 
Bead-adsorbed proteins are submitted to the same shear stress in both conditions. 
In the standard condition (Figure 41.A), the column is entirely emptied and then filled so that 
triple interfaces are periodically created at the bead surfaces. In the other condition (Figure 41.B), 
the same liquid volume is displaced but the solution meniscus always stays above the beads i.e. 
beads are always immersed. Therefore, no triple interfaces are created on the beads but proteins 
adsorbed at their surface are submitted to the same hear stress (due to the liquid passing through 
the bead network at the same flow rate) as in the sandard condition. One should note that the 
triple interface surface ratio is the same as in the previous experiment. By comparing the HI 
aggregation kinetics of these two experimental conditions, it is possible to determine which one, 
between dynamic triple interfaces and the hydrodynamic shear stress affects interfacially 
adsorbed proteins. Results are shown in Figure 42. 
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Figure 42: HI aggregation kinetics in the presence (circles, standard bead condition) and in the absence (diamonds) of 
dynamic triple interfaces, at equivalent shear stress.  
THT fluorescence is measured at 4, 5, 6, 7 and 8 hours, simultaneously for both conditions.  
The background fluorescence of a fresh and filtered HI solution (without amyloid fibril) with 20 µM of  THT (10.35 ± 1.81 
A.U) is subtracted. 
Error bars are estimated to be ± 23.5 % of the measured value and are representative of three different experiments.  
In the standard bead condition, the THT fluorescence starts at 36.65 A.U, increases to 56.65 A.U 
at 5 hours and then increases roughly linearly witha rate of 9.8 A.U per hour until 8 hours. When 
beads remain immersed (diamonds), the THT fluorescence reaches 8.65 A.U after 4 hours and 
increases linearly between 5 and 8 hours at a rate of 4.2 A.U per hour. During all the experiment, 
the THT signal of the standard bead condition, where dynamic triple interfaces are created on 
beads, is between 3.03 to 4.24 times higher than in the other condition. This experiment shows 
that the increase of HI aggregates is potentially quadrupled when the increase of the triple 
interface surface is doubled (which is equivalent to the previous experiment (3.1), and equals 
2.53). 
After 8 hours, the experiment is stopped and the THT fluorescence of 20 beads, for each 
condition, is recorded. It equals 38.78 ± 8.42 A.U for the standard bead condition (Figure 41.A) 
and 27.56 ± 3.54 A.U for the other one (Figure 41.B). The background fluorescence of 20 plain 
beads in 200 µL of TN + 20 µM of THT is subtracted (5 ± 1 A.U). This confirms the presence of 
strongly attached amyloid fibrils at the bead surface, with a larger amount in the case of the 
standard bead condition. 
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This experiment clearly demonstrates the dominating role and the accelerating effect of dynamic 
triple interfaces on HI aggregation. Indeed, at equivalent shear stress, the increase of the dynamic 
triple interface surface accelerates HI aggregation and the amount of amyloid fibrils created 
increases with the amount of triple interface surface vailable. Also, the THT signal ratios remain 
between 3 and 4 whether additional shear stress is created by the presence of beads (Figure 42) or 
not (Figure 38), thus showing that hydrodynamic shear stress on interfacial adsorbed HI proteins 
alone does not induce their aggregation. 
 
3.1.3 Effect of the liquid bead sweeping speed 
Now that the role of dynamic triple interfaces on protein aggregation has been established, we 
can look further into its mechanism. When the liquid is withdrawn from the column, the solution 
meniscus sweeps the bead surface, creating moving triple interfaces. One could imagine that the 
speed with which the meniscus sweeps the surface can be of importance in the aggregation 
process. The difficult part of studying the effect of the sweeping speed on HI aggregation kinetics 
is to compare, simultaneously, experiments with different sweeping speeds but with the same 
total number of column full/empty cycles. The total number of liquid cycles sets the total number 
of dynamic triple interfaces that are created which obviously impacts the aggregation kinetics. 
We designed an experiment with two standard bead con iti ns in which the flow rates and thus 
the sweeping speeds are different. In the fast sweeping condition, the flow rate is two times 
higher than in the slow sweeping condition. A pump synchronization is needed to keep the same 
total number of pumping cycles in both conditions. The pumps are synchronized as described in 
Figure 43. Both are started simultaneously and fill the columns with 0.5 mL of HI solution. In the 
fast sweeping condition, the column is filled two times faster so a waiting time is set to finish the 
filling of the column of the slow sweeping condition. Then, both pumps initiate the emptying of 
the columns at the same time. Again, the column is cleared out faster in the fast sweeping 
condition so another waiting time is needed. When both columns are empty, a new pumping 
cycle begins. With this pump programing, the column fill/empty cycles have the same overall 
duration. Figure 44 shows the aggregation kinetics of both conditions. 
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Figure 43: Schematic view of the two different experimental conditions. 
The HI solution is represented in blue, the column bed support (beneath the beads) in black, and the beads by black disks. 
∆V represents the displaced liquid volume. 
A, standard bead condition. 
B, pump cycle description. 
The ordinate axis represents the filling state of the column. The pump programs of the slow and fast sweeping conditions 
are represented in blue and red, respectively. The flow rate is set to 4 mL/min for the fast sweeping condition and to 2 
mL/min for the slow sweeping one. 
 
Figure 44: HI aggregation kinetics in the fast (circles) and slow (diamonds) sweeping condition, at equivalent total number 
of pumping cycles. 
THT fluorescence is measured at 4, 5, 6, and 7.25 hours, simultaneously for both conditions. 
The background fluorescence of a fresh and filtered HI solution (without amyloid fibril) with 20 µM of  THT (10.35 ± 1.81 
A.U) is subtracted. 
Error bars are estimated to be ± 23.5 % of the measured value and are representative of three different experiments. 
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After 4 hours, the THT signal is 29.65 A.U for the fast sweeping condition and 14.65 A.U for the 
slow sweeping one. Both signals have a linear increase with a rate of 12.9 and 8.5 A.U per hour, 
to reach 68.65 and 40.65 A.U after 7.25 hours. The fluorescence of the beads, measured after the 
end of the experiment, is 34.78 ± 21.77 and 45.22 ± 0.51 A.U for the fast and slow conditions, 
respectively. The background fluorescence of 20 plain beads in 200 µL of TN + 20 µM of THT is 
subtracted (5 ± 1 A.U). 
The HI aggregation kinetics of the fast sweeping condition seems to be globally faster, its THT 
fluorescence being from 1.69 to 2 times higher, than the one of the slow condition. However, 
there are more amyloid fibrils that remain attached on the beads of the slow condition. The 
sweeping speed may have an impact on the release into solution of amyloid fibrils, formed at the 
bead surface. Amyloid fibrils, as they grow at the bead surface, can be ripped off by the liquid. 
Therefore, a higher sweeping speed possibly accelerat s the creation of HI aggregates and 
influences their distribution (in solution or surface adsorbed) but does not strongly affect the total
amount of fibrils created. It also should be noted hat the beads located at the bottom of the 
column spend a longer time in a dry state in the fast sweeping condition than in the slow one. 
This could potentially have an effect on the HI aggre ation kinetics but, with the current setup, it 
is not possible to study separately the effect of the sweeping speed and the drying time of the 
hydrophobic surface. 
3.1.4 Effect of material surface chemistry 
We have shown, in our setup, that HI aggregation is triggered by the creation of dynamic triple 
interfaces. These are formed at the meeting of an air/liquid interface and a hydrophobic solid 
surface (beads). Since it is not possible to modify the hydrophobic nature of an air/liquid 
interface, it should be interesting to study the impact of the solid surface hydrophobicity on HI 
aggregation. 
We used beads treated with NaOH and silanized beads to compare the effect of hydrophilic and 
hydrophobic surfaces on HI aggregation. Kinetics with both bead types are shown in Figure 45. 
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Figure 45: HI aggregation kinetics of a standard bead condition with hydrophobic (circles) and hydrophilic (diamonds) 
beads. 
THT fluorescence is measured at 4, 5, 6, 7 and 8 hours, simultaneously for both conditions. 
The background fluorescence of a fresh and filtered HI solution (without amyloid fibril) with 20 µM of  THT (10.35 ± 1.81 
A.U) is subtracted. 
Error bars are estimated to be ± 23.5 % of the measured value and are representative of three different experiments. 
In presence of hydrophobic beads (circles), the THT fluorescence signal at 4 hours is 54.65 A.U 
and then increases roughly linearly with a rate of 14.6 A.U per hour between 5 and 8 hours. For 
hydrophilic beads (diamonds), the THT fluorescence starts at 29.65 A.U after 4 hours of 
experiment. From 5 hours, it rises linearly until 8 hours at a rate of 17.1 A.U per hour. The THT 
fluorescence of beads, after the experiment, is 16.75 ± 7.25 A.U for the hydrophobic ones and 
2.33 ± 1.22 A.U for the hydrophilic ones. The background fluorescence of 20 plain beads in 200 
µL of TN + 20 µM of THT is subtracted (5 ± 1 A.U). 
The THT fluorescence of the hydrophobic bead condition is higher than the one of the 
hydrophilic bead condition during all the experiment. Furthermore, the fluorescence recorded at 
the hydrophilic bead surface is nearly equal to the on  measured for functionalized beads not 
incubated with HI whereas the hydrophobic surface, in presence of HI, accumulates a significant 
amount of amyloid fibrils. Thus, the hydrophobic nature of the beads seems to favor the 
formation of amyloid fibers at its surface. 
In conclusion, we firstly demonstrate in paragraph 3.1.2 that dynamic triple interfaces have an 
accelerating effect on HI aggregation kinetics and that hydrodynamic shear alone, applied on 
interfacial adsorbed proteins, does not trigger HI aggregation. Then, the effect of the air/liquid 
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interface sweeping speed on a hydrophobic surface hs been studied (3.1.3). We found that the 
sweeping speed does not have an important impact on HI aggregation kinetics. Finally, it has 
been shown in paragraph 3.1.4 that amyloid fibrils do not form or attach to hydrophilic surfaces 
such as NaOH treated glass, suggesting that amyloid fibr ls are created on hydrophobic surfaces 
only, which is in agreement with other HI aggregation studies (Ballet et al. 2012; Nault et al. 
2013). This set of experiments establishes the predominant role of dynamic triple interfaces over 
hydrophobic surfaces under slow agitation for HI aggre ation. The industrial processes that 
involve the meeting of an air/liquid interface and a hydrophobic solid/liquid interface, such as 
mixing or transport in hydrophobic containers, should thus be carefully watched to avoid protein 
aggregation. 
Although a forward step has been made in the understanding of the origin of agitation-induced HI 
aggregation, a microscopic insight into its mechanism s still missing. Two major questions still 
remain unanswered: where and how are amyloid fibrils created? In the previous setup, it is 
supposed that the amyloid fibrils are created on the column walls and the bead surfaces that are 
swept by the solution meniscus. Nevertheless, it is not possible to have a real-time observation of 
these areas. We could have stopped the experiment as soon as the solution THT fluorescence was 
higher than the base line but the fibrils that are in solution are fibrils ripped off from a solid 
surface. This means that the aggregation process on the surface is already too advanced to give 
any insight into its mechanism of origin. Also, a visualization of the liquid behavior is needed to 
fully understand the dynamic triple interface effect on HI aggregation. Therefore, a completely 
new setup that is able to localize the first created amyloid fibrils and follow their growth in situ 
and in real time is needed and described in the following chapter. 
 
3.2 Growth kinetics of insulin aggregates at the triple interface 
3.2.1 Instrumentation 
HI agitation-induced aggregation has been a long time studied phenomenon revealing that HI has 
a nucleation-driven and hydrophobic surface-dependent aggregation, and that amyloid fibrils 
form on the hydrophobic surface. The amyloid nature and structure of HI aggregates is also 
documented as well as interfacial HI adsorption. However, a piece is still missing in the HI 
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agitation-induced aggregation puzzle: Do the nuclei randomly form on the hydrophobic surface 
or are there specific locations that favor their formation? To answer this question, it requires an 
in-situ and real-time visualization of the growth of the HI aggregates which has not been done 
until now and that is the purpose of this chapter. The results of the previous chapter give us a 
good indication of where the amyloid fibrils form and grow: on a hydrophobic surface swept by 
an air/ liquid interface (i.e. a dynamic triple interface). One, if not the most important part of this 
work is to design and realize a setup that creates dynamic triple interfaces in a controlled, 
observable manner and that allows the characterization of the amyloid fibril growth on a solid 
surface. Such a setup implies the following specifications: a non-destructive characterization, at a 
micrometer scale, of both the liquid morphology and the amyloid fibrils at a solid surface, 
periodic measurements over a long experimental time, and an instrumental, time-resolved 
coupling between a microfluidic system and the chosen characterization techniques.  
First of all, a characterization technique has to be carefully chosen. Several techniques have been 
used to characterize amyloid fibrils but few of them fulfill the needed specifications. Scanning 
electron microscopy (SEM) and standard atomic force microscopy (AFM), although very good in 
terms of resolution, are not applicable because they require sample treatment (metal plating and 
dying, respectively) so they cannot be used in real time. AFM in liquid can be destructive and is 
too sensitive to liquid movement. Infrared spectroscopy (ATR-FTIR) and surface plasmon 
resonance (SPR) are not compatible with an in-situ microscopic observation. Dynamic light 
scattering (DLS) is a bulk characterization method. Obviously, this list is not exhaustive but there 
are some of the standard techniques used in protein stability studies and that could be available to 
us. In regard of this, we chose THT fluorescence microscopy for surface amyloid fibril growth 
characterization and reflection interference contrast microscopy (RICM) to observe the liquid 
behavior at the surface. These two techniques are non-destructive, can be used in-situ to monitor 
aggregation kinetics during several hours. Also, both techniques can be used with the same 
optical microscope with only a few adjustments to switch from one to the other. 
The used microscopic setup is composed of a standard optical microscope, a camera, a motorized 
stage and a shutter (to avoid photobleaching). Then, a microfluidic system that creates dynamic 
triple interfaces and that is compatible with their observation by the chosen techniques was 
designed. The general idea is still the same as in 3.1, a solution going back and forth on a solid, 
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hydrophobic surface in order to have the surface rep atedly swept by the solution meniscus. The 
swept surface has to be plane, transparent and less than 150 µm thick to be visualized with an 
Olympus 60x oil objective. A rectangular microchannel seems to be the most adapted. 
Additionally, the microchannels should be disposable and replaceable for each new experiment. 
We chose to use industrially made microchannels (Microfluidic Chipshop ref 01-0175-0138-02) 
because (i) they are made of only one material (by contrast with homemade PDMS 
microchannels on glass surface or parallel flow chambers), and (ii) the fabrication is highly 
reproducible so that microchannels are identical in terms of dimension and surface 
hydrophobicity which increases the experimental reproducibility. For the pumping, options were 
limited, peristaltic pumps are known to aggregate HI and pressure controllers were not adapted to 
liquid movement in 2 directions. We thus kept a syringe pump due to its highly reproducible, 
forward as well as backward, liquid displacements. The syringe was adapted to manipulate small 
liquid volumes and to minimize the HI solution volume required per experiment. The last part of 
the setup is the thermalisation of the microchannel. The heating system has to be small enough to 
be placed on the microscope stage without obstructing i s movement, compatible with the two 
characterization techniques and transparent to visually control the liquid movement inside the 
microchannel. We chose to use a homemade transparent heater described in paragraph 2.7.3. 
Finally, the microfluidic system and the microscopic setup have to be coupled and automatized. 
A single THT fluorescence image acquisition during the experiment implies a specific and well-
timed action sequence: stop the pump cycle when the microchannel is filled, open the shutter, 
acquire an image, close the shutter and resume the pump cycle. This sequence is repeated several 
times during a timelapse acquisition. The different devices are synchronized with an Image Pro 
Plus “macro” (that is a user-written visual basic program). The syringe pump and the shutter are 
connected to the computer via a RS-232 port and controlled with ASCII commands given by the 
constructor. A plug-in named CRS232C and its associated dynamic link library (detailed in 
Appendix M) is used to write on RS-232 ports from an Image Pro Plus macro. The camera and 
the motorized stage are controlled by the macro thanks to the captdpcam and Lstep4 dynamic link 
libraries provided by Media Cybernetics and Markhauzer. The device configurations are detailed 
in Figure 46. 
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Figure 46: Device hardware and software configurations for macro controlling. 
The architecture of the timelapse acquisition visual basic program is shown in Figure 47 and the 
program script is given in Appendix L. It begins with the initialization of the pumping cycle loop. 
One should note that the pump cannot be programmed action by action. It is necessary to first set 
each loop action parameter (direction of the flow, flow rate, dispensed volume) one by one but 
this initialization phase does not start the pump. Once the pump program has started, it cannot be 
stopped by the computer. After the pumping cycling loop initialization, it enters the image 
acquisition loop. At each iteration, it first sends an opening order to the shutter, then an 
acquisition order to the camera, after, a closing order to the shutter and finally a run order to the 
pump. The macro waits until the pumping cycle loop is finished before starting the next iteration 
so that the microchannel is filled and the pump is stopped when the image is acquired, which 
ensures a good image quality. Note that two serial ports cannot be used at the same time. Each 
order sent is accompanied with a port initialization, an opening and a closing command. No bugs 
are encountered even after 6 hours of experiment. However, small z-focus readjustments are 
needed over the time-course of the experiment. 
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Figure 47: Architecture of the time-lapse acquisition visual basic program. 
The squares represent loops and i represents the loop’s total iteration number. 
This whole setup has been realized to study in situ and in real time the growth of HI aggregates at 
a dynamic triple interface. The results of this study are reproduced as a research article published 
in Langmuir which is presented in the following section. 
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3.2.2 Microscopic study of the growth of amyloid fibril at the triple interface (published 
in Langmuir , 2016, 32 (49), pp 13009–13019) 
Most of the following content appears in an article published in Langmuir (DOI: 
10.1021/acs.langmuir.6b03314) and is the main achievem nt of my work. Here, we provide the 
article reviewed and accepted manuscript, slightly modified to fit within the thesis framework. 
Insulin aggregation at a dynamic solid-liquid-air 
triple interface 
Thibaut Frachon1,2, Franz Bruckert1, Quentin Le Masne2, Emmanuel Monnin2 and Marianne 
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ABSTRACT  
Therapeutic proteins are privileged in drug development because of their exquisite specificity 
which takes roots in their three dimensional conformation in solution. During their 
manufacturing, storage and delivery, interactions with material surfaces and air interfaces are 
known to affect their stability. The growing use of automated devices for the handling and 
injection of therapeutics increases their exposure to protocols involving intermittent wetting, 
during which the solid-liquid and liquid-air interfaces meet at a triple contact line, which is often 
dynamic. Using a microfluidic setup we analyze the eff ct of a moving triple interface on insulin 
aggregation in real time over a hydrophobic surface. We combine THT fluorescence and 
reflection interference microscopy to monitor concomitantly insulin aggregation and the 
morphology of the liquid as it dewets the surface. We demonstrate that insulin aggregates in the 
region of a moving triple interface and not in regions submitted to hydrodynamic shear stress 
alone, induced by the moving liquid. During dewetting, liquid droplets form on the surface 
anchored by adsorbed proteins and the accumulation of amyloid aggregates is observed 
exclusively as fluorescent rings growing eccentrically round these droplets. The fluorescent 
rings expand until the entire channel surface sweeped by the triple interface is covered by 
amyloid fibers. Based on our experimental results, we propose a model describing the growth 
mechanism of insulin amyloid fibers at a moving triple contact line where proteins adsorbed at a 
hydrophobic surface are exposed to the liquid-air interface. 
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INTRODUCTION 
Therapeutic proteins have opened new avenues in disease treatment because their unequaled 
specific interactions allow drug targeting with unprecedented molecular precision. This property 
comes at the price of guaranteeing their native conformation, which is inherently far more 
complex and less stable for proteins than for chemically synthesized drugs. Insulin and 
monoclonal antibodies (mAb) are the most produced and administered therapeutic proteins and 
their structural stability is not only determining their therapeutic value but also the economic 
viability of their production.  
Besides the multiple environmental factors affecting protein stability (temperature, pH, ionic 
strength, and others), protein aggregation triggered by adsorption at material or air interfaces is 
emerging as a crucial parameter commanding conformational stability 1, 2, 3, 4. Indeed, during their 
fabrication, storage, transport and up to their delivery, therapeutic protein solutions are constantly 
in contact with different material surfaces and very often exposed to air, which can be considered 
as a smooth and flexible hydrophobic interface. Moreover, in medical devices used for 
reconstitution or injection, protocols involving intermittent wetting expose the protein solutions 
to a triple solid-liquid-air interface, which is often dynamic (pump cavitation, agitation, air 
bubbles in tubing, headspace in perfusion bags).  
It is well documented that insulin adsorption at materi l surfaces, in particular hydrophobic ones, 
and at the liquid-air interface is detrimental for its stability and leads to accelerated amyloid 
aggregation. Sluzky and colleagues 5 pinpointed in a pioneering study that insulin aggregates 
only in the presence of hydrophobic surfaces when agitated. Since then numerous studies have 
shed light on kinetic, structural and nucleation aspects of interfacial insulin aggregate formation 
and it is widely accepted that interfacial effects play an important role in insulin stability (for 
recent examples see 6, 7, 8, 9). For antibodies, usually formulated at very high therapeutic 
concentrations, interface adsorption is one of the parameters guiding formulation strategies. 
Among many examples, Couston and colleagues 10 have examined the structural organization and 
surface loading of a mAb at relevant pH and surfactant conditions on silica. A repetitive rupture 
of the air-liquid interface has been shown to induce the aggregation of mAbs11 and the effect of a 
liquid-air interfacial mAb layer on the rheological properties of mAb solutions has been 
examined 12.  
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The above selected studies underline that a detailed m chanistic understanding on how 
therapeutic proteins organize at interfaces is a timely subject, which takes all its importance in the 
context of today's drug development. In this study, we focus on insulin adsorption and 
aggregation at a dynamic triple solid-liquid-air interface, mimicking intermittent wetting 
phenomena encountered in numerous industrial protocols. Although some recent studies are 
analyzing the effect of a moving air-liquid interface in the context of therapeutic protein 
aggregation 12, 13, 14, a detailed real-time assessment of the protein fate at a moving triple contact 
line is still missing.  
It is commonly accepted that proteins have surfactant-like properties and adsorb on hydrophobic 
interfaces by displacing weakly bound water moleculs2, 15, 16. Secondary structure 
rearrangements allowing the establishment of hydrophobic interactions with the material or air 
interface stabilize their adsorption, counterbalancing the surface dehydration with an entropy 
gain. Subsequently an interfacial protein layer organizes, in which packing density, lateral 
interactions, cooperative effects and aggregation are known to operate at different rates, 
depending on the nature of the protein 2. At a moving triple interface, several interfacial 
phenomena co-occur, likely potentiating the above effects. Indeed, proteins adsorbed at the solid-
liquid and air-liquid interfaces collide at this point inducing higher local concentrations and 
therefore intensifying intermolecular interactions. Moreover, a moving liquid-air interface 
submits the locally concentrated proteins to partial dehydration enhancing conformational 
instability due to the loss of an integer hydration shell that proteins tend to retain 17. This is 
especially true when protein adsorption is strong eough to prevent their dissociation from the 
surface as the liquid is removed.  
We therefore developed a microfluidic setup allowing the movement of an insulin solution back 
and forth over a hydrophobic surface, thereby displacing the triple solid-liquid-air interface 
locally and continuously in a controlled way (Figure 48). Insulin is known to aggregate and form 
amyloid fibers at hydrophobic surfaces and at the liquid-air interface following nucleation-based 
aggregation kinetics 9. The alpha-helix-rich native conformation of the insulin monomer unfolds 
upon adsorption to form a beta-sheet. The stacking of beta-sheets between adjacent monomers 
leads to the rapid formation of amyloid fibers, detectable by Thioflavin T (THT) fluorescence 18.
Combining reflection interference contrast and fluorescence microscopy, we monitor, in real time 
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and concomitantly, the morphology of the liquid film and the formation of insulin amyloid 
deposits on the material surface, respectively. We demonstrate that insulin fibers exclusively 
form in the region of intermittent wetting, but not in the region exposed to hydrodynamic shear 
stress alone, remaining always wet. We show that the triple contact line is the place where the 
first aggregates are created and we measure the growth kinetics of insulin amyloid aggregation at 
the edge of liquid droplets. Finally we propose a simple physico-mathematical model describing 
the forces driving these phenomena. 
 
RESULTS AND DISCUSSION 
We designed a model experiment to be able to observe insulin aggregation at a dynamic triple 
solid-liquid-air interface. In a microchannel (Figure 48) an insulin solution is repetitively moved 
back and forth between two positions (lower and upper level) such that the channel comprises 
three different regions: a region which is always wet (blue in Figure 48), a region which is 
intermittently wet (dotted in Figure 48) and a region which is always dry (white in Figure 48). 
This setup allows a direct in situ analysis of the effect of a moving triple solid-liqu d-air interface 
on protein aggregation. Moreover a direct comparison between insulin aggregation kinetics at the 
triple solid-liquid-air interface and at the solid-quid interface is possible within the same 
experiment. Thioflavin T (THT) fluorescence is used to monitor the formation of amyloid 
deposits and reflection interference contrast micros opy (RICM) to monitor the morphology of 
the liquid film after liquid receding in real time. A constant 37°C temperature is maintained in the 
setup by a transparent heater.  
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Figure 48: Setup schematics of the microchannel experiment. 
A, side view. 
B, top view. 
Blue color represents the protein solution, white the air and grey the chip material. Dimensions are in mm. The x-axis 
represents the length of the channel and defines the position at which images are taken. Upper and lower levels 
correspond to the far left and far right meniscus positions during a cycle. The displaced liquid volume during each cycle is 
defined by the pump parameters and equals 2 µL. The cycle duration corresponds to the time the liquid takes to reach the 
upper level and to come back to the lower level and equals 15 s. ROI represents the microscope objective position and the 
field of view during a time lapse acquisition. 
Insulin amyloid aggregates only grow in the intermittently wet region where triple 
interfaces are created on a hydrophobic surface. 
Insulin aggregation kinetics was recorded using THT fluorescence images acquired every 10 
cycles (150 s) at the ROI (Figure 48) during the experiment, when the liquid reached the upper 
level in the channel. The mean grey level of the images, representing the amount of fibrils created 
on the surface of the micro channel, is reported in Figure 49.A as a function of time. The 
recorded fluorescence signal follows a standard, nucleation-dependent behavior with three 
distinct phases: a lag phase (I in Figure 49.A), when the fluorescence remains very low, a growth 
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phase (II in Figure 49.A) during which the fluorescn e increases strongly with time and amyloid 
fibers are forming on the surface and a plateau phase (III in Figure 49.A) when the fluorescence 
stabilizes indicating that no more fibers are created. The duration of the lag phase varies between 
60 min and 180 min, as commonly observed for nucleation-dependent insulin aggregation5, 23. 
When the same experiment was performed at room temperature, amyloid fibers also formed, but 
on a much longer time scale (6 to 8 hours). Insulin aggregation kinetics is therefore thermally 
activated, as expected. 
 
Figure 49: Insulin aggregation is caused by a moving triple interface on a hydrophobic surface. 
A : HI aggregation kinetics. 0.5 g/L HI is cyclically moved between the lower and the upper level (15 s per cycle), at 37°C. 
The mean THT fluorescence at ROI (Figure 48) is plotted as a function of time. I, II and III represent the different phases 
of insulin aggregation kinetics.  
B-D : Aggregate distribution along the x-axis (Figure 48) of the microchannel after 6 hours of cycling at 37°C, measured 
by THT fluorescence after washing for 0.5 g/L HI in a COC microchannel (B), 0.5 g/L BSA in a COC microchannel (C) 
and 0.5 g/L HI in a glass microchannel (D). Vertical bars represent the upper (dotted line) and lower levels (solid line).  
Error bars represent the standard deviation of the average pixel grey value for each image. The results of pannels A and B 
are representative of 8 independent experiments.  
When the plateau phase was reached, the HI aggregate distribution was determined using a 
sequence of consecutive THT images along the x-axis covering the dry, the intermittently wet 
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and the constantly immersed regions (Figure 48). The mean grey level of each image, indicative 
of the amount of HI fibrils created at each position, is shown in Figure 49.B. The fluorescence 
signal remains very low both in the constantly wet and dry regions, documenting the absence of 
amyloid aggregates in these areas. Thus, no HI aggregates are desorbed from the surface and 
deposited randomly during the experiment. On the opposite, in the intermittently wet region, the 
THT fluorescence is drastically increased, the highest signal being observed at the upper level, in 
the region remaining dry for the longest time between immersion cycles. Amyloid aggregates are 
thus only created on the surface in the intermittently wet region, where they remain strongly 
attached, delimitating this aggregation-prone region sharply from adjacent wet and dry zones. 
The difference of the fluorescence signal between th  always wet and intermittently wet regions 
shows that the presence of a triple interface is critical to induce HI surface aggregation. At this 
low flow rate, the shear rate corresponds approximately to 60 s-1 and shear stress alone (due to 
the liquid movement on the surface) is well below values sufficient to trigger aggregation of 
cytochrome c 24. However the presence of a moving triple interface potentiates the effects of local 
shear stress enough to trigger HI amyloid aggregation. This observation is in accordance with the 
literature, where it is well established that shear stress alone is not detrimental for protein 
aggregation or inactivation but the combination of shear stress with interfacial adsorption 
phenomena is affecting protein stability 25. For mAbs, for example, Biddlecombe and colleagues 
have demonstrated and quantified in a thorough analysis that mAb monomer depletion is sizeable 
above shear rates of 5000 s-1 at a solid-liquid interface 26. This indicates that in the triple interface 
zone, forces that exceed shear stress alone are pres nt and are sufficient to denature proteins 27. 
The control experiments using BSA (Figure 49.C) or insulin in a glass channel (Figure 49.D) 
show that there is no amyloid fiber formation inside the microchannel in these cases. The 
mechanism triggering the observed HI aggregation is thus dependent on the concomitant 
presence of a hydrophobic surface and a moving air-liquid interface and is not observed for BSA. 
HI amyloid aggregates are observed concomitantly with droplets left on the surface after 
the liquid has receded  
RICM was used to observe and characterize the hydrophobic surface at the ROI when the 
meniscus of the solution is at the lower level positi n in the channel (Figure 48). Characteristic 
RICM images of the surface at three time points chosen in the lag phase (I in Figure 49.A), the 
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growth phase (II in Figure 49.A) and the plateau phase (III in Figure 49.A) during the HI 
aggregation kinetics are shown in parallel with THT fluorescence images at the same time points 
(Figure 50). The black discs surrounded by a white ring seen on RICM images (Figure 50.B, D 
and F) correspond to liquid droplets left on the surface when the liquid has receded. The cross 
shape on the droplets is a camera artifact and is not visible by direct observation in the objective. 
Fluorescence corresponding to surface-adsorbed HI amyloid aggregates is observed in Figure 
50.A, C and E. 
 
Figure 50: The position of THT-positive insulin aggregates correlates with the position of droplets on the dewetted surface. 
Microscopic images at ROI showing THT-positive amyloid aggregates (THT fluorescence, left panels, A, Cand E) and 
liquid droplets (dark circles surrounded by a bright ring, observed in RICM, right panels, B, D and F) at the different 
phases of insulin aggregation (I, II, and III).  
RICM images are taken when the liquid is at the lower level (channel dewetted) and fluorescence images are taken when 
the liquid is at the upper level (channel filled). The field of view corresponds to 200 µm x 150 µm. The results shown are 
representative of 8 independent experiments. 
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Right from the start of the first cycles, liquid droplets appear on the surface (Figure 50.B). 
However, during the whole lag phase, no THT-positive aggregates are observed on the 
fluorescence images (Figure 50.A). When the growth phase is reached, liquid droplets are still 
visible on the RICM images (Figure 50.D) and amyloid aggregates start to appear as circles 
(Figure 50.C). The fluorescent rings are extending u til the entire channel surface is covered by 
amyloid fibers (Figure 50.E). At this time, the plate u phase is reached, no more droplets form on 
the surface (Figure 50.F) but a continuous liquid film remains above the fibers after liquid 
withdrawal. These observations demonstrate that HI amyloid aggregate growth is intimately 
correlated to the presence of droplets and that the creation of an aggregate layer modifies the 
water-retaining properties of the initially hydrophobic material surface.  
 
Liquid droplets are anchored by proteins adsorbed on the micro channel surface and 
reform at the same location cycle after cycle. 
It should be noted that when a buffer solution was used instead of the protein solution, more and 
smaller droplets were observed during the dewetting period, at 37°C (Figure 55.A). The presence 
of insulin therefore has a strong effect on liquid film dewetting. Moreover, we noticed that the 
liquid droplets remain at the same position during most of the experiment with HI. RICM time-
lapse images are used to calculate a droplet superim osition index (see Experimental Section), 
which represents the percentage of droplets that reform at the same location after 10 wetting-
dewetting cycles. For the experiment shown in Figure 51, the lag phase is estimated to extend 
from 0- 60 min, the growth phase from 60-100 min and the plateau phase is situated beyond 100 
min (based on fluorescence images taken from time to time during the entire experiment). 
Plotting the superimposition index as a function of time (Figure 51.A), reveals a rapid increase 
during the first 30 min, then a stabilization until 90 min before a sharp decrease. Droplets appear 
immediately after the first liquid withdrawal. Long before any THT fluorescence is detectable, 
droplets are anchored to the surface and remain at the same place for much of the growth phase, 
before disappearing at the end of the growth phase. Th  same droplet anchorage is also observed 
when a BSA solution is used in the experiment, indicating that amyloid fibers are not necessary 
to anchor droplets. In the absence of protein however, droplets reformed randomly on the surface, 
and the superimposition index remained below 0.15 (Figure 55.B). Droplet anchorage can, thus, 
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be explained by a progressive modification of the surface hydrophobicity during the lag phase. 
Indeed, during the initial wetting-dewetting cycles, the gradual adsorption of proteins most likely 
modifies the nature of the surface locally from hydrophobic to hydrophilic, thus creating 
energetically favorable wetting zones, where water is preferentially retained.  
The adsorbed proteins thus anchor the droplets, which in turn supply further proteins and thereby 
initiate the aggregation process at their very edge, where solid material, liquid and air meet, as is 
demonstrated hereafter.  
 
 
Figure 51: Droplet anchorage and droplet formation kinetics.  
A, Droplet superimposition index at ROI, represented as a function of time.  
B, Droplet formation kinetics is calculated on a set of representative droplets and is shown as a function of time. 
I, II and III indicate the lag phase, growth phase and plateau phase of insulin aggregation kinetics, respectively. The 
results shown are representative of 3 independent experiments. 
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A closer observation of the droplet reformation has been done with the acquisition of RICM 
movies at the ROI during several cycles (see Movie S1), covering the entire aggregation process. 
After the liquid recedes, droplets reform by gathering the liquid that remains as a thin film on the 
microchannel surface around them. Their diameter thefore increases rapidly (Movie S1). An 
average speed for the reformation of a droplet can thus be calculated by the difference of the 
droplet radii at the beginning and end of the dry phase during the aggregation kinetics (Figure 
51.B). The results show a linear decrease of this speed until a complete liquid film is formed on 
the surface.  
All these observations fit with the idea that amyloid fibers grow at the micro-channel surface. As 
they grow, a porous, proteinaceaous zone is created, retaining the liquid and decelerating its 
movement during droplet formation. This is reminiscent of the effect of anchored polymers on 
the dewetting velocity of a liquid thin film 28. 
HI amyloid aggregates grow eccentrically around droplets at the triple contact line  
The superimposition of RICM and fluorescence images, s parated by 10 cycles (Figure 52.A), 
shows that the amyloid aggregates form only around the droplets. Overlaying consecutive 
fluorescence images, separated by 20 cycles (Figure 52.B), shows that amyloid fibers form 
exclusively at the outer edge of the existing fluorescent ring. No fibers grow on the surface inside 
the droplets or on the one devoid of droplets.  
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Figure 52: Progressive accumulation of insulin amyloid aggregates at the edge of the droplet.  
A, Superimposition of an RICM image (droplets represented as red circles) and a THT fluorescence image (THT-positive 
amyloid aggregates in green) taken 10 cycles later at ROI. The right panel shows a magnification of the region highlighted 
in A (red square).  
B, Superimposition of two THT fluorescence images taken at a 20 cycle interval. THT-positive amyloid aggregates are 
represented in red for the first image and in green for the following one. Overlapping fluorescent pixels between both 
images appear in yellow (see yellow arrowhead in the magnification at the right). The right panel shows a magnification of 
the region highlighted in B (red square). 
The newly formed THT-positive aggregates appear in green (see green arrowhead in the magnification at the right) at the 
outer border of the already formed fluorescent aggregate ring. 
These results demonstrate that the triple contact line, where a droplet edge meets the 
microchannel surface, is a local trigger for HI aggregation. The presence of a growing amyloid 
fiber ring around the droplets explains the gradual slowdown of droplet formation kinetics and 
their stable anchoring at the same place.  
Kinetics of the formation of HI amyloid fibers at a moving solid-liquid air interface 
In order to study the growth kinetics of HI amyloid f bers near the triple interface, four droplets 
with different sizes were selected in a time-lapse fluorescence movie corresponding to the 
experimental results of Figure 49.  By quantitative mage analysis, the radial distribution of 
newly formed aggregates was determined (see Materials and Methods) during the time course of 
the aggregation kinetics, from which the total amount of aggregates created over a 10 cycle 
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interval (Σexp) and the radial distance at which most of these newly formed aggregates appear 
(8/9:;:< ) were calculated. 
Figure 53.A and B represent the evolution of Σexp and 8/9:;:<  with time, respectively. During phase 
II (growth phase, 150-180 min, 120 cycles) Σexp increases quasi exponentially, with an 
experimental growth rate };:< = 0.0226 ~ 0.0009	pp[K. During the same time interval, 
8/9:;:<  increases quasi linearly with time defining an experimental velocity for amyloid fiber 
formation Z;:< = 0.0282 ~ 0.0061	μW ∙ pp[K, confirming that new aggregates accumulate 
on the outer edge of the ring of previously formed ones. As time goes on, the position of the triple 
interface moves away from the center of the droplet, driven by the formation of new aggregate 
fiber layers on the material surface and the droplets progressively flatten until no more droplets 
form.  
 
Figure 53: Detailed growth kinetics of the aggregate ring formed around droplets. 
Results from four different droplets are represented with square, circle, diamond and cross symbols. An overall fit of the 
results is displayed with a continuous line. 
A, Net fluorescence increase over a 10 cycle interval, Σexp, as a function of the number of cycles. Data are fitted by an 
exponential function with an amplitude of 915 ± 273 at 600 cycles and an experimental growth rate of A@B = .  ~
. 	AK 
B, Radial position of the maximal fluorescence increase, =>?@A@B , as a function of the number of cycles. Data are fitted by a 
linear function with a y-intercept of 9.00 ± 1.15 µm at 600 cycles and a linear coefficient of 
>?@A@B = .  ~ . 	μ>. AK 
Results are representative of three independent experiments. 
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The formation of protein aggregates at the edge of the droplets during phase II can be explained 
as follows.  The region surrounding the droplet contains surface-bound amyloid fibrils, which (i) 
anchor the liquid droplet and (ii) act as a porous reservoir of liquid, bringing further insulin in 
contact with aggregated insulin. Insulin from the air-liquid interface is brought into close 
proximity of adsorbed fibers during dewetting. Adsorption of these insulin molecules on insulin 
fibers leads to their incorporation into the fiber. The partial dehydration induced by the receding 
liquid film favors intermolecular interactions between adsorbed proteins and protein fibrils, 
leading to amyloidal fiber growth. The driving force for the conformational change could in part 
be provided by the release of solvation water around the insulin molecules concomitant with the 
formation of intermolecular hydrogen bonds. An induced decrease of the protein hydration layer 
is well known to accompany adsorption and aggregation phenomena at hydrophobic interfaces16. 
Our results imply that amyloid aggregates grow at the surface around the droplets rather than 
being formed elsewhere (e. g. at the liquid-air interface) and being deposited there. Indeed, we 
observe that during the growth phase, the gain in THT fluorescence intensity increases by a factor 
6 (Figure 53.A between 620-700 cycles), whereas the radius of the fluorescence ring (and hence 
the droplet) increases only about 1.2 times (Figure 53.B between 620-700 cycles). It is therefore 
unlikely that protein aggregates originate from the air-liquid interface because the amount 
deposited should only marginally increase with time. In contrast, this strong fluorescence 
increase better fits with the idea that new insulin fibers grow in contact with existing ones. The 
fact that in the presence of nonionic surfactants (Tween® 20 or 80), no THT-positive HI 
aggregates are observed in our system stresses the importance of interfacial adsorption in HI 
amyloid aggregation (Figure 56). Indeed polysorbates are added to most therapeutic protein 
formulations in order to prevent interfacial stresses, as these amphiphilic molecules preferentially 
adsorb at hydrophobic interfaces, thus keeping proteins in solution29.  
 
Physico-mathematical model of insulin amyloid fiber growth at a moving triple interface 
From the above consideration, a simplified model of insulin aggregation is presented below that 
takes into account key observations: (i) amyloid fibers form at the surface, (ii) they prevent a full 
dewetting of the surface, (iii) they allow amyloid f ber growth at the periphery of the droplets and 
(iv) no amyloid fiber growth is observed inside thedroplets.  
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Figure 54.A illustrates schematically the growth of insulin amyloid aggregates at the triple 
interface, located at the edge of a droplet. The distribution of amyloid fibers attached to the 
surface at a distance r to the center of the droplet after cycle t is called L (r, t). L may represent 
the size and/or the density of fibers. We hypothesize that at a given cycle t, the droplet margin 
anchors at the position r where L (r, t) is maximal, which is called rmax (t). We assume (i) that, 
after a given number of cycles t, the formation of new aggregates takes place in the dewetted 
zone only, for r > r max (t) and (ii) that the growth is governed by a combination of two factors: the 
hydration of the deposited proteins and the amount f fibrils already present. Existing fibrils thus 
play two roles: they constitute a reservoir for insulin solution and a collection of binding sites for
incoming insulin molecules.  
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Figure 54: Physico-mathematical model of amyloid fiber formation at the triple interface. 
A, Top: schematic view of the triple interface at the edge of a droplet anchored on an aggregate ring. Bottom: the 
associated dehydration function. The droplet is represented in blue and the distribution of amyloid fibers as white bars. 
The fiber length or density, L(r) , depends on r, the radial distance to the center of the droplet. The liquid droplet anchors 
at the radius where the aggregate distribution is maximal (rmax). The aggregates outside the droplet are partially wet. ω 
represents the characteristic length of the dehydration function.  
B-F, Results from a SciLab simulation with k = 0.81, ω = 0.54 µm and σ = 0.76 µm. Time (t) is expressed in wetting-
dewetting cycles (1 cycle = 15 s) with respect to the onset of aggregation. The radial position is expressed in µm with 
respect to rmax (0). The simulation is performed for 100 cycles. The results are shown at = 0 (blue line), 24 (purple line), 49 
(red line), 74 (orange line), and 99 (yellow line) cycles.  
B, Amyloid fiber length distribution L (r, t) as a function of radius r.  
C, Evolution of =>?@ , the distance at which most amyloid fibers grow with respect to the number of cycles.  
D, Dehydration function D (r, t) as a function of radius r.  
E, Evolution of Σth, the amount of new insulin aggregates grown per cyle with respect to the number of cycles.  
F, Distribution of new fibers ∆L (r, t) between cycle t and t+1 as a function of radius r. 
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The growth of amyloid fibrils, ∆L (r, t), after each wetting-dewetting cycle is thus represented by 
the following equation:  
 ∆(!, () = 
 × g(! − !/9:(()) × (!, () Equation 25 
 
where k is a rate constant and D (r) a non-dimensional dehydration function (Figure 54.A). The 
fiber length distribution after a wetting-dewetting cycle, L (r, t+1) is thus iteratively calculated 
by: 
 (!, (  1) = (!, ()  ∆(!, () Equation 26 
 
for ! ≥ 0, ( ≥ 0. At each cycle, rmax (t+1) is recalculated and used in the next iteration step. The 
initial distribution of amyloid aggregates at the edg  of a droplet, at t = 0, is modeled by a 
Gaussian function L (r, 0), centered at rmax (0) = 0 where σ is the width of this initial aggregate 
distribution: 
 (!, 0) = KGT Equation 27 
 
The dehydration function, D (r) represents the degree of hydration of the protein layer as a 
function of the distance to rmax (t). Since no new amyloid aggregates are created in the wet region (! < !/9:), we assume that for r < 0, D(r) = 0. We then assume that the dehydration function 
progressively increases around the droplet to reach 1 in the fully dehydrated region, with a 
characteristic distance ω. A simple expression is thus: 
 X!	! > 0, g(!) = 1 − K	G Equation 28 
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The behavior of this system of coupled differential equations depends on three parameters, k, σ 
and ω. For a fixed set of parameters, a numerical simulation is conducted over 100 wetting-
dewetting cycles using Scilab. At each cycle, Σth the amount of new protein aggregates created 
per cycle, is calculated using  
  = I ∆(!, ()	 %! Equation 29 
 
and 8/9: , the distance at which amyloid fiber growth is maximal, is defined as the radial position 
r where ∆L (r, t) is maximal. We also calculate w (t), the width of the zone of newly grown 
amyloid fibers, defined by the interval where ∆L (r, t) > 0.25. 
A wide range of parameters is studied: 0.5 < k  2, 0.074 < ω < 0.74 and 0.3 < σ < 3. Figure 54 
shows a representative example of such a simulation, with k = 0.81, ω = 0.54 µm and σ = 0.76 
µm. After a short transitory period (about 30 cycles), new amyloid material grows at each cycle 
in the form of an annulus that moves at a constant velocity and increases in amplitude (Figure 
54.C, E and F). During this stable period, the width of the zone of fiber formation, w, remains 
constant (Figure 57), whereas 8/9:  and Σth increase linearly and exponentially with the number 
of cycles, respectively, in accordance with experimntal observations. A theoretical aggregation 
velocity vth is determined by a linear fit of 8/9:  and a theoretical characteristic rate αth is 
obtained from an exponential fit of Σth between 30 and 99 cycles. The constant growth width, W, 
of the fiber formation zone is defined as w at t = 99 cycles. In Figure 58, we represent the effect 
of σ, k and ω on vth, αth and W. vth is proportional to σ and ln	(
) and independent of ω (Figure 
58). αth linearly increases with k and σ and exponentially decreases with ω (Figure 58). W 
increases as a function of ln(k) and σ and decreases as a function of ω (Figure 58).  The rate 
constant k increases the width of the fiber growth zone, which explains the increased theoretical 
aggregation velocity vth and the theoretical aggregation rate αth. At high ω, fibers that are close to 
the droplet edge are submitted to a smaller dehydration function and therefore grow less. 
Nevertheless 8/9:  is attained at the same distance from the droplet edge, which explains the 
constant value of vth. 
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Using these simulations, it is possible to determine, for each studied droplet, a specific set of 
parameters (σ, ω, and k) that matches our experimental determined values for vexp and αexp (results 
shown in Figure 59). First, σ is experimentally determined from the first fluoresc nce image in 
the movie where a fluorescent ring is visible around the droplet. The radial fluorescence intensity 
profile is extracted and fitted with two Gaussian fu ctions to determine the fluorescence ring and 
the background (see Materials and Methods). σ is equal to the standard deviation of the Gaussian 
function that fits the fluorescent peak. Second, k is calculated from vexp and the linear relationship 
between vth and ln(
), using the value of σ already determined, since vth is independent of ω 
(Figure 58). Third, ω is determined from αexp and the exponential relationship between αth and ω 
(Figure 58), using the values of σ and k previously determined. 
Comparing the results obtained for each droplet, the value of the dehydration characteristic 
distance ω  is remarkably constant, whereas σ and k display more variability. The fact that k is 
close to one indicates that the amount of fibers at the triple interface, most exposed to 
dehydration, could potentially double at each cycle. 
Alternatively, a unique set of parameters can be det rmined similarly from the fits of Σexp and 
8/9:;:<  described in Figure 53 by pooling all the data. An average σ (0.53 ± 0.16 µm) is used as an 
input to calculate values of k (1.07 with a 60% confidence interval between 0.59 and 1.92) and ω  
(0.50 ± 0.01 µm) that fit all the data. The theoretical values of vth and αth are estimated to be 
0.0280 µm.cycle-1 and 0.0222 cycle-1, which is close to the experimental values v xp = 0.0282 ± 
0.0061 µm.cycle-1 and αexp = 0.0226 ± 0.0009. Using this set of parameters we calculate the width 
of the fiber formation ring at each cycle, after the transitory period, which equals 0.397 ± 0.006 
µm (Figure 58). This confirms that new amyloid fiber growth is restricted to the close proximity 
of the droplet, in the region where the solid-liquid and liquid-air interfaces meet. 
 
Conclusion  
In this work we present the first in situ, real-time analysis of insulin amyloid aggregation at a 
dynamic triple contact line. While insulin is likely to adsorb at all of the interfaces present in our 
setup, the conformational changes and intermolecular interactions necessary to form THT-
positive aggregates are triggered preferentially by the forces acting at the triple contact line. Our 
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study reveals a new mechanism for protein aggregation driven by the partial dehydration of 
surface-adsorbed proteins at the edge of droplets where solid-liquid and liquid-air interfaces 
meet. Human insulin is known to bind THT when adsorbed at hydrophobic surfaces5, 7. It has 
been shown to be monomeric at the air-liquid interface at pH 2 6, 30. Moreover it is well 
established that the insulin monomer is the most aggregation-prone form at hydrophobic 
interfaces5, 31. Therefore, at the triple contact line, three crucial parameters come together: high 
and possibly monomeric insulin concentration at the air-liquid interface, adsorbed and possibly 
denatured proteins at the solid-liquid interface and partial dehydration that favor amyloid fiber 
growth. Moreover air-liquid interfaces, in contrast to solid-liquid interfaces, allow for interfacial 
diffusion of adsorbed proteins and therefore can contribute to favorable local protein orientations 
which, combined with the stabilization of adsorption- nduced conformational changes, can lead 
to aggregation nuclei formation and amyloid fiber growth. In addition, mechanical efforts exerted 
at the droplet edge, where capillary forces are important, may also contribute to de novo fiber 
formation, by fragmenting existing fibers and therefo  creating more elongation sites. A 
relationship between amyloid fiber fragmentation propensity and growth rate has indeed been 
documented for yeast Sup35 prion 32. 
The role of interfaces in the amyloid aggregation of other proteins has been studied. Jean and 
colleagues33 have shown, for islet amyloid polypeptide (IAPP) and amyloid β peptide (Aβ), that 
their surface-active properties lead to a local protein enrichment at the air-liquid interface above 
the critical fibrillar concentration, thus enhancing amyloid fibrillation in the presence of an air-
liquid interface. Similarly, Morinaga and colleagues34 have demonstrated that, at low 
concentrations (5 µΜ), the presence of an air-water interface triggers fibrillation of Aβ, which 
does not occur in the absence of such an interface, at this concentration after 3 weeks. For α 
synuclein, an air-water interface has been shown to i duce surface-catalyzed nucleation and/or 
branching35. Altogether these studies highlight the importance of the local protein enrichment as 
a determining factor in the amyloid aggregation process at air-liquid interfaces. However, in these 
studies, the presence of solid surfaces, where protins could adsorb, is not considered.  
The role of solid surfaces is evidenced by the facttha  agitation strongly enhances aggregation 
kinetics, which is not explained by the concentration effect at interfaces alone. Morinaga and 
colleagues34 for instance highlight the effect of agitation on Aβ amyloid aggregation at the air-
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liquid interface. Although not discussed in their study, it is likely that Aβ amyloids originate at 
the well border, where the air-liquid interface transiently meets the solid-liquid interface before 
spreading over the entire air-liquid interface by diffusion. 
Compression or rupture of the air-liquid interface strongly enhances mAb aggregate 
accumulation11, 13. In these studies an intermittently wet surface was created either on a rotating 
needle or on the walls of a tilted vial, but the authors did not analyze the presence of protein 
aggregates at this place. Similarly the aggregation of recombinant human growth hormone is 
strongly enhanced at dynamically renewed air-liquid interfaces by bubble aeration14. For the 
production of air bubbles and for the stirring of the solution, hydrophobic surfaces were also 
present in this study. The adsorption of proteins at uch hydrophobic solid surfaces is therefore 
likely to create a similar situation of intermitten wetting than the one mimicked in our setup, 
accelerating protein aggregation by partial dehydration of proteins and by capillary forces acting 
at the triple contact line. 
Despite the accumulating evidence of interfacial effects on protein stability, many solid-liquid or 
liquid-air interface studies do not observe protein aggregation in real time and do not consider the 
triple contact line, although it is generally present in most conventional setups. Concerning 
practical applications, our study explains why agittion can be detrimental to protein stability in 
pharmaceutical containers, where an air headspace or bubbles are often unavoidable. The 
possible formation of wetting-dewetting zones at interfaces, where proteins strongly adsorb, 
should thus be carefully examined in industrial processes, as they can be the trigger for aggregate 
formation.  
Supporting information 
Movie S1: RICM visualization of droplet reformation at the microchannel surface. 
RICM visualization of droplet reformation at the microchannel surface. Two wetting/dewetting 
cycles are shown. The first dewetting period starts t 3.99 s and ends at 11.69 s, the second 
dewetting period starts at 19.18 s and ends at 26.95 s. Droplets first appear as grey circles, 
progressively darkening at the center surrounded by a white ring. These grey level changes are 
related to the variation of the liquid contact angle when the droplet rises from the initial liquid 
thin film. 
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Figure 55: RICM image and RGB superimposition image of liquid droplets using TN buffer with 20 µM THT.   
Using a buffer solution, droplets are not anchored at the same place cycle after cycle 
A, RICM image, at ROI, of liquid droplets left at the microchannel surface by TN buffer supplemented with 20 M THT 
during a dewetting period after 468 cycles. 
B, RGB superimposition image of two consecutive RICM images (separated by 10 cycles) of a TN buffer solution during 
the dewetting period. The superimposition index of (B) = 0.06. 
 
 
Figure 56: Effect of Tween® 20 and 80 on HI aggregation kinetics. 
The addition of polysobates in solution inhibits insulin amyloid aggregation. A solution of 0.5 g/L HI with 20 M THT 
containing 200 ppm Tween®20 (circles, T20) or 80 (crosses, T80) is cyclically moved between the lower and the upper level 
(15 s per cycle) at 37°C. 
A, HI aggregation kinetics. The mean THT fluorescence at the ROI (Figure 48) is plotted as a function of time.  
B, Aggregate distribution along the x-axis (Figure 48) of the microchannel after 6 hours of cycling at 37°C, measured by 
THT fluorescence after washing with TN buffer. The relative positions of the upper and lower levels are indicated by solid 
and dotted lines, respectively. 
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Error bars are omitted for clarity reasons. The standard deviation of the fluorescence grey levels did not exceed 21 A.U. 
 
 
Figure 57: Distribution of new fibers and its width, W, that is constant between 30-99 cycles 
A numerical simulation was performed with the following parameters: σ = 0.53 µm, k = 1.07, ω = 0.50 µm. 
A, Distribution of new fibers ∆L(r, t) gained at each cycle as a function of radius r.  
B, Width of the newly amyloid fiber growth zone, W, as a function of the number of cycles. 
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Figure 58: Effect of the initial distribution width  σ, the dehydration characteristic distance ω and the rate constant k on 
the theoretical aggregation velocity vth, the theoretical characteristic rate αth, and the constant growth width W. 
A, Theoretical aggregation velocity vth as a function of the width of the initial aggregate distribution σ, ω = 0.44 µm, k = 1 
(squares) and k = 2 (circles). 
B, Theoretical characteristic rate αth as a function of the width of the initial aggregate distribution σ, ω = 0.44 µm, k = 1 
(squares) and k = 2 (circles). 
C, Constant growth width, W, as a function of the initial aggregate distribution σ, ω = 0.44 µm, k = 1 (squares) and k = 2 
(circles). 
D, Theoretical aggregation velocity vth as a function of the dehydration function characteristic distance ω, with σ = 0.37 
µm and k = 1.57 (circles), with σ = 0.50 µm and k = 1.23 (squares), and with σ = 0.76 µm and k = 0.84 (triangles). 
E, Logarithm of the theoretical characteristic growth rate αth as a function of the dehydration function characteristic 
distance ω, with σ = 0.37 µm and k = 1.57 (circles), with σ = 0.50 µm and k = 1.23 (squares), and with σ = 0.76 µm and k = 
0.84 (triangles). 
F, Constant growth width, W, as a function of the dehydration function characteristic distance ω, with σ = 0.37 µm and k = 
1.57 (circles), with σ = 0.50 µm and k = 1.23 (squares), and with σ = 0.76 µm and k = 0.84 (triangles). 
G, Theoretical aggregation velocity vth as a function of the logarithm of the rate constant k, for σ = 0.37 µm and ω = 0.44 
µm (circles), for σ = 0.50 µm and ω = 0.29 µm (squares), for σ = 0.76 µm and ω = 0.74 µm (triangles). 
H, Theoretical characteristic growth rate αth as a function of the rate constant k, for σ = 0.37 µm and ω = 0.44 µm (circles), 
for σ = 0.50 µm and ω = 0.29 µm (squares), for σ = 0.76 µm and ω = 0.74 µm (triangles). 
I, Constant growth width, W, as a function of the logarithm of k, for σ = 0.37 µm and ω = 0.44 µm (circles), for σ = 0.50 µm 
and ω = 0.29 µm (squares), for σ = 0.76 µm and ω = 0.74 µm (triangles). 
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 vexp (µm) vth (µm) αexp  αth k (cycle-1) σ (µm) ω (µm) 
Droplet 1 0.0368 0.0363 0.0232 0.0200 0.81 0.76 0.53 
Droplet 2 0.0223 0.0221 0.0234 0.0236 1.57 0.37 0.56 
Droplet 3 0.0265 0.0266 0.0214 0.0213 1.10 0.50 0.51 
Droplet 4 0.0274 0.0271 0.0223 0.0219 1.23 0.49 0.57 
Standard 
deviation 
0.0102 0.0101 0.0001 0.0025 0.54 0.28 0.02 
Pooled 
results 
0.0282 0.0280 0.0226 0.0222 1.07 0.53 0.50 
 
Figure 59: Summary of the experimentally determined parameters vexp, αexp and σ and the deduced values of k, ω, vth and 
αth for the four analyzed droplets according to the model.  
The last line gives the corresponding parameter values for the pooled results of Figure 53. 
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4.1 Summary of the experimental results 
4.1.1 Context and motivations 
With the growing use of therapeutic proteins and the development of associated medical delivery 
devices, protein stability becomes a major concern in pharmaceutical industrial processes 
(production, storage, delivery…). The scope of our work is to investigate the stability of 
therapeutically relevant proteins and in conditions that apply to storage and delivery systems used 
for these molecules. In these processes, proteins ca  lose their native conformation by unfolding 
at hydrophobic interfaces, leading to the formation of insoluble aggregates. Insulin is one 
example of such an aggregation-prone protein, which easily forms amyloid fibrils on 
hydrophobic surfaces under agitation. Within a devic  containing a protein solution, hydrophobic 
interfaces are found at the border between hydrophobic materials and liquid and between air and 
liquid. These different interfaces come into close proximity in processes, involving intermittent 
wetting, that are frequently used in industry. We th refore focus our study on the region where a 
solid/water and an air/water interface meet, called the triple interface, which seems critical for 
protein stability. 
 
4.1.2 Choice of the experimental approach 
In the literature many different setups and experimntal conditions have been used to characterize 
aggregation kinetics and conformation of insulin and other proteins at different interfaces. A 
direct comparison of protein aggregation kinetics at different interfaces is however hampered by 
several facts. Protein aggregation in general and of insulin in particular is influenced by a 
plethora of physico-chemical parameters (temperature, pH, concentration, agitation, additives, to 
cite but the most prominent) and comparisons of aggregation kinetics are only valid within 
identical or at least very similar experimental conditions. Also, the experimental setups used to 
explore the interfacial behavior of proteins at thesolid-liquid or liquid-air interfaces are very 
different concerning: 
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i) the physicochemical nature of these interfaces: e. g. a protein adsorbed to a hydrophobic liquid 
(oil) or air interface has a much more lateral diffusion freedom than when adsorbed to a solid 
hydrophobic material interface. 
ii) the interfacial surface areas to which the protein is exposed can be orders of magnitude 
different: e. g. a few mm2 for a mm-sized bead to several tens of cm2 for a Langmuir tray setup. 
The dependency of insulin aggregation kinetics on the available interfacial surface area has been 
documented as early as the pioneering work of Sluzky and coworkers (Sluzky et al. 1991). 
iii) the timescales and sensitivity of the biophysical techniques, with which the accumulation 
and/or the conformational state of proteins can be probed at different interfaces, vary to a great 
extent: e.g. surface plasmon resonance (SPR) is a real time (seconds) optical technique that is 
sensitive to the mass accumulating at a functionalized gold surface (typically pg.mm-2) with a 
penetration depth of about 100 nm, whereas the conformational state of material-adsorbed protein 
can be assessed by Total Attenuated Reflectance Fourier Transformed Infrared Spectroscopy 
(ATR-FTIR) with a time resolution in the order of minutes and a penetration depth of about 1 
µm, thus integrating the signal from adsorbed and soluble protein above the functionalized 
crystal. 
Precisely because of these difficulties, we put much effort into designing setups in which the 
solid-liquid and the triple solid-liquid-air interface could be directly compared within the same 
experiment under identical solution conditions. We chose to particularly use human insulin 
because it is a relevant, well-known and economically important therapeutic model protein for 
stability studies. We performed experiments under physiological conditions that correspond to 
the ones used in storage and delivery processes and used THT fluorescence which is common 
measurement for amyloid aggregation. We organized our work in two parts: As a first part, we 
investigated whether the presence of dynamic triple nt rfaces has an accelerating effect on 
insulin aggregation kinetics and, as a second part,we observed and characterized the growth of 
insulin amyloid fibrils at a triple interface. 
 
CHAPTER 4: Discussion and Conclusion 
121 
4.1.3 Demonstrating the accelerating effect of dynamic triple interfaces on HI 
aggregation 
In order to demonstrate that the formation of dynamic triple interfaces is critical for insulin 
stability, we built the following setup (Figure 32): a column containing hydrophobic beads was 
repeatedly filled then emptied by an HI solution. The amount of HI amyloid aggregates, in 
solution and attached to the bead surface, was monitored by THT fluorescence every hour and at 
the end of the experiment, respectively. Each time, two experiments were run in parallel with 
different conditions in order to have the same experimental factors (temperature, age of the 
solution…) which allows a direct comparison of the different conditions. We showed that the 
creation of dynamic triple interfaces at the bead surface greatly accelerates the HI aggregation 
kinetics and that shear stress alone, applied on the adsorbed proteins at the bead surface, was not 
detrimental for HI stability (Figure 42, the shear r te has been estimated to be 491 s-1 maximally). 
The amount of HI aggregates released in solution increased potentially 4-fold when the surface of 
dynamic triple interfaces is doubled. 
By comparing the THT fluorescence level obtained after 8 hours: 108 ± 25 A.U with the THT 
fluorescence value of a fully aggregated 0.5 g/L HI solution (averaged at 11454 ± 1500 A.U), we 
could deduce that, after 8 hours of liquid cycling, in presence of dynamic triple interfaces, at least 
0.95 % of the solution was aggregated. The exact percentage is probably higher because we 
didn’t take into account the aggregated proteins adsorbed at the bead surface. We also showed 
that less HI aggregates grow in the presence of hydrophilic beads (Figure 45) and that no 
aggregates were attached to these beads. Finally, we observed that a faster liquid sweeping speed 
favored HI aggregation (Figure 44) but we couldn’t conclude whether it was an effect of the 
sweeping speed or of the time spent in a dry state. Nevertheless, we saw that less HI aggregates 
remained attached at the bead surface when a fasterswe ping speed was used, indicating that the 
sweeping speed had an impact on the release in solution of the aggregates formerly attached at 
the surface. 
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4.1.4 Observation of the HI aggregate growth at the triple contact line 
To achieve our second objective, we designed a model experiment (Figure 48), where we 
observed the formation of insulin amyloid fibers by optical microscopy as a protein solution 
moved repetitively back and forth in a microfluidic channel. Thioflavin T fluorescence was used 
to monitor the formation of amyloid deposits and reflection interference contrast microscopy was 
used to monitor the morphology of the liquid film after receding. The strength and the originality 
of our setup came from the ability to make a direct comparison between insulin aggregation 
kinetics at the liquid-solid interface and at the triple contact line within the same experiment. It 
also allowed a direct, real-time and in-situ visualization of the growth of the amyloid fibers at a 
triple interface.  
We demonstrated that insulin fibers mainly form in regions of intermittent wetting, but not in 
regions exposed to hydrodynamic shear stress alone, remaining always wet. As shown in Figure 
49.B, at the end of the experiment, no THT-positive insulin aggregates were detected in the 
constantly wet region, which was located beyond the lower level of the meniscus (continuous line 
at the left on Figure 49.B). The formation of amyloid insulin aggregates in the intermittently wet 
region followed the typical 3-phase nucleation-dependent kinetics (Figure 49.A), already largely 
documented in the literature (Sluzky et al. 1991) at timescales that are typical for the 
experimental conditions used. Under the same conditi s, no THT-positive aggregates formed 
with BSA or in the presence of a hydrophilic microchannel in the timeframe of the experiment 
(Figure 49.C and Figure 49.D). Note that BSA can form THT-positive amyloid fibers under 
certain experimental conditions, that were not met in our set up (pH 7.4, NaCl 125mM, 37°C); it 
indeed requires a temperature elevation to 65°C (Juárez et al. 2009). Additionally, we tested the 
aggregation of human insulin in the presence of nonionic surfactants (Tween20® and Tween80® 
at 200 ppm) in our system. No aggregation was observed for both polysorbates (Figure 56) 
confirming that surfactants prevent the proteins from adsorbing to hydrophobic interfaces and 
thus from aggregating. 
The growth of protein aggregates on the surface was then characterized. We showed that the 
liquid droplets left after the microchannel surface d wetting (Figure 50) were anchored by a 
surface adsorbed protein layer, even before the apparance of aggregates, and that they reformed 
at the same location cycle after cycle (Figure 51.A). We observed that the HI amyloid aggregates 
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grew only at the edge of the liquid droplets (Figure 52) where the solid/liquid and air/liquid 
interfaces met, demonstrating the fact that the triple nterface is a preferential place for the 
aggregation onset. The total amount of HI amyloid fibril created increased exponentially with the 
number of liquid cycles (Figure 53.A) and the maximum fibril depot location moved linearly 
away from the center of the droplet with the number of the liquid cycles (Figure 53.B). The HI 
amyloid aggregate layer created at the microchannel surface formed a porous medium that 
progressively modified the surface wetting properties from hydrophobic to hydrophilic (Figure 
51.B) until the surface was completely covered by the fibril medium which retained the water and 
created a complete and continuous liquid film at the surface after dewetting (Figure 50.E and F). 
At this stage, no more aggregates were created. A schematic summary of these observations is 
presented in Figure 60. Note that in presence of BSA, we only observed the droplet anchoring 
(step 1). 
 
Figure 60: Schematic view of the observed HI aggregate growth at the triple interface during the deweting phase. 
Step 1: liquid droplets are anchored at the surface of the microchannel by the adsorbed proteins and reform at the same 
place cycle after cycle. 
Step 2: THT-positive HI aggregates start to appear at edge of the droplets. 
Step 3: the aggregates grow at the periphery and radially outwards of the droplets. No aggregates are observed inside the 
droplet. 
Step 4: the microchannel surface is entirely covered by an HI amyloid fibrous medium. The droplets are replaced by a 
continuous liquid film that remains at the microchannel surface. 
THT-positive HI aggregates are represented in green, the bottom surface of the microchannel in grey and the HI solution 
in blue. 
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4.1.5 Triple interface HI aggregate growth model 
Subsequently, we built a model that could fit the observed triple interface aggregate growth 
mechanism (Figure 54). Based on our previous observations, our growth mechanism relied on the 
combination of two principles: the formation of new aggregates increases with protein 
dehydration and with the amount of amyloid fibrils already created. We therefore hypothesized 
that new amyloid fibrils grow near or at existing fibrils when the adsorbed insulin film was 
transiently exposed to air. We designed an empirical function, called dehydration function D(r), 
to represent the dehydration state of the protein. The dehydration function was 0 inside the liquid 
droplet, increased progressively in the triple interface region to reach 1 outside of the droplet. The
amount of newly formed HI aggregates at each cycle is governed by the product of the 
dehydration function and the amount of already formed amyloid fibrils. This implied that, 
because the dehydration function is 0, no aggregates were formed inside the droplet and that, 
because the amount of already formed aggregates is 0, no aggregates were formed outside the 
triple interface region. The beginning of the triple interface region was arbitrarily set to the 
maximum fibril depot location and moved away from the droplet center at each cycle. We 
managed to find parameters for which the model fitted he experimental data, validating the 
model’s pertinence. Our model predicted that, at each cycle, the surface amyloid layer is radially 
extended by 0.397 ± 0.006 µm. 
In conclusion, it is therefore apparent that, under th  conditions studied, the kinetics of insulin 
aggregate formation at the triple line is greatly enhanced compared to that at the solid-liquid or 
liquid-air interfaces alone. Without doubt, insulin adsorbs at all of the hydrophobic interfaces 
present in our setup, but the conformational changes and intermolecular interactions necessary to 
form THT-positive aggregates are triggered preferentially by the phenomena acting at the triple 
contact line. Our experiments illustrate how the formation of a triple solid/liquid/air interface in 
industrial processes may lead to protein instability and that the addition of polysorbates could 
reduce this risk. 
One could think otherwise that the air/water interface is the location where protein aggregates are 
created. In the following section, we clarify the role of air/water interfaces in insulin aggregation, 
then, we propose a mechanism for the formation of HI aggregation nuclei and finally, based on 
the literature, we extend our findings to other protein aggregation cases.  
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4.2 Discussing the role of the air/water interface in protein agitation-
induced aggregation 
4.2.1 The air/water interface as a partially unfolded insulin monomer supplier for the 
solid/water interface at the triple contact line 
In our experimental setups, we cannot directly monitor nsulin aggregation at the air-liquid 
interface. Nevertheless, indirect evidence allows us to claim that insulin doesn’t aggregate at the 
air-liquid interface within the timeframe of the experiment. In chapter 3, the creation of triple 
interfaces at the bead surface has an accelerating effect on the HI aggregation but since amyloid 
fibrils are present both in solution and at the bead surface, we cannot conclude whether the HI 
aggregates are ripped off the bead surface or if the air/water interface rupture release HI 
aggregates in solution and deposits them on the bead surface. However, in chapter 4, we observe 
that the microchannel surface located at the center of the droplets, in the intermittently wet 
region, remains free of THT-positive aggregates (see Figure 52 in our study), similarly to the one 
of the constantly wet region (Figure 49.B). If air/water interface-created aggregates had formed, 
we would expect them to sediment with time and to deposit randomly on the channel surface. 
Another possibility could be that amyloid fibrils created at the air/water interface always remain 
in the bulk. Ballet’s study (Ballet 2010) showed that a HI solution agitated in a hydrophilic 
microwell plate, where a mobile air/water interface is indeed present, is stable for days, 
confirming that no HI aggregate is present in the bulk. Therefore, we conclude that insulin 
amyloid aggregate formation at the air/liquid interface must be inexistent or at least several 
orders of magnitude slower than that at the moving triple line.  
One should note that insulin has been shown to exist as a monomer at the liquid-air interface only 
at acidic pH (pH = 2 in (Johnson et al. 2012; Khan et al. 2015)). There isn’t a direct evidence for 
the existence of insulin as a monomer when adsorbed on the channel surface or at the air/water 
interface at pH 7.4. The works of Brange and Havelund (Brange and Havelund 1983) and Sluzky 
and colleages (Sluzky et al. 1992) identified the insulin monomer as the least stable species in 
solution and proposed a model that identified the monomer as the most aggregation-prone species 
at hydrophobic material interfaces. In line with the above cited literature, we therefore suppose 
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that the interfacial-adsorbed insulin is likely to be monomeric or at least the ones that are partially 
unfolded upon adsorption and that are involved in the formation of aggregation nuclei. 
However, we are aware that HI aggregation at the air/w ter interface has already been observed 
but only when intermolecular interactions are triggered by additional factors such as additives, 
pH or ionic concentration variations or an increased urface pressure, which affect the molecular 
conformation of insulin molecules at the air-water interface or can accelerate insulin aggregation 
into amyloid fibers (Johnson et al. 2012; Pérez-López et al. 2011; Liu et al. 2012; Nieto-Suárez et 
al. 2008). The air-liquid interface seems therefore less effective in promoting insulin amyloid 
aggregation. 
 
4.2.2 Hypothesis on the formation of initial HI aggregation nuclei 
We propose the following mechanism for the formation of HI aggregation nuclei at the triple 
interface: the contact between an air/liquid and a solid/liquid interface increases the concentration 
of interfacial-adsorbed and partially unfolded monomers and favors their interaction and self-
assembly by replacing unwanted interactions with water molecules by more energetically 
favorable protein-protein interactions. In the presence of protein complexes that underwent 
conformational changes, a new free energy minimum could also become available for native 
proteins that are trapped between the two layers of interfacially-adsorbed proteins. Due to these 
new possibilities of interaction, they could in turn unfold at the contact of already unfolded 
monomers and participate to the self-assembly (or agg egation nucleus) formation. We suggest 
that the stable HI pre-aggregate self-assemblies (that are THT-negative during the lag-phase and 
then then turn into THT-positive amyloid aggregates after sufficient protein accumulation) form 
on the solid surface. We believe that the solid surface-protein interfacial interaction is stronger 
than the air-protein one because of the intrinsic properties of the air/water interface which is 
flexible and in perpetual movement. During the movement of the air/water interface, protein 
hydrophobic parts that were at the interface could be put back in contact with water molecules, 
modifying the protein equilibrium state and its free nergy minimum, potentially leading to the 
protein desorption and the return to its native conformation. Even if HI self-assemblies are 
formed at the air/water interface, they should be quickly released in solution, disassemble and 
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retrieve their native conformation. In the opposite, the protein equilibrium state when adsorbed at 
a solid/water interface cannot but perturbed by the int rface movement so that the protein 
remains adsorbed. Therefore, when the air/water intface moves, one partially unfolded protein 
adsorbed at the air/water interface can interact with another one adsorbed at a solid/water 
interface. In order to keep the free energy minimum corresponding to the unfolded state, the 
protein should leave the air-water interface in favor of a protein-protein interaction at the 
solid/water interface. HI self-assemblies and aggreation nuclei at the triple contact line are thus 
formed by an unfolded monomer transfer from the air/w ter interface to the solid/water interface 
at the triple contact line, leading to an HI unfolded monomer accumulation that forms 
aggregation nuclei. The depletion of protein adsorbed at the air/water interface may also create a 
concentration gradient, thus, a protein diffusion from the bulk toward the depleted interface.  
We propose that this mechanism explains the anchoring of liquid droplets during dewetting, 
before ThT-positive structures appear. It holds also for BSA, a protein known to strongly bind 
hydrophobic surfaces. This mechanism may be extended to the repeated meeting of two 
hydrophobic interfaces in general and not restricted to the combination of a solid/water and 
air/water interface. However, in the case of two identical interfaces (for instance air bubbles or 
tubing in peristaltic pumps), the protein transfer from one to the other is not explained by the 
previous arguments and needs further investigations. 
 
4.2.3 Are dynamic triple interfaces critical in other protein aggregation processes? 
In the studies cited in the introduction, agitation, rotation, rupture or direct compression/dilation 
of the air-water interface is found to tremendously accelerate the kinetics of aggregation of other 
therapeutic proteins. In these works, the experimental conditions bring into play solid surfaces, 
that are the polypropylene vial walls in (Bee et al. 2012), a rotating needle in (Rudiuk et al. 2012) 
or the plastic bag surface in (Vieillard et al. 2013), which are intermittently wet then dried, 
creating triple interfaces similar to the ones studied in our setups. These intermittent wetting 
zones are likely to form protein aggregates more rapidly than the air/water interfaces alone that 
are studied by the authors. In a recent publication, Torisu and coworkers (Torisu et al. 2016) 
submitted a cyclo-olefin polymer vial filled with an IgG1 antibody solution to orbital or rotating 
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shaking, using a friability test apparatus. A friability test apparatus is similar to a washing 
machine drum (Figure 61). It is often used in the parmaceutical industry to test the durability of 
tablets.  
 
Figure 61: Picture (right) and schematic view (left) of a friability test apparatus.  
Right picture taken from http://www.panomex.com/pharmaceutical-instruments/friability-tester.html and left picture 
from http://www.pharmacopeia.cn/v29240/usp29nf24s0_c1216.html. 
In this study, it is used to put the vial upside-down at a controlled frequency. They showed that 
the drop and shaking stress provoked by the friability test apparatus induce the IgG1 antibody 
aggregation contrary to a “shaking-only” stress induced by orbital shaking, at the same rotation 
speed. Furthermore, transferring an ‘unstressed’ IgG1 antibody solution into a vial that has 
previously been repeatedly dropped and shaken, triggers the formation of antibody aggregates but 
transferring a ‘stressed’ solution into a new vial doesn’t have an effect. Also, CD spectroscopy 
analysis showed that the bulk protein conformation is ot modified after orbital shaking or vial 
drop cycles. From these observations, they conclude that a cavitation phenomenon that happens 
during vial drops causes the unfolding of the antibod es which are then able to adsorb and 
accumulate at the solid surface of the vial thanks to olution shaking. Further solution agitation 
desorbs small surface adsorbed IgG1 aggregates that act as seeds for the formation of larger 
aggregates. A schematic view of the IgG1 aggregation pathway proposed by Torisu and 
colleagues is shown in Figure 62. 
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Figure 62: IgG1 aggregation pathway proposed by Torisu and coworkers. 
Step 1: unfolding of IgG1 molecule caused by cavitation during vial drops. 
Step 2: adsorption of unfolded IgG1 on the vial surface by solution agitation. 
Step 3: desorption of unfolded antibody by shaking. 
Step 4: increase in subvisible particles resulting from a cycle of dropping and shaking. 
Unfolded antibodies, antibody aggregate seeds on vial surfaces, and antibody aggregates are shown in red. Native 
antibodies are represented in blue. Figure taken from (Torisu et al. 2016). 
We interpret their observations slightly differently: we suggest that the IgG1 molecules adsorb 
spontaneously at the hydrophobic vial surface and partially unfold (see examples in (Tan and 
Martic 1990) or in (Engel et al. 2002)), forming a monolayer film that can only interact with 
other unfolded antibodies. During vial drops, the contact between the vial surface and an 
air/water interface (creation of a triple interface) promotes the interactions between unfolded 
proteins that are adsorbed at the interfaces and the accumulation of the unfolded species at the 
vial surface, leading to aggregate formation. We are skeptical that unfolded antibodies are present 
in solution because (i) no conformational change is ob erved after vial drops or orbital shaking 
and (ii) the protein’s native conformation corresponds to the free energy minimum state in the 
bulk solution so that the unfolded state could be maintained without the addition of a 
destabilizing condition such as the presence of a hydrophobic interface. Therefore, we propose 
that the aggregation seeds (or nuclei) and the aggregate formation are both taking place on the 
vial surface. The aggregates are released in solution by shaking when they are large enough to be 
stable in the bulk solution. However, we share Torisu et al conclusion on the fact that a 
combination of the creation of dynamic air/water interfaces in presence of a solid surface where 
partially unfolded proteins are adsorbed is the driving force of protein agitation-induced 
aggregation. 
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Amyloid beta peptide (Aβ1-42) and Islet Amyloid PolyPeptide (IAPP) are well-known examples 
of small proteins able to form amyloid fibers. Are they also sensitive to the triple interface? 
Interface-induced protein aggregation is observed only when adsorbed proteins adopt a stable 
conformational change at the interface and when the local protein concentration at the interface is 
high enough to trigger intermolecular interactions. These conditions are met for different proteins 
at different concentrations and timescales: e.g. critical fibrillar concentration for IAPP = 1.2 µM, 
for Aβ = 4 µM in the conditions used in (Jean et al. 2012). We also tried a few experiments to test 
whether Aβ1-42 also form aggregates in our microchannel experiment. At 84 µM, THT-positive 
aggregates appeared quasi-instantaneously in solution and didn’t attach to the hydrophobic 
microchannel surface (Appendix N). In the used conditions, amyloid beta peptide aggregation 
seemed to be spontaneous and not interfacially induced. At a lower concentration, 5 µM, no 
THT-positive Aβ1-42 peptide aggregate appear in our microchannel after 3 hours of liquid cycling. 
Longer incubation times or higher temperatures may be necessary to observe amyloid fiber 
formation under these conditions. Other Aβ peptides could also be studied. Because of lack of 
time, we did not pursue these experiments. 
In the present section, we discussed the interfacial effect that lead to protein aggregation. One 
could wonder if other physical phenomena such as droplet evaporation or capillary flows could 
also lead to protein aggregation. This is the point explored in the next section. 
 
4.3 How can physical effects lead to protein aggregation at the triple 
contact line? 
4.3.1 Particle deposition at the triple contact line by the coffee-ring effect 
In our microchannel setup, the ring-like shape of the amyloid aggregate deposits surrounding 
liquid droplets is particularly reminiscent of the triple contact line particle deposition 
phenomenon called “coffee-ring effect”. The coffee-ring effect results of capillary flows that are 
created inside of a liquid droplet containing particles in suspension, during its drying on a solid 
surface, which concentrates the particle at the triple contact line. In the following, we describe the
physical phenomena that lead to the coffee-ring effect. 
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When a liquid droplet enters in contact with a solid surface, it can either spread completely by 
creating a film (complete wetting) or partially by creating a spherical cap (partial wetting) over 
the substrate. The behavior of the droplet is determined by the spreading parameter S, that is a 
function of the three interface (solid/liquid, solid/vapor and liquid/vapor) surface tensions 
(Equation 30). 
  =   − (¡  ¡ ) Equation 30 
With S, the spreading parameter, if S > 0 the wetting is complete and if S < 0, the wetting is 
partial.  , ¡	#$%	¡  represent the surface tension of the solid/vapor, slid/liquid and 
liquid/vapor interfaces, respectively. 
 In case of a partial wetting (S < 0), the liquid droplet is at an equilibrium state when a contact 
angle θe is reached, balancing the different surface tensions according to the Young-Dupre law 
(Figure 63 and Equation 31). 
 
Figure 63: Schematic view of a liquid droplet (in blue) that partially wets a solid substrate (in grey).  
The blue arrows represent the different interface surface tension force vectors. θe is the contact angle at the equilibrium 
state.  
The figure is taken from (Tay 2011). 
   = ¡¡  cos F; Equation 31 
Where θe is the contact angle between a solid surface and a liquid droplet at an equilibrium state. 
When evaporation takes place, a hydrodynamic flow is created inside the droplet, which is 
governed by vapor diffusion. The gas phase in close proximity of the liquid/gas interface is 
saturated with vapor. As the gas phase is not saturated with vapor far away from the interface, the 
vapor diffuses outward. Deegan and coworkers expressed the evaporation flux profile along the 
liquid/gas interface by analogy with an electrostatic problem. They evidenced a flux divergence 
at the triple contact line so that the evaporation rate is higher in this area (Deegan et al. 1997). 
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Therefore, we should observe that the droplet radius progressively shrinks. However, the droplet 
triple contact line is pinned to the solid surface due to the balance of the surface tensions at the 
equilibrium state so that every liquid molecule that evaporates should be replaced in order to 
preserve the surface tension balance. A radially outwards capillary flow is thus induced inside the 
droplet to compensate the evaporation loss (Figure 64.B). If the liquid droplet contains a solute, 
the capillary flow will concentrate it at the triple contact line during evaporation, leading to a 
coffee-ring effect (Figure 64.A). 
Hu and Larson pushed further the study of the evaporation of a sessile droplet. They pointed out 
that the divergent evaporation flux profile along the liquid/gas interface causes a temperature 
gradient and thus a surface tension gradient along the interface, which contributes to in a liquid 
flow towards the lower surface tension regions so from the triple contact line to the droplet apex 
(Figure 64.D) (Hu and Larson 2005). This is called the Marangoni effect. It is defined by a mass 
transfer along an interface induced by a surface tension gradient. They also showed that the 
Marangoni effect, although it is very weak in water, could suppress the coffee-ring effect for 
octane droplets containing poly(methyl methacrylate) (PMMA) particles (Figure 64.C) (Hu and 
Larson 2006). In another study, Li and coworkers confirmed that in water, even with a high 
temperature gradient between the contact line and the droplet apex, the Marangoni effect is not 
sufficient to suppress the coffee-ring effect contrary to a fast enough evaporation rate that results 
in a particle trapping at the air/liquid interface and a homogeneous deposit after drying (Li et al. 
2016). 
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Figure 64: Hu and Larson’s coffee ring effect experiments. 
A, ring deposition pattern from the drying of a water droplet containing fluorescent polystyrene micro-particles.  
B, predicted flow field in a drying water droplet.  
C, central deposition pattern from the drying of an octane droplet containing PMMA particles.  
D, the flow field in a drying octane droplet, imaged with fluorescent probes (top) and predicted (bottom).  
Figures adapted from (Hu and Larson 2006). 
One should note that the coffee-ring effect could happen even if the triple contact line is not 
always fixed during the evaporation process. Rio and colleagues showed that, in the case of a 
moving triple contact line, the particle deposition is dictated by the competition between the 
evaporation-induced capillary flow that concentrates the particles at the triple contact line and the 
hydrodynamic flow caused by the triple contact line movement that redistributes the particle in 
the bulk. Under a critical contact line velocity, the capillary flow is predominant causing a stick-
slip movement of the contact line i.e. the contact line is periodically pinned by particles deposited 
at the solid surface leading to further particle deposition (concentric coffee-rings) until the triple 
contact line is depinned (Rio et al. 2006). 
Generally speaking, the coffee-ring effect depends on numerous factors such as the nature and the 
size of the particles in the liquid phase, rate of evaporation, ambient humidity, surface 
hydrophobicity, liquid surface tension, the presence of surfactants and many others. For instance, 
Yunker and colleagues (Yunker et al. 2011) showed that in the case of a micro-sized ellipsoidal 
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particle suspension, the particles are homogeneously deposited on the solid surface after the 
droplet evaporation in contrast to a micro-sphere particle suspension which is subject to the 
coffee-ring effect. The ellipsoid particles are trapped by the air/water interface where they 
aggregate and are not transported to the triple conta t line. One other example is the study 
conducted by Sett and coworkers where they observe a ing deposition of Aβ25-32 amyloid fibrils 
on a glass substrate after evaporation and a homogene us deposition on a Teflon-coated substrate 
(inhibition of the coffee-ring effect by a hydrophobic substrate) (Sett et al. 2015). 
The coffee-ring effect is an issue in many applications involving droplet drying such as inkjet 
printing, surface coating, DNA and protein microarrays and cell patterning. It can also be turned 
into an advantage for particle patterning or diagnostic assays. Indeed, the concentration of protein 
of interest along with their specific marker at theriple contact line could enhance the sensitivity 
of diagnostic assays. Also, the morphology of the particle deposit could give information on the 
protein state (aggregated or not) or even on the protein type (mutant or not). Devineau and 
colleagues observed that the screening of functionalized polystyrene particle charges by protein 
adsorption suppresses the coffee-ring effect by favoring the adsorption of the protein-particle 
complex at the air/liquid interface. However, at high protein concentration, the unfolding and 
reorganization of the particle adsorbed proteins leads to a coffee-ring effect recovery caused by 
an increase of the protein-particle complex charge. Moreover, they showed that a single amino 
acid mutation in human hemoglobin (h-HbA) significantly modifies the particle deposition 
pattern after evaporation of a droplet of a mutant h-HbA solution with charged polystyrene 
particles in suspension (Devineau et al. 2016). 
One could wonder if the observed triple interface aggregates growth mechanism in our 
microchannel setup would possibly be a deposition mechanism where the aggregates form 
elsewhere than on the surface (in the bulk or at the air/water interface) and are then deposited at 
the triple contact line by the coffee-ring effect. The coffee-ring effect is heavily dependent of the 
shape of the particles. By analogy with Yunker and colleagues experiment (Yunker et al. 2011), 
if amyloid aggregates were present at the air/water int face of the droplet, they should deposit 
homogeneously at the microchannel surface which is not the case. In the same way, because the 
aggregates created are of very different size and have an elongated shape, if they were formed 
elsewhere than at the triple interface, they should deposit everywhere on the surface. However, 
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native HI proteins could be considered as spherical particles. We could imagine a coffee-ring 
effect similar phenomenon that could carry the bulk HI proteins toward the triple contact line 
with the consequence of a local increase of the protein concentration next to the triple interface 
favoring protein-protein interactions and a constant supply for the aggregation centers. Also, Sett 
and coworkers showed that the Aβ amyloid fibril ring-pattern deposition is suppressd by using a 
hydrophobic surface which is the case in our microchannel experiment. We therefore conclude 
that the coffee ring effect is not the of HI amyloid fibril growth around droplets. 
Furthermore, the main argument against a triple contact line aggregate deposition by the coffee-
ring effect is that, in our system, the droplet triple contact line is not pinned to the surface. 
Indeed, we observed a progressive increase of the droplet area during the dewetting period. In the 
following section, we will investigate the microchannel surface dewetting and the observed 
droplet growth in more details to understand the involved mechanism. 
 
4.3.2 Physical explanation of the droplet growth at the microchannel surface 
In our microchannel experiment, the dewetting phase starts with the passing of the solution 
meniscus (Figure 65.A) followed by a “precursor liquid film” (in Figure 65.B) of about 200-300 
µm long. This precursor film breaks up into droplets left on the microchannel surface (Figure 
65.C and D). 
 
Figure 65: Four consecutive frames of an RICM movie (15 frames per s) starting at the passing of the solution meniscus in 
the ROI.  
The meniscus is moving from the right to the left. 
In the frame A, the liquid is represented in black and the precursor film in grey.  
The frame B represents the precursor film.  
In frame C, the precursor film (light grey) splits into droplets (dark grey disks).  
Frame D shows the liquid droplets left after the breaking of the precursor film. 
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We observed that the radius of the droplets left on the microchannel surface was increasing 
throughout the entire dewetting phase (namely droplet formation kinetics as shown in Figure 
51.B). This droplet radius increase could be related to (i) a droplet spreading while its volume 
remains constant caused by a decrease of the contact a gle or (ii) a droplet volume increase. Note 
that the droplets are constantly spreading during all the dewetting phase whereas the pressure 
decreases when the pump pulls the liquid and increases when the pump pushes it. Therefore, it is 
not likely that the pressure was responsible for the observed phenomenon. The contact angle 
decrease could be caused by a surface tension change phenomenon during the dewetting phase 
due to the progressive air saturation in water. As water molecules evaporate from the residual 
liquid film surrounding the droplets, the solid/air surface tension   increases, leading to a 
contact angle θe decrease (see the Young equation reported in Equation 31) allowing the droplet 
spreading. However, a closer look at the RICM movie’s first frame where the droplets appear 
(Figure 66.A) and last frame before the microchannel filling (Figure 66.B) reveals a change in the 
droplet interference fringe pattern which convinces us of a droplet volume increase. 
 
Figure 66: RICM movie frames of (A) the droplet appearance on the microchannel surface (dewetting phase first frame) 
and (B) the end of the dewetting phase (last frame of the dewetting phase) with, in black, the liquid that is filling the 
microchannel. 
Now that we have established that the droplet radius increase during the dewetting phase is 
caused by a volume increase, we need to determine the origin of the water that is progressively 
incorporated into the droplets. 
First of all, the extra water volume has to be determined. To do so, we suppose that the droplets 
are half spheres with a volume equal to 4πr3 / 6. We calculate a mean droplet surface area, with a 
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similar ImageJ analysis than in 2.7.5, for the first and last frame of a dewetting phase RICM 
movie. We suggested that the mean droplet surface area is equal to πr2, in order to determine a 
mean droplet radius and then a mean droplet volume. Finally, we multiply the mean droplet 
volume calculated with the number of droplets to estimate the total droplet volume. The total 
droplet volume difference between the first and the last dewetting phase movie frame represents 
the water volume that has been incorporated into the droplets during one dewetting cycle. We 
evaluate this volume to 2160.5 ± 287.7 µm3. 
Two possible origins for the water uptake can be identified: 
(i) Residual water between the droplets on the surface is progressively sucked up by the droplets 
or (ii), water from the ceiling of the microchannel feed the droplets on the surface by 
evaporation/condensation due to a temperature gradient. 
We investigate both possibilities: 
(i) Residual water between the droplets on the surface is progressively sucked up by the droplets, 
either by capillary forces or by evaporation-condensation. Note that when we estimated earlier 
the thickness of the precursor film, the value of the film thickness was relative to the grey level 
between the droplets but there is no clue to say if the grey level corresponds to the microchannel 
surface or to a remaining residual liquid film. However, if residual water is present between the 
droplets and progressively transferred to the droplets, we should see a change in the RICM signal 
attributed to the surface between droplets between images during the dewetting phase. We 
therefore measure the mean background grey level of the rames of a dewetting phase RICM 
movie but observe no significant change. The mean background grey level always remains the 
same within error bars (see example in Figure 67). Therefore, it is unlikely that residual water 
remaining as a thin film between droplets feeds the droplets. 
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Figure 67: Background mean grey level of each frame during a dewetting phase (RICM movie).  
Error bars represent the standard deviation of the average pixel grey value for each frame. 
We also calculated the theoretical available volume of the residual water on the surface between 
the droplets. We determined the total surface area between the droplets using the first frame of a 
dewetting phase RICM movie. Because no interference fringe appears between the first and last 
frame of the RICM movie, the residual water film thickness decrease must be less than λ / 
(4nwater) = 103 nm (see the RICM technique paragraph in 2.5.2). If we multiply the total surface 
between droplets by a 103 nm thickness, we can estimate a maximal available volume of residual 
water which is 922.5 ± 10 µm3. It is smaller than the calculated water volume incorporated into 
the droplets: 2160.5 ± 287.7 µm3 (see results in Figure 68). Thus, we confirm by this approach 
that it is unlikely that the drops gain water from a thin surface film. 
(ii) During the microchannel experiment, a transparent heater is placed at the top of the 
microchannel in order to heat up the system at 37 °C. Therefore, inside the microchannel, there is 
a hot spot at the top surface and a cold spot at the bottom surface, where the ROI is. We suppose 
that, at the start of the dewetting phase, droplets are equally present at the top and bottom 
microchannel surface and that the deposition is the same for both surfaces (although it should 
slightly differ because of the temperature differenc  that induces surface tension changes). One 
could imagine that the water of the top surface droplets can be transferred, by an evaporation-
condensation process caused by the temperature gradient, to the bottom surface droplets. This 
could only be possible if the water volume of the droplets at the top surface is approximately 
equal to the incorporated water volume at the bottom surface. Since we cannot image the top 
surface, we can estimate the initial volume of the droplets left at the top surface to be equal to the 
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one recorded for the first frame of a dewetting phase movie at the bottom surface. We calculate 
the total volume ratio between the top surface droplets at the beginning of the dewetting period 
and the bottom surface droplets at the end of the dewetting period: this ratio equals 1.82 (see the 
image analysis results in Figure 68) which matches with the hypothesis (ii) in which we expect 
this ratio to be less than 2. It is likely that theop surface droplets do not evaporate entirely.  
A summary of all the data calculated using the image nalyses is displayed in Figure 68. 
 
Figure 68: ImageJ analysis results of the first and last frame of a dewetting phase RICM movie.  
The errors are calculated using an alternative threshold during the image analysis. 
Then, it is necessary to verify if the provided electrical power is sufficient enough to evaporate 
the top surface droplet water. The necessary energy Evap to evaporate a water volume of 2160.5 ± 
287.7 µm3, corresponding to the incorporated water volume, is calculated as following: 
 ¢e9< = ∆e9< × Wu9;G = 4.89 × 10K£¤ Equation 32 
Where ∆Hvap is the water specific latent heat of vaporization and is equal to 2264.76 kJ/kg at 
atmospheric pressure and 20 °C and mwater is the water mass to evaporate. 
The provided energy Eel by heating is calculated below: 
 ¢;s = ¥;s × ( × rt¦§¨ = 3.93 × 10K©¤ Equation 33 
Where Pel is the power applied to the transparent heater, calculated with the calibration curve in 
Figure 34 and is equal to 0.34 W, t is the time duration of the dewetting phase and which is 
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approximately 11 s (the dewetting phase RICM movie has 170 frames and is acquired at 15 
frames per second), Sobs is the analyzed surface area (10496.9 µm²) and STH is the surface of the 
transparent heater (10 cm²). 
The furnished energy emanating from the heater is thu sufficient to evaporate the incorporated 
water volume. 
A better estimation of the energy available could be done by taking into account the 
microchannel plastic thermal conductivity. The energy E that is transferred to the microchannel is 
estimated as follows: 
 ¢ = 2rt¦ × ∆ × ( = 2.96 × 10K©¤ Equation 34 
Where λ is thermal conductivity of the microchannel plastic and is equal to 0.12 W/(m.K), ∆T is 
the temperature difference between the topside and the bottom side of the microchannel and is 
equal to 3.8 K, t is the time duration of the dewetting phase (11 s), Sobs is the analyzed surface 
area (10496.9 µm²) and e is the thickness of the microchannel chip (1.77 mm). 
The transmitted energy inside the microchannel, as measured from the temperature difference, is 
thus also sufficient to evaporate the droplets thatare located at the top surface. It confirms that 
the hypothesis (ii) could possibly be the reason of the observed droplet growth.  
We also study the detailed kinetics of the dewetting phase volume increase of single droplets to 
confirm the above proposed evaporation/condensation mechanism. The surface area of a single 
droplet is determined for each frame of a dewetting phase RICM movie thanks to the ImageJ 
plugin “Cell Magik Wand Tool” (implemented by Theo Walker). From the surface area, we 
deduce the droplet radius (the droplet is supposed to be a half sphere) then the droplet volume. 
An example is shown in Figure 69. 
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Figure 69: Single droplet volume evolution during a complete dewetting period.  
The droplet volume is plotted as a function of time. The black and the red dotted lines represent the xperimental data 
and the obtained fit, respectively.  
These data are representative of 3 different single droplets in which the droplet volume increase ratio is between 1.83 and 
2.1 and the droplet radius difference between 0.95 and 1.18µm. Error bars are omitted for clarity reasons and worth ± 3.8 
µm3. 
In the experimental data, we observe, first, a transitory period of 0.93 seconds where the droplet 
volume seems to remain constant and then a steady increase of the volume. The data can be fitted 
with the following equation: 
 X!	( ª ∆(, 3 = 3	X!	( > ∆(, 3 = J − «K((K∆)) Equation 35 
With ∆t, the length of the transitory period (0.93 s), V, the droplet volume in µm3, V0, the droplet 
volume during the transitory period equal to 167.5 µm3 and A, B and C, the fit parameters. 
In Figure 69, the best experimental data fit (red dotted line) is found with A = 317, B = 149.6 and 
C = 0.22. The transitory period could be explained by the time needed to evaporate the top 
surface droplets. If we replace t, in Equation 33, by the transitory period time, we can calculate 
the energy emanating from the heater during the transitory period which equals 3.3210-6 J. This 
value is close to the one found to evaporate the requir d water volume from the top surface 
(4.8910-6 J in Equation 32), validating our argument. 
In conclusion, it is physically possible that during the dewetting phase, the water of the droplets 
that are formed at the top microchannel surface progressively evaporates, then condensates into 
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the droplets located on the bottom microchannel surface due to a temperature gradient inside the 
microchannel, leading to a bottom surface droplet volume increase. 
 
The bottom surface droplet volume increase results in he droplet dilution by the incorporation, 
by evaporation/condensation, of water that comes from the microchannel top surface. It leads us 
to a first question: is HI diffusion quick enough to compensate for the volume increase. Inside the 
droplet, we calculate the HI lateral diffusion coefficient in Equation 36: 
 g = 
61^! = 109.4	μW/U Equation 36 
Where D is the translational diffusion coefficient, k is the Boltzmann constant and equals 1.38  
10-23 J/K, T is the temperature and equals 310.15 K, η is the water viscosity (0.000692 Pa.s) and r 
is the radius of the human insulin hexamer, estimated to 3 nm. 
The average surface droplet area increase during the dewetting phase is estimated to 16.5 µm2. 
The HI diffusion is thus fast enough to homogenize ts concentration inside the droplet 
throughout the dewetting phase; which is compatible with amyloid fibril growth during the 
dewetting phase. However, we notice, from the previous analysis, that the droplet radius increase 
during the dewetting phase is averaged at 0.9 µm (Figure 68) whereas the width of the newly 
formed aggregate ring at each cycle is estimated to 0.397 µm (see the pooled results of Figure 
59). The new amyloid fibrils are not formed on the entire surface that is swept by air/water (0.9 
µm) but only where fibrils are already present and have been air-exposed for the longest time 
(schematics in Figure 70). The air/water interface sw eping alone is thus not sufficient to trigger 
the fibril growth. Additionally, the longer the time during which fibrils are exposed to air, the less 
they are in contact with HI molecules from the droplet. Given the limited volume of the droplets, 
it is therefore difficult to envision that new fibrls form during the dewetting phase, in the last 
seconds, at a rate that increases exponentially with the number of cycles. This points out to an 
important question: when does the amyloid fibril growth take place, during the dewetting phase 
or during the wetting phase? 
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Figure 70: Schematics of the bottom surface droplet growth with respect to the position of the newly formed HI 
aggregates.  
The bottom surface HI solution droplet at the begining of the dewetting phase is represented in blue and is annotated 
Dinitial . The one at the end of the dewetting phase is represented by a blue dotted line and is annotated Dfinal. The green 
rectangles represent the newly formed amyloid fibrils. 
 
4.4 When do the amyloid fibrils grow? 
4.4.1 THT fluorescence signal analysis during consecutive complete wetting/dewetting 
cycles 
In the middle of the growth phase, we monitored the evolution of the THT fluorescence during 
several consecutive complete wetting/dewetting cycles (fluorescence movie). An example is 
shown in Figure 71, where the mean fluorescence level of each frame is represented as a function 
of time during two complete wetting/dewetting cycles.   
 
Figure 71: Mean grey level of each frame during consecutive wetting/dewetting cycles (THT fluorescence movie).  
D and W indicate the dewetting and wetting phase, respectively.  
Error bars are omitted for clarity reasons and worth ± 5 A.U. 
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The drastic increase of the THT fluorescence signal corresponds to the passing of the bulk 
solution and is caused by its high intrinsic fluoresc nce level. We observe a small fluorescence 
increase during the wetting phase and a fluorescence de rease due to photobleaching during the 
dewetting phase. The fluorescence increase could either represent the formation of new amyloid 
fibrils or a recovery of the fluorescence due to the replacement of photobleached THT molecules 
by new ones (fluorescence recovery). Therefore, in order to avoid any misinterpretation of the 
data, it is necessary to first estimate the amplitude of the THT fluorescence recovery during the 
wetting phase. 
 
4.4.2 Contribution of the THT exchange (fluorescence recovery after photobleaching) to 
the fluorescence gain 
To estimate the maximum THT fluorescence that can be recovered during the wetting phase, we 
are going to compare a fluorescence movie, where the illumination is continuous, to a time-lapse 
experiment, where acquisition phases are separated by cycles of wetting/dewetting. At the end of 
time-lapse experiments, as in Figure 49.A, we noticed that the fluorescence level in the ROI was 
significantly lower than in the surrounding area, which was never exposed to illumination (an 
example is shown in Figure 72). This means that the THT fluorescence photobleached during the 
illumination phases never fully recovered during the ten consecutive wetting/dewetting cycles 
that followed. 
 
Figure 72: Consecutive fluorescence images of the microchannel surface, including the ROI, after 4 hours of experiment.  
The darker region corresponds to the illuminated and photobleached area during the time-lapse experiment.  
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This implies that the total time where the ROI is in contact with THT (namely during the wetting 
phase) between two image acquisitions is not long enough to totally recover its fluorescence. One 
time-lapse image acquisition lasts maximally 1 second and is occurring once every 10 liquid 
cycles. The ROI surface is wet (i.e. in contact with THT) during 4 seconds during each liquid 
cycle so that the ROI is exposed during a total 40 seconds between two consecutive acquisitions. 
During this time where the ROI is in contact with TH , the fluorescence recovered from 
photobleaching but Figure 72 shows that this time is insufficient to fully recover the THT 
fluorescence level.  
In a fluorescence movie, the ROI is constantly illuminated so that the time during which the 
fluorescence recovers is reduced to 4 second (wetting phase time), ten times less than the 
fluorescence recovery period of a time-lapse acquisition. Therefore the fluorescence recovery in a 
fluorescence movie should be even further reduced. We estimate it to be at most 1/10th of the 
photobleached fluorescence (4 sec/40 sec).  
 
4.4.3 Evidence for amyloid fibril growth during the wetting phase 
During the wetting phase, the average fluorescence signal increased by 1.97 ± 0.46 (greyscale 
units) (Figure 73.C). The average fluorescence loss by photobleaching during a dewetting phase 
is 3.73 ± 0.98 (greyscale units) (Figure 73.C) so that we estimated the fluorescence recovery 
during a wetting phase to be less than 3.73 / 10 = 0.37 ± 0.1 (in greyscale), as explained above. 
The observed fluorescence signal increase is thus too important to be due to fluorescence 
recovery alone. Furthermore, new surface THT-positive materials are indeed observed between 
the last frame of a dewetting phase (Figure 73.A) and the first frame of the following dewetting 
phase (Figure 73.B). Therefore, we conclude that net amyloid fibril growth occurs during the 
wetting phase and we calculate a mean fluorescence gain during the wetting phase, normalized to 
the initial fluorescence, of 0.0269 ± 0.0066 (grey l vel) (Figure 73.C). The question of the origin 
of this fluorescence increase will be discussed in paragraph 5.4.5. We want here to show that this 
fluorescence increase matches the observed fluorescence kinetics of amyloid fibers rings (Figure 
53).  
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Figure 73: Fluorescence movie ImageJ analysis. 
A, last frame of a dewetting phase of a fluorescence movie.  
B, first frame of the next dewetting phase of the same fluorescence movie.  
C, ImageJ fluorescence movie analysis. The mean fluorescence gain between the first and last frame of a wetting phase is 
given by the frame mean grey level difference. This result is divided by the mean grey level of the first frame of the wetting 
phase to obtain the normalized fluorescence gain after a wetting phase. The photobleaching is given by the mean grey level 
difference between the first and last frame of a dewetting period. The displayed results are an average over 8 liquid cycles 
from two different fluorescence movies. The error is given by the standard deviation of the data pool. 
For this purpose, we compare this mean fluorescence gain acquired during the wetting phase with 
a normalized fluorescence gain, Gth(t), calculated with our physico-mathematical model (as
described in Equation 37), using the theoretical parameters found for the pooled results (Figure 
59).  
 (() = ­ ∆(!, ()%!
­ (!, () %!  Equation 37 
Where L(r,t) is the amyloid fibril distribution at cycle t, ∆L(r,t) represents the amount of newly 
formed aggregates between cycle t and t+1. 
The obtained function Gth(t) is shown in Figure 74. 
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Figure 74: Normalized fluorescence gain Gth(t) as a function of the number of cycles, obtained from a Scilab simulation 
with k = 1.07, ω = 0.50 µm and σ = 0.53 µm.  
The red line represents a data fit with the empirical function y = 0.3999 x-0.626. 
The fluorescence movie was acquired about 80 cycles aft r the onset of HI aggregation, which 
gives a theoretical normalized fluorescence gain of Gth = 0.0257 (calculated using the equation 
fitting the data points in Figure 74), very close to the one found experimentally (0.0269 ± 
0.0066).  
In Figure 74, we notice that Gth seems to tend to constant value. To check this point, we 
determine an analytical expression for Gth. It has been shown previously (Figure 53) that the net 
fluorescence increase, Σexp(t), can be fitted by an exponential function. We can, thus, write: 
 I ∆((, !)%! = ®¯°(() = J±QPR Equation 38 
With A, the amplitude and αexp, the experimental growth rate. 
And 
 I (!, () = I ((( − 1, !)  ∆(( − 1, !))%!

  Equation 39 
 
If we expressed ∆L(t-1,r) in its exponential form, we obtain: 
 I (!, () = J±QPR(K)  I (( − 1, !)%!

  Equation 40 
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In the same way, we rewrite L(t-1,r):  
 I (!, () = J±QPR(K)  J±QPR(K)  I (( − 2, !)%!

  Equation 41 
 
And so on until we obtain: 
 I (!, () = J±QPR(K)  J±QPR(K)  ⋯ J  I (0, !)%!

  Equation 42 
 																		= J(1  ±QPR  (±QPR)  ⋯ (±QPR)K)  I KGT%!  Equation 43 
With σ, the width of the initial aggregate distribution. 
Here, we recognize a geometric sequence with a common ratio of ±QPR so we ultimately obtain: 
 I (!, () = J³
1 − ±QPR1 − ±QPR ´  k2 √1 Equation 44 
 
Now, we can calculate Gth: 
 (() = ­ ∆(!, ()%!
­ (!, () %! =
J±QPR
J l1 − ±QPR1 − ±QPR m  k2 √1
 Equation 45 
 
When the HI aggregation is advanced, t >> 1 so the ±QPR terms are preponderant and we can 
approximate Gth as: 
 (() →·̧ ¸¹ J
±QPR
J±QPR±QPR − 1
= ±QPR − 1 = 0.0229 Equation 46 
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The experimental, simulated and analytically calculated normalized fluorescence gains are very 
close to each other, which thus reinforces the hypothesis that HI fibril growth happens during the 
wetting phase and shows its compatibility with the macroscopically observed growth rate. 
 
4.4.4 Kinetics of THT fluorescence increase during the wetting phase 
We now turned to the kinetics of the THT fluorescence signal increase during a wetting phase. 
Figure 75 shows the fluorescence movie frame mean grey level with respect to the one of the first 
frame of a wetting phase as a function of time. It can be fitted with the following equation:  
 C(() = C/9:(1 − Kº) Equation 47 
Where F(t)t represents the fluorescence increase during a wetting phase (in grey level), Fmax 
represents the THT fluorescence maximum (in grey level) and γ, the amyloid fibril growth rate 
during a wetting phase (in s-1). Fmax and γ are the fit parameters. 
 
Figure 75: THT fluorescence increase during a wetting phase.  
The mean grey level of the fluorescence movie frames during a wetting phase, minus the one of the first wetting phase 
frame, is represented as a function of time. The red line represents a data fit with the equation y = 2.21  (1 – exp (-1.99x). 
This result is representative of data obtained for 9 different wetting phases. Error bars represent the maximal standard 
deviation. 
From 9 different wetting phase analyses, we determine values for Fmax and γ that equal 2.43 ± 
0.37 in grey level and 2.91 ± 1.20 s-1, respectively. To what correspond this fluorescence 
increase? Again there are two possibilities that we are going to examine separately.  
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A first possibility is that this kinetics corresponds to the growth of new amyloid fibers from 
insulin in solution, at the surface of amyloid fibers that were dehydrated during the dewetting 
phase. Under this assumption, the kinetics represents insulin incorporation. The derivative of the 
fluorescence increase function can be expressed as a function of the HI bulk concentration, [HI] , 
an association constant, ka, that measures the propensity of bulk HI proteins to be incorporated 
into an amyloid fibril and, Nfree, the number of available HI incorporation sites: 
 %C(()%( = 
9»¼½¾G;; = 
9»¼(C/9: − C(()) Equation 48 
 
The equation solution is: 
 C(() = C/9:(1 − KO»¨¿¼) Equation 49 
 
Therefore, we can estimate ka which represents the association rate for the incorporation of native 
HI into an existing amyloid fiber: 
 
9 = »¼ = 3.40 × 10i	ÀKUK Equation 50 
With [HI]  = 86 µM and γ = 2.92 s-1. 
As a comparison, Figure 76 gives examples of associati n constants calculated in other studies 
with different experimental approaches. 
Our ka value is in the range of the ones found in the litrature. It is not surprising that the 
association constants differ from each other because the experimental conditions are not the 
same, each favoring a specific type of interaction. However, since amyloid aggregate form is 
similar for all studies, all aggregation mechanisms should be close to each other. Note that we 
may underestimate the association constant if we consider that only HI monomers are able to get 
incorporated in amyloid fibrils. Since HI monomers account for only 10% of the total HI 
concentration, the ka referring to the active molecular species should be 10 times higher. 
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Source 
Insulin 
type 
Temperature 
(°C) pH Aggregation induction ka (M
-1.s-1) 
(Knowles et al. 
2007) Bovine 20 2.5 
Seeding with surface 
adsorbed fibrils 9.2 103 
(Lee et al. 2007) Human 65 1.6 Spontaneous 7.64 105
(Sluzky et al. 
1992) Bovine 37 7.4 
Presence of 5 Teflon beads 
and a stirring at 80 rpm 5.0 103 
Our work Human 37 7.4 
Presence of a dynamic triple 
interface 3.4 104 
Figure 76: Examples of association constant for HI aggregation found in the literature. 
Alternatively, one can consider that the observed kinetics corresponds to the incorporation of 
THT molecules brought by the solution to new HI fibers that were formed during the dewetting 
phase (second possibility). Under this assumption, the kinetics represents the binding of THT 
molecules to newly formed amyloid fibril. Reasoning as above, one would thus determine, 
instead of a HI association constant, a THT binding constant kb:  
 
t = »¼ = 1.46 × 10©	ÀKUK Equation 51 
With [THT]  = 20 µM and γ = 2.92 s-1. 
This result is in accordance with the kb values found by LeVine (LeVine 1995) and Kuznetsova 
(Kuznetsova et al. 2012) that are 3.2  105 M-1s-1and 1.2  105 M-1s-1, respectively. Therefore, 
the fluorescence increase observed during the wetting phase could, instead of being due to the 
formation of new amyloid fibrils, be caused by the THT molecule binding on amyloid fibrils that 
were created during the previous dewetting phase. 
In the following section, we will therefore propose two different amyloid fibril growth 
mechanisms, one occurring during the wetting phase nd one other occurring during the 
dewetting phase. 
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4.4.5 Proposition of two different model for the amyloid fibril growth 
From the above considerations, it is clear that the duration of protein exposition to air is a critical 
factor in HI aggregation. Only sufficiently air-exposed amyloid fibrils can recruit HI proteins to 
grow or form new HI aggregates. This explains the results obtained in 3.1.3 (page 81), showing 
that the air/water interface sweeping speed has an effect on the HI aggregation kinetics. Indeed, 
in the case of faster sweeping speed, the hydrophobic beads, where the proteins are adsorbed, 
stay longer in a dry state, which accelerate the HI aggregation kinetics. Based on this affirmation, 
we can imagine two different pathways for the amyloid fibril growth:  
(i) A wetting phase amyloid fibril growth mechanism (schematically described in Figure 77, left): 
During the dewetting phase, the HI aggregates that are sufficiently air-exposed undergo a 
conformational reorganization. This conformational rearrangement allows the amyloid fibrils to 
recruit native HI proteins from the bulk during the n xt wetting phase. 
 (ii) A dewetting phase amyloid fibril growth mechanism (schematically described in Figure 77, 
right): 
At the onset of the dewetting phase, when the liquid retreats, HI proteins remain adsorbed on the 
amyloid fibrils that were previously formed on the microchannel surface. During the dewetting 
phase, some of the HI fibril-adsorbed proteins that are sufficiently exposed to air undergo a 
secondary structure transition from alpha helices to beta-sheets to form new amyloid fibrils in 
contact with older ones. These amyloid fibrils can also recruit the air/water interface-adsorbed 
and partially unfolded HI monomers. Then, during the next wetting phase, THT molecules are 
incorporated into the newly formed amyloid fibrils.  
Figure 77: Schematic view of the two proposed amyloid fibril growth mechanisms (next page). 
Left, wetting phase amyloid fibril growth mechanism. 
Right, dewetting phase amyloid fibril growth mechanism. 
The green, red and black rectangles represent THT-positive HI aggregates, adsorbed air/water interface-adsorbed and 
partially unfolded HI monomers and HI proteins, conformationally changed due to dehydration, respectively. The green 
crescents correspond to the reorganized amyloid fibrils. Bulk native HI proteins are represented by black dots. The HI 
solution is represented in blue. The microchannel surface is represented in grey. 
 
CHAPTER 4: Discussion and Conclusion 
153 
 
Figure 77: Schematic view of the two proposed amyloid fibril growth mechanisms. 
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We are convinced that the mechanism (ii) is more lik ly to occur because, contrary to (i), it 
explains that amyloid fibers do not appear in the inner border of the liquid droplets. It also 
explains why much faster HI aggregation kinetics is observed at the triple interface, with the 
incorporation of the air/water interface-adsorbed HI monomers onto existing amyloid fibers, 
compared to regions between liquid droplets where there are much less amyloid aggregates 
providing “template” for the conformational change. Nevertheless a conclusive experiment is 
awaited, which could consist in exchanging the HI + THT solution with THT alone after 
dewetting. If the fluorescence increase is still present, model (ii) holds, if it disappears, model (i) 
is true.   
The last point to be discussed is the position of the beginning of the triple interface region. In our
physico-mathematical HI growth model, described in F gure 54, we suppose that the triple 
interface region begins at the highest amyloid fibril on the surface. An interesting study from 
Muller and coworkers (Muller et al. 2008) shows that above a critical thickness (around 3.5-4.5 
nm) of polyelectrolyte brushes adsorbed on a polystyrene solid surface, a water droplet passes 
from a partial to a complete wetting. One could imagine that, after a significant accumulation of 
amyloid fibrils at the microchannel surface, the fibril media could gain the ability to retain the 
water molecules, in the same way as the polyelectrolyte brushes. This is also in favor of model 
(ii).  Therefore, the limit of the triple interface r gion could be defined by a critical surface 
amyloid fibril layer thickness. It could also explain that once the thickness of the fibril layer has 
reached a critical value, even a long exposure to air cannot trigger the formation of new fibrils. 
 
4.5 Perspectives 
4.5.1 Experimental perspectives towards initial events leading to insulin aggregation 
Our work reveals the exact location of the onset of HI agitation and hydrophobic surface induced 
aggregation in physiological conditions and its major contributors. The next step towards a 
complete understanding of its mechanism is the study of the HI adsorption and conformational 
change at the triple interface before the appearance of THT-positive aggregates. Since the 
aggregate formation is known, it is possible to usemore resolved characterization methods that 
have a higher sensitivity. The next challenge is to associate a microfluidic setup that creates 
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dynamic triple interfaces in a controlled, predictable and repeatable way with an appropriate 
characterization technique. We tried two approaches in order to observe the HI solid surface 
adsorption kinetics at a triple interface: SPRi (surface plasmon resonance imaging) and wet-
surface enhanced ellipsometric contrast microscopy (wet-SEEC) characterization. 
We managed to alternatively fill then empty a SPR chamber with a HI solution. A 
hydrophobically functionalized gold prism was used as a solid surface. We didn’t see any 
difference in the HI adsorption kinetics between fillings. We could explain that because the 
creation of triple interfaces was not well controlled and the liquid was often completely removed 
from the SPRi prism surface, corresponding to the scenario that took place between two liquid 
droplets in our microchannel experiment where no aggre ate formation was observed. This 
technique has also two severe drawbacks: it is verycostly in terms of consumables and the 
experiment is conducted at room temperature which extends the HI aggregation lag-time at a 
point that is not reasonable. We also had the idea of using the QCM-D technique (quartz 
microbalance with dissipation monitoring), which gives similar information to the SPRi 
technique (the mass of the adsorbed material at the quartz surface and the amount of water that is 
retained on the adsorbed layer) but we didn’t have the possibility to make experimental trials. 
The use of engineered glass substrates (T-SiO2 urf slides purchased from Nanolane) that greatly 
enhance the resolution of the wet-SEEC microscopy showed more promising results. Ducret and 
coworkers (Ducret et al. 2012) used wet-SEEC to observe the slime secretion of Myxococcus 
xanthus cells. They also showed that the wet-SEEC technique is able to characterize nanolayer 
deposits of a thickness of 0.2 nm. Since the hydrodynamic radius of an insulin monomer is 1.5 
nm, this technique should be appropriate for the observation of HI solid surface adsorption. We 
performed a trial at the Adhesion and Inflammation Lab in Marseille, with the help of Olivier 
Theodoly and Marie-Paule Valignat. A PMDS microchannel was casted on the top of a T-SiO2 
surf. We rendered the T-SiO2 surf hydrophobic and used it as a solid surface for dynamic triple 
interfaces and realized the same experiment that is described in paragraph 3.2. We succeeded to 
create liquid droplets when we withdrew the solution from the microchannel but not in a 
controlled and repeated manner and the experiment was hampered by the fact that the PDMS was 
more hydrophobic than the functionalized surf so that HI aggregate formation was favored on the 
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PDMS surface. However, we observed interesting “objects” on the surface where droplets were 
created (Figure 78). 
 
Figure 78: Wet-SEEC image of the T-SiO2 surf microchannel surface, in liquid, after 24 liquid cycles. The red arrows 
highlight material deposits left on the microchannel surface by solution droplets. 
In regard of these preliminary experiments, we consider that the wet-SEEC technique is highly 
relevant for the next step of our study. Combined with a total internal fluorescence microscopy 
(TIRF) observation (with THT as conformational marker), a complete description of the HI 
aggregation process could be possible. During the lag-time, the thickness of the HI layer 
adsorbed at the solid surface could be monitored as a function of the number of liquid cycles by 
wet-SEEC microscopy. Then, during the growth phase, when aggregates start to appear, the 
amount of HI attached to the solid surface could be correlated with the fluorescence signal 
corresponding to the amyloid aggregates. Other amyloid beta-sheet markers, other than THT, 
could also be tested. For example, Amytrackers, commercialized by Ebba Biotech AB, have been 
shown to be more sensitive than THT for the detection of pre-fibrillar HI aggregates (Klingstedt 
et al. 2011). The main challenge remaining is to develop a robust setup creating controlled 
dynamic triple interfaces and allowing, in-situ and i  real-time, the use of both fluorescence and 
wet-SEEC microscopy. 
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4.5.2 Precautions in protein handling during industrial processes 
Our work showed that the repeated creation of triple nterfaces, which is encountered in most of 
the pharmaceutic industrial processes for both liquid and lyophilized formulations, is a major 
cause of insulin instability. The control of the protein interfacial adsorption, by using adapted 
hydrophilic materials or additives such as polysorbates to compete the protein adsorption, greatly 
reduces the risks of protein aggregation. However, one could imagine other methods to avoid the 
protein degradation in industrial processes without changing the materials (that are often in 
plastic) or the protein formulation. Some alternative methods for standard processes are discussed 
below: 
Liquid formulations are usually very sensitive to pr tein degradation in industrial processes. The 
most obvious and frequent process that comes in mind is protein solution mixing. For proteins 
that exhibit a nucleation-dependent aggregation behavior such as insulin, there is a period of time 
(lag-phase) where no aggregates are created so that mixing (i.e. creation of triple interfaces) 
could be harmless for proteins, provided that the mixing time doesn’t extend beyond the 
aggregation lag-time. It has also been shown that sear stress alone is not sufficient to trigger 
aggregation and, even better, that a high shear stress could slow the aggregation nuclei formation. 
The mixing time could therefore be reduced by increasing the solution flow or agitation rate. One 
should carefully note that increasing the agitation rate often also increases the number of triple 
interfaces created which decreases the aggregation l g-time. For a mixing time superior to the 
aggregation lag-time, a possibility to achieve it whout damaging the protein is to periodically 
get rid of the nucleation sites. For example, in the case of insulin which has a surface-induced 
aggregation, a periodical change of container before reaching the end of the lag-phase could 
extend or even restart the lag-phase (nucleation sites are located on the surface of the container 
and thus removed by changing the container). For prteins that aggregate in solution, one could 
add hydrophilic solid stirrers to containers that are filled entirely without headspace. In that case, 
when the container is shaken, the fluid movement and therefore mixing is induced by the 
movement of the objects without the creation of triple interfaces. 
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Filtration is also a processing step that could be dangerous for protein stability. It could be 
compared to our setup described in chapter CHAPTER 3: where a protein solution passes through 
a bead network. The bead network could be equivalent to a filtration membrane and the 
interstices between the beads to filtration pores (we are aware that in most of the filtration steps 
the pores are much smaller than in our setup). If we consider our results, the presence of air 
bubbles could be critical for the protein stability but a degassed solution should remain stable 
even if a high flow rate (leading to a high shear stress) is used during the filtration.  
Similarly, in microfluidic systems, the repeated contact with air bubbles on a solid surface (such 
as tubing) could trigger protein aggregation. In the best scenario, air bubbles should be removed 
but their presence may be tolerated if they are controlled and do not come into contact repeatedly 
with a solid surface.  
For the transport and the storage of protein solutions, the containers should be filled entirely, 
without headspace, to increase the solution stabiliy. If, in the worst case, aggregation is still 
possible, it will be limited by protein diffusion, extending the lag-phase to weeks or even months. 
Lyophilized formulations are generally more stable than liquid formulations during transport and 
storage but the freeze-thawing process can trigger the formation of aggregates. In the freezing 
phase, the formation of numerous ice crystals creates liquid/solid interfaces where the proteins 
can adsorb and possibly unfold as shown in (Strambini and Gabellieri 1996). Therefore, the 
contact of ice crystals with container walls, air bub les or even other ice crystals could create 
triple interfaces and favor protein aggregation. An interesting study (Chang et al. 1996) showed a 
similar protein denaturation behavior during freezing and when it is surface-induced by shaking 
in the presence of Teflon beads. This study also showed that Tween80® increased the protein 
solution stability during freezing processes. Additionally, lyophilized formulations are submitted 
to the same triple interface issues encountered by liquid formulations during and after 
reconstitution. 
Last but not least, in any processes, it is essential to control the temperature. Indeed, an elevated 
temperature favors protein unfolding thus their aggre ation and also increase protein dehydration 
if they are exposed to air, which accelerate the aggregation kinetics. 
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One should keep in mind that these indications, based exclusively on scientific considerations, 
have to be balanced with the constraints that are important in an industrial setting, like cost- and 
time-efficiency of automated protocols, validation t  meet quality control standards or regulation 
regarding additive use.  
In conclusion, the choice of material surface, the careful design of fluid movement and the 
definition of adapted protocols in devices handling protein solutions could greatly enhance their 
stability, as well as a proper choice of excipients i  formulation in order to anticipate the stability 
issues that could be encountered in the different stage  of the product life cycle. 
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List of abbreviations 
Aβ: Amyloid β peptide 
AFM: Atomic force microscopy 
Ag: Antigen 
AgNW: Silver nanowire 
ATR-FTIR: Attenuated total reflectance Fourier-transform infrared spectroscopy 
A.U: Arbitrary unit 
B: Blue 
BCA: Bicinchoninic acid assay 
BSA: Bovine serum albumin 
c: Compacity 
CD: Circular dichroism 
COC: Cyclo-olefin copolymer 
CR: Compression/dilatation ratio 
D(r,t): Dehydration function 
D: Total volumetric flow rate 
d: Volumetric flow rate inside a microchannel 
DLS: Dynamic light scattering 
DNA: Deoxyribonucleic acid 
e: The thickness of the microchannel chip 
E: Energy transferred to the microchannel 
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Eel: The provided energy by heating 
Evap: The necessary energy to evaporate a water volume 
F: Integrated fluorescence intensity profile 
FITC: Fluorescein isothiocyanate 
G: Green 
Gth: Theoretical normalized fluorescence gain 
gl: Grey level 
HI: Human insulin 
I: Radial fluorescence intensity profile 
IAPP: Islet amyloid polypeptide 
IDP: Intrinsically disordered proteins 
Ig: Immunoglobulin 
k: Rate constant 
ka: Association rate for the incorporation of native HI into an existing amyloid fiber 
kb: THT binding constant 
L: The amyloid fiber length distribution 
mwater: The water mass to evaporate 
mAb: Monoclonal antibody 
MEMS: Microelectromechanical systems 
MFI: Microflow imaging 
MW: Molar weight 
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n: Number of microchannels 
Pel: The power applied to the transparent heater 
PDMS: Polydimethylsiloxane 
QCM-D: Quartz microbalance with dissipation monitoring 
R: Red 
Rb: Radius of a bead 
Rcol: Radius of the column 
rmax: The position of the maximum of the aggregate distribu ion 
Rmc: Radius of the microchannels created by the bead ntwork 
RGB: Red green blue 
RICM: Reflection interference contrast microscopy 
ROI: Region of interest 
Sbead: Total bead surface 
Scol: Column wall surface sweeped by the meniscus 
Sobs: Analyzed surface area 
STH: Surface of the transparent heater 
SDS: Sodium dodecyl sulfate 
SEEC: Surface enhanced ellipsometric contrast microscopy 
SSNMR: Solid state nuclear magnetic resonance 
SPRi: Surface plasmon resonance imaging 
STEM: Scanning transmission electron microscopy 
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TERS: Tip-enhanced Raman spectroscopy 
THT: Thioflavin T 
TIRF: Total internal reflection fluorescence 
TN buffer: Tris-HCl 25 mM and NaCl 125 mM buffer  
UV: Ultraviolet 
V: Droplet volume 
V0: The droplet volume during the transitory period 
vexp: Experimental velocity for amyloid fiber formation 
vth: Theoretical aggregation velocity 
W: Constant growth width of the aggregates 
Y: Yellow 
αexp: Experimental growth rate 
αth: Theoretical characteristic growth rate 
γ: Amyloid fibril growth rate during the wetting phase 
ΔHvap: The water specific latent heat of vaporization 
ΔI: Differential fluorescence increase distribution 
ΔL: Distribution of new fibers 
Δt: The time of the transitory period 
ΔT: The temperature difference between the topside an  the bottom side of the microchannel 
ΔV: Displaced liquid volume 
8/9:;:< : Radial position of the maximal fluorescence increase 
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8/9: : Radial position of the maximal fluorescence increase calculated with the model 
Σexp: The total amount of aggregates created over a 10 cycle interval 
Σth: The total amount of aggregates created per cycle calculated with the model 
σ: Width of the initial aggregate distribution 
σbead: Shear stress at the bead surface 
σwall: Shear stress at the column wall 
ω: Characteristic length of the dehydration function 
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Appendix 
 
Appendix A: Schematic view of a Chipshop microchannel  
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Appendix B: General developed formula of cyclic olefin copolymers 
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Appendix C: Micro Bio-Spin column schematics (adapted from Bio-Rad website) 
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Appendix D: Olympus IX71 microscope schematics, taken from Olympus IX7 manual 
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Appendix E: Cram representation of dichlorodimethylsilane. 
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Appendix F: Determination of the Tecan baseline. THT fluorescence of fresh and filtered 
TN, TN + 20 µM THT, 86 µM HI + 20 µM THT and 86 µM HI solutions (five wells of 200 
µL each in a 96 microwell plate, measured 4 times each). Std stands for standard deviation. 
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Appendix G: Mean grey level at the surface of a microchannel filled with TN buffer and 20 
µM THT after different washing procedures. 
 
In the no wash condition, the microchannel is directly filled with a TN solution containing 20µM 
THT. 
In the H2O condition, the microchannel is previously washed with 10 mL of deionized water. 
In the SDS condition, the microchannel is previously washed with 10 mL of 5% SDS, then 10 
mL of deionized water, then 10mL of 96% ethanol andfi ally 10 mL deionized water. 
  
No Wash H2O SDS
Grey level 64.69 33.62 25.73
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Appendix H: Picture of the adapted 125 µL syringe 
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Appendix I: Picture of the microchannel experiment setup 
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Appendix J: Preparation of the PDMS mixture 
Combine PDMS and curing agent in a beaker at a 10:1 volume ratio. 
Mix thoroughly with a spatula in order to achieve a homogeneous mixture. This step will cause 
bubbles to form within the mixture. 
Place the mixture in a vacuum for approximately 20 minutes until all the air bubbles are removed. 
PDMS is then ready for application. 
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Appendix K: Picture of the transparent heater 
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Appendix L: Visual Basic program for time-lapse acquisition automation 
Sub ProgPumpAR (program definition) 
Dim r As Integer 
Dim i As Integer 
Dim c As Integer 
r=IpCrs2Close() (close all the RS232 ports) 
Wait 1   (a waiting time is needed between commands) 
r=IpCrs2InitPort(5,9600,8,0,0,1)  (RS232 port configuration, here port com 5 which is 
the syringe pump port, 9600 baud rate, 8bits, no parity, no flow control) 
r=IpCrs2Open()    (open the previously initialized port) 
(Here, the syringe pump program is implemented. Note that during this whole step, the pump is 
not working, it is the pump program definition. The pump program will only be started in the 
image acquisition step. The pump program is composed f 99 cycles of pulling then pushing the 
syringe piston. The IpCrs2Write is a writing command on the RS232 port, vbCr is a carriage 
return.) 
r=IpCrs2Write("PHN 1" & vbCr) (definition of the phase 1 of the syringe pump program) 
Wait 1 
r=IpCrs2Write("FUNLPS" & vbCr) (start of the loop function) 
Wait 1 
r=IpCrs2Write("PHN 2" & vbCr) (definition of the phase 2 of the syringe pump program) 
Wait 1 
r=IpCrs2Write("FUNRAT" & vbCr) (start the pump) 
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Wait 1 
r=IpCrs2Write("RAT30MH" & vbCr) (flow rate definition, here 30 mL/min corresponds to 
the flow rate using a 1 mL syringe. With a 125 µL syringe, it corresponds, in fact, to 16 µL/min) 
Wait 1 
r=IpCrs2Write("DIRWDR" & vbCr) (set the direction of the pump, i.e. pushing or pulling the 
syringe piston) 
Wait 1 
r=IpCrs2Write("VOL60" & vbCr) (set the displaced volume. Again, 60 µl corresponds to the 
displaced volume using a 1 mL syringe. With a 125 µL syringe, it corresponds, in fact, to a 
displaced volume of 2 µL) 
Wait 1 
r=IpCrs2Write("PHN 3" & vbCr) (definition of phase 3)
Wait 1 
r=IpCrs2Write("FUNRAT" & vbCr) (start the pump) 
Wait 1 
r=IpCrs2Write("RAT30MH" & vbCr) (set the flow rate) 
Wait 1 
r=IpCrs2Write("DIRINF" & vbCr) (set the pump direction) 
Wait 1 
r=IpCrs2Write("VOL60" & vbCr) (set the displaced volume) 
Wait 1 
r=IpCrs2Write("PHN 4" & vbCr) (definition of the phase 4) 
Wait 1 
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r=IpCrs2Write("FUNLOP 10" & vbCr) (end the loop after 10 repeats) 
Wait 1 
r=IpCrs2Write("PHN 5" & vbCr) (definition of the phase 5) 
Wait 1 
r=IpCrs2Write("FUNSTP" & vbCr) (end the pump program definition) 
Wait 1 
(Here starts the acquisition procedure which is comp sed of a for loop. At each iteration, the 
shutter is opened, an image is acquired, then the shutter is closed and the pump program is 
started. The next iteration will start when the pum program is finished) 
r=IpCrs2Close()   (close the pump port) 
For i=1 To 100    (start a for loop with 99 repeats) 
r=IpCrs2InitPort(6,9600,8,0,0,1)  (initialize the RS232 port of the shutter) 
r=IpCrs2Open()    (open the port) 
r=IpCrs2Write("@")   (open the shutter) 
r = IpAcqSnap(ACQ_FILE)  (acquire an image) 
r=IpCrs2Write("A")   (close the shutter) 
r=IpCrs2Close()   (close the port) 
r=IpCrs2InitPort(5,9600,8,0,0,1)  (initialize the RS232 port of the pump) 
r=IpCrs2Open()    (open the port) 
r=IpCrs2Write("RUN" & vbCr)  (start the pump program) 
Wait 147    (waiting time for 147 seconds to let the pump program 
finish) 
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r=IpCrs2Close()   (close the port) 
Next i     (next iteration) 
Wait 1 
r=IpCrs2Close()   (close the port) 
End Sub    (end of the program) 
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Appendix M: CRS232C plug-in 
Asynchronous Serial Port Support Plug-In for Image Pro Plus V. 4.0 
This document will introduce you to a plug-in tool t  control the serial port of your computer 
from Image Pro Plus 4.0 (IPP). This is an original 232C asynchronous communication plug-in 
named CRS232C. 
This plug-in is asynchronous in the sense that it does not require to read the input buffer or wait 
for a response after sending a command. It supports a unilateral communication between the 
device and the 232C port. 
Installation 
 Click Start. 
 Select Run. 
 Type A:\Crs232c\menuinst.exe and press OK at the Run dialog box. 
 Select the destination directory and press OK. 
 The program will copy the necessary files and setup the corresponding entries at the 
 Image Pro Plus menus. 
 
CRS232C Asynchronous Communication Plug-In 
Function Description: 
 
Function Name: IpCrs2InitPort  
Description: Initial port setting. 
Parameters: 
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 Port:  Select the communication port to open. Valid values range from1 to 4. 
 Baudrate: Communication speed rate. Valid values are 9600, 48 0, 2400 and 1200. 
 Bits: Number of bits to transmit. 
 Parity:  Communication parity parameter. Valid values are NONE, ODD and EVEN  
  parity. 
 Flowctrl:  Communication flow control protocol. Valid values are XON/XOFF. 
 Stopbits: Stop bits are ONE, ONE and HALF and TWO. 
 
Function Name: IpCrs2Open  
Description: This function opens the serial port and starts the thr ads that will manage the 
asynchronous communication. 
Return Value: Returns 1 if successful and 0 otherwise. 
 
Function Name: IpCrs2Read  
Description: Reads the data received from the communication port.
Return Value: Returns 1 if successful and 0 otherwise. 
Parameters: 
 InData:  Text buffer that will contain the read data. 
 
Function Name: IpCrs2Write  
Description: Sends a string of characters to the communication port.
Return Value: Returns 1 if successful and 0 otherwise. 
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Parameters: 
 OutData: Text buffer with the data to be transmitted.. 
 
Function Name: IpCrs2Close 
Description: Close, and free the resources used by the communication port. 
Return Value: Returns 1 if successful and 0 otherwise. 
 
Function Name: IpCrs2Reset 
Description: Close and try to open the communication port used. This function is useful in case 
there is some bottleneck of data transmitted. 
Return Value: Returns 1 if successful and 0 otherwise. 
  
 
183 
Appendix N: THT fluorescence image of an amyloid beta peptide solution at 84 µM just 
after being injected in the microchannel. 
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Résumé étendu 
Les protéines thérapeutiques et leurs dispositifs médicaux associés sont de plus en plus utilisés 
dans le domaine de la santé. Le maintien de leur stabilité dans les procédés de production, 
stockage, transport et d’administration est une problématique majeure de l’industrie 
pharmaceutique. Dans ces procédés, les protéines peuvent perdre leur conformation native, 
conduisant à la formation d'agrégats insolubles. Le modifications chimiques, l'exposition à des 
forces de cisaillement (fort débit fluidique), la température, le pH et les interactions avec les 
matériaux et/ou les interfaces gazeuses sont autant de facteurs qui peuvent nuire à leur stabilité. 
L’injection d’une solution contenant des agrégats de protéines entraine une baisse de son 
efficacité et, dans le pire des cas, une réponse immunitaire non désirée. Il est donc primordial 
d’étudier et de comprendre les phénomènes physico-chimique altérant la stabilité des protéines 
afin concevoir au mieux les procédés industriels et de limiter les risques d’agrégation. 
L'insuline est une petite protéine de 51 acides aminés ntervenant dans la régulation du taux de 
glucose dans l’organisme. C’est une des protéines thérapeutiques les plus utilisées dans le cadre 
du traitement du Diabetes. Elle est, de plus,  bienconnue et souvent choisie pour des études de 
stabilité. En effet, celle-ci est peu stable et propice à l'agrégation. L’agrégation de l’insuline se 
traduit par la formation de fibres amyloïdes avec une structure bien spécifique (empilement de 
feuillet béta) et facilement caractérisables. Cette organisation de protéines particulière, dite 
amyloïde, est la cause de maladies neurodégénératives telles que Alzheimer ou Parkinson et du 
Diabetes de type 2. La formation des fibres amyloïdes n’est pas encore bien comprise et nécessite 
de plus amples investigations afin de pouvoir un jour guérir les maladies dont elles sont 
responsables. 
Dans cette thèse, nous étudions la stabilité des protéines thérapeutiques dans les procédés 
industriels. Nous concentrons notre étude sur la région où se rencontre une interface solide / eau 
et une interface air / eau, appelée triple interfac, ce qui semble essentiel pour la stabilité des 
protéines. En effet, lors du mouillage intermittent d’une surface, les interfaces air/liquide et 
liquide/solide se confondent en une seule et même interface, créant ainsi une zone favorisant 
fortement l'agrégation des protéines. Un exemple de mouillage intermittent, rencontré 
fréquemment dans les procédés industriels, est le passage du ménisque d’une solution de 
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protéines sur une surface solide (flacons ou tuyaux) lors de son agitation ou de son transport. 
Nous avons choisi d'utiliser l'insuline humaine comme modèle de protéine. Ce travail est organisé 
en deux parties: tout d’abord, nous avons étudié l’effet de la présence d'interfaces triples sur la 
cinétique d'agrégation de l'insuline, ensuite, nous avons observé et caractérisé, par microscopie de 
fluorescence, la croissance des fibre amyloïdes précisément à la triple interface. Pour cela, nous 
avons conçu une série d’expériences inédites dans lesquelles les interfaces solide-liquide et triple 
solide-liquide-air sont comparées directement, in situ et en temps réel.  
 
Le premier chapitre de résultats vise à démontrer l'effet accélérateur d'une triple interface solide / 
liquide / air en mouvement sur la cinétique d'agrégation de l’insuline. Une façon simple de créer 
des triples interfaces dynamiques est de remplir puis vider répétitivement une colonne avec une 
solution d’insuline. Afin d’augmenter le nombre de triples interfaces, des billes en verre ont été 
ajoutées dans la colonne (à la surface de chaque bille, une triple interface se crée lors du passage 
du ménisque de la solution). La quantité d'agrégats formés, en solution et à la surface des billes, a 
été quantifiée par fluorescence en utilisant un marqueur de conformation, la thioflavine T (THT). 
Chaque fois, deux expériences ont été exécutées en parallèle avec différentes conditions pour 
avoir les mêmes facteurs expérimentaux (température, âg  de la solution ...) permettant une 
comparaison directe de l’effet des différentes conditions expérimentales sur la cinétique 
d’agrégation. Nous avons observé que la création d'interfaces triples dynamiques sur les billes 
fonctionnalisées hydrophobes accélère considérablement la cinétique d'agrégation et que les 
forces de cisaillement appliquées aux protéines adsorbées à la surface des billes, dues au 
mouvement du liquide sur la surface, ne sont pas préjudiciables à la stabilité de l’insuline (la 
vitesse de cisaillement a été estimée à 491 s-1 au maximum). La quantité d'agrégats en solution 
est potentiellement quadruplée lorsque la surface des interfaces triples dynamiques est doublée et, 
après 8 heures d’expérience, environ 0,95% des protéines se sont agrégées. Nous avons 
également montré que moins d'agrégats étaient formés en solution en présence de billes 
fonctionnalisées hydrophiles et qu'aucun agrégat n'était formé à leur surface. Enfin, nous avons 
observé qu'une vitesse de balayage liquide plus rapide favorise l’arrachage des fibres amyloïdes 
de la surface des billes vers la solution. 
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Cette première étude a permis de souligner le rôle primordial de la triple interface dans le 
mécanisme d’agrégation d’une solution d’insuline sous agitation à pH 7 et 37 °C. Néanmoins, 
deux importantes questions demeurent sans réponse: ù t comment sont créées les fibrilles 
amyloïdes? Il n'est pas possible, avec cette expérience, d'observer le comportement du liquide 
afin de déterminer si les agrégats se forment à la triple interface. En outre, une visualisation en 
temps réel de la zone de triple interface est nécessair  pour comprendre pleinement l'effet 
d'interface triple dynamique sur l'agrégation HI. Par conséquent, une configuration complètement 
nouvelle, capable de localiser les premières fibrilles amyloïdes créées et de suivre leur croissance 
in situ et en temps réel est nécessaire. 
 
Le deuxième chapitre de résultats décrit tout d’abord la conception et l’instrumentation d’un 
dispositif expérimental inédit qui crée des interfaces dynamiques de manière contrôlée, répétable 
et observable et qui de plus permet la caractérisation, in situ et en temps réel, de la croissance des 
fibrilles amyloïdes sur une surface solide. Une telle configuration implique les spécifications 
suivantes: une caractérisation non destructive, à l'échelle micrométrique, à la fois de la 
morphologie du liquide et des fibres amyloïdes sur une surface solide, des mesures périodiques 
sur une longue période expérimentale, et une synchro isation entre le système microfluidique et 
la prise d’image. Le principe général de l’expérienc  consiste à faire des allers-retours avec une 
solution d’insuline à 0.5 g/L dans un canal microfluidique. Le marqueur fluorescent THT a été 
utilisé pour observer la formation des agrégats d’insuline et le contraste d'interférence (RICM), 
pour observer la morphologie le liquide résiduel à la surface du microcanal après le retrait de la 
solution. La force et l'originalité de notre expérience proviennent de la visualisation et de la 
quantification directe, en temps réel et in situ de la croissance des fibres amyloïdes à la triple 
interface et de comparer directement la cinétique d'agrégation d'insuline à l'interface liquide-
solide et à la triple interface. 
Lors de cette étude, nous avons démontré que les fibres amyloïdes d'insuline se forment 
principalement à la surface (COC, hydrophobe) du microcanal lorsque celle-ci est 
alternativement mouillée puis séchée. En effet, à la fin de l'expérience, aucun agrégat d'insuline 
n'a été détecté dans la région constamment mouillée du microcanal, par contre, dans la région 
alternativement mouillée puis séchée, la formation d'agrégats d'insuline suit une cinétique 
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classique, déjà largement documentée dans la littérature. Dans les mêmes conditions, aucun 
agrégat n’est formé avec une solution de BSA ou dans un microcanal en verre (hydrophile). Nous 
avons aussi étudié l'agrégation de l'insuline en présence de tensioactifs (Tween20® et Tween80® 
à 200 ppm) et là encore, aucune agrégation n'a été observée confirmant que les tensioactifs 
empêchent les protéines d'adsorber à des interfaces hydrophobes et donc d'agréger. 
La croissance des agrégats de protéines à la surface a ensuite été caractérisée. Nous avons montré 
que des gouttelettes de liquide laissées à la surface du microcanal, après le retrait de la solution, 
sont ancrées par une couche de protéine adsorbée et qu'elles se reforment au même endroit aller-
retour après aller-retour. Nous avons observé que la formation de fibres amyloïdes ne se faisaient 
qu’au voisinage des gouttelettes liquides, là où les interfaces solide / liquide et air / liquide se 
rencontraient, démontrant ainsi que l'interface triple est un endroit privilégié pour l'apparition de 
l'agrégation. Nous avons aussi montré que la quantité totale de fibrilles amyloïdes HI créée a 
augmenté de façon exponentielle avec le nombre d’aller-retour jusqu’à ce qu’un film de fibres 
amyloïdes recouvrent entièrement la surface du microcanal. Une fois cette couche d’agrégats 
formée, elle retient un film liquide même après le retrait de la solution empêchant la formation de 
nouveaux agrégats. 
Suite à ces observations, nous avons construit un modèle mathématique décrivant la croissance 
des agrégats observée à la triple interface et reposant sur deux principes : la formation de 
nouveaux agrégats augmente avec la déshydratation des protéines et avec la quantité de fibres 
amyloïdes déjà créées. Nous faisons l’hypothèse que les nouvelles fibres se développent à 
l’extrémité des fibres existantes lorsque celles-ci ont été exposées à l’air. Notre modèle prédit 
que, à chaque aller-retour, la couche amyloïde de surface est prolongée radialement de 0,397 ± 
0,006 µm. 
Dans un dernier chapitre, nous discutons de la possibilité de la formation d’agrégats à l’interface 
air / liquide, qui semble finalement être peu probable dans le cas de l’agrégation d’une solution 
d’insuline sous agitation à 37 °C et pH 7 et nous proposons un mécanisme pour la formation de 
noyaux d'agrégation d’insuline à l'interface triple: l  contact entre une interface air / liquide et 
une interface solide / liquide favorise l’interaction entre les monomères d’insuline adsorbés aux 
interfaces air / liquide et solide / liquide et leur auto-assemblage en remplaçant des interactions 
protéine-eau, énergiquement défavorable, par des int ractions protéine-protéine.  
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Nous évoquons ensuite divers phénomènes physiques, comme l’effet Marangoni, qui pourraient 
intervenir lors du séchage d’une goutte de liquide laissée temporairement exposée à l’air, puis 
nous proposons deux voies différentes pour la croissance des fibres amyloïdes: 
(i) Un mécanisme de croissance en phase liquide: 
Pendant la phase de séchage (lorsque le liquide se r tir ), les agrégats suffisamment exposés à 
l'air subissent une réorganisation conformationnelle. Ce réarrangement conformationnel permet 
aux fibres amyloïdes (déjà formées) d’incorporer des protéines d’insuline natives de la solution 
lors de phase liquide suivante. 
 (ii) un mécanisme de croissance en phase de séchage: 
Au début de la phase de séchage, les protéines restent adsorbées sur les fibres amyloïdes déjà 
formées sur la surface du microcanal. Les protéines adsorbées qui sont suffisamment exposées à 
l'air subissent une transition de structure secondaire pour former de nouvelles fibres amyloïdes au 
contact des plus anciennes. Ensuite, pendant la phase de mouillage suivante, les molécules de 
THT sont incorporées dans les fibres amyloïdes nouvellement formées. 
En conclusion, nos travaux ont montré que la création d'interfaces triples dynamiques, 
phénomène rencontré dans la plupart des procédés industriels pharmaceutiques pour les 
formulations liquides et lyophilisées, est une cause majeure d'instabilité des protéines. Le 
contrôle de l'adsorption interfaciale des protéines, en utilisant des matériaux hydrophiles adaptés 
ou des additifs tels que les polysorbates pour concurrencer l'adsorption des protéines, et des choix 
judicieux de circuits fluidiques, minimisant les bulles d’air, les interfaces hydrophobes et les 
phénomènes de mouillage intermittent, réduisent considérablement les risques d'agrégation des 
protéines. 
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Therapeutic protein aggregation at the triple interface air-liquid-solid: relevance to medical devices for drug 
delivery 
Agrégation des protéines thérapeutiques à l'interface triple solide/liquide/air : application aux dispositifs 
médicaux pour l'administration de médicaments 
Abstract: 
Due to the high specificity of their interactions, proteins are increasingly used in therapy and represent a vast 
majority of the global pharmaceutical market. Neverth less, these molecules are fragile and therapeutic protein 
stability is a major concern in pharmaceutical industry. Protein degradation and aggregation can occur at every step 
during production, storage, transport and delivery. In this thesis, we interrogate the possible role of intermittent 
wetting in protein aggregation. Intermittent wetting frequently occurs in protocols involving pumping (cavitation), 
agitation, and liquid handling. During intermittent wetting, the air/liquid and liquid/solid interfaces meet at a triple 
line or triple interface, which is a local trigger for protein aggregation because it concentrates the mechanical action 
of the recessing fluid on the surface adsorbed proteins. We study the effect of surface intermittent we ting on insulin 
aggregation. Our results demonstrate that the triple interface line, where an air/water interface meets a hydrophobic 
surface, allows progressive protein accumulation, and finally triggers local insulin aggregation. We also show that 
shear stress, alone, is not detrimental for protein stability. Additionally, Additives such as polysorbates were tested, 
showing that the modification of the surface tensio of a protein solution impacts its ability to form aggregates. 
Based on this work, we propose recommendations for the design of drug delivery and preparation devices in order to 
limit the risk of protein aggregation at the triple interface. 
Résumé : 
En raison de leur haute spécificité d’interaction, les protéines thérapeutiques sont de plus en plus utili ées et 
représentent une part majoritaire du marché pharmaceutique. Néanmoins, ces molécules sont fragiles et leur stabilité 
est une problématique majeure pour l'industrie pharmaceutique. La dégradation des protéines thérapeutiques peut 
survenir à chaque étape de leur cycle de vie : production, stockage, transport et administration au patient. Les 
modifications chimiques, l'exposition à des forces d  cisaillement (fort débit fluidique), la température, le pH et les 
interactions avec les matériaux et/ou les interfaces gazeuses sont autant de facteurs qui peuvent nuire à la stabilité de 
ces protéines. De plus, l'utilisation croissante de dispositifs médicaux automatisés pour la manipulation et l'injection 
de protéines thérapeutiques augmente drastiquement le risque de dégradation. Dans cette thèse, nous étudions l’effet 
et le rôle de la triple interface solide/liquide/air sur l'agrégation des protéines. Ce phénomène se produit fréquemment 
dans les procédés de manipulation d’une solution de protéines thérapeutiques (cavitation, agitation…). Lors d’un 
mouillage intermittent, les interfaces air/liquide et liquide/solide se confondent en une seule et même interface 
appelée triple interface ou ligne triple. La ligne triple est une zone favorisant fortement l'agrégation des protéines. 
Notre étude, basée sur l’insuline, montre que la ligne triple cause une accumulation progressive de protéines qui 
déclenche, après une période de nucléation, leur agrég tion, précisément à l’endroit de cette ligne triple. Nos 
résultats démontrent aussi que les forces de cisaillement, seules, n’entrainent pas l’agrégation de l’insuline. De plus, 
nous observons que la diminution de la tension superficielle (induite par l’ajout de polysorbates) d'une solution de 
protéines  réduit le risque de formation d’agrégats. En conclusion de ce travail, nous proposons des recommandations 
pour la conception des dispositifs médicaux de préparation et d’administration de protéines thérapeutiques. 
 
